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 Type I diabetes mellitus (T1DM) is an autoimmune disease caused by auto-
reactive T-cell-mediated destruction of insulin-producing β-cells. Effective encapsulation 
strategies can protect the transplanted islets from direct attack by host immune cells while 
maintaining insulin secretion. To achieve this goal, I have developed a hydrogel 
conformal coating using a visible light-mediated interfacial thiol-ene 
photopolymerization. Unlike conventional chain-growth visible light polymerizations, no 
additional cytotoxic co-initiator or co-monomer was required in thiol-ene gelation 
scheme for rapid gelation. More importantly, islets coated with thiol-ene gel maintained 
their viability and function in vitro. In addition to microencapsulate β-cells, the second 
objective of my dissertation focuses on developing a macroencapsulation technique using 
thiol-ene hydrogel with bioactivity and anti-inflammatory property. While islet 
transplantation holds potential in permanently reversing T1DM, this procedure initiates a 
cascade of inflammatory processes. To address this issue, we have developed thiol-ene 
hydrogel crosslinked by thiolated β-cyclodextrin (βCD). The conjugation of amphiphilic 
βCD affords enhanced loading and prolonged release of curcumin, an anti-inflammatory 
drug candidate but with poor water solubility. In addition, bioactive peptide such laminin-
derived peptide flanked with two cysteine residues could be readily incorporated through 
orthogonal crosslinking, thus mimicking extracellular microenvironment in the pancreatic 
islets. Finally, in order to provide coated β-cells with an ideal biomechanical 
microenvironment, it is essential to identify a suitable gel stiffness to support the viability 
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and functions of β-cells. To this end, a thiol-allylether hydrogel with on-demand tunable 
matrix stiffness was developed. Specifically, host molecule βCD was immobilized in the 
hydrogel network to provide binding sites for soluble guest molecule poly(ethylene 
glycol)-adamantane. Gel stiffness was tuned through introducing reversible host-guest 
interactions. After in situ stiffening of the cell-laden hydrogel, the encapsulated β-cells 
showed increased in insulin mRNA expression, suggesting the profound impact of matrix 









 In 2012, 29.1 million of Americans were diagnosed with diabetes. Among them, 
1.3 million have suffered from Type 1 diabetes mellitus (T1DM), which is an 
autoimmune disorder caused by auto-reactive T-cells that destroy insulin-producing 
pancreatic β-cells in the islets of Langerhans [1]. The destruction of β-cells leads to 
inadequate insulin secretion, which leads to hyperglycemia. Current standard of therapy 
to restore glucose homeostasis is through multiple daily insulin injections or implantation 
of insulin delivery devices [2]. However, tight glycemic control through insulin 
administration requires frequent monitoring of blood glucose levels. In addition, patients 
experience various degrees of discomfort from exogenous insulin delivery. While whole 
pancreas or islet transplantation can provide T1DM patients with insulin-independence, 
these approaches are reserved for diabetic patients with hypoglycemia unawareness due 
to a significant shortage of donor organs [3-5]. The outcome of islet transplantation, 
however, is heavily influenced by blood mediated inflammatory response (IBMIR), 
which can destroy more than half of the transplanted islets shortly after surgery [6-8]. 
Furthermore, patients receiving donor islets are required to undergo lifelong 
immunosuppressant therapy. In order to improve the lifespan of transplanted islets, 
scientists and engineers have been developing encapsulation technologies to separate 
allogenic or even xenogenic islets from host tissues [9-18]. To this end, 
microencapsulation and macroencapsulation strategies have been introduced as devices to 
improve the outcome of islet transplantation [19-24]. Table 1.1 summarizes the 
advantages and disadvantages of each encapsulation approach. A successful 
permselective immune isolation barrier should be able to prevent infiltration of host 
immune cells while permitting facile exchange of nutrients and metabolites, 
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including oxygen, glucose, and insulin [2]. More importantly, this encapsulation strategy 
should support the survival and preserve the functions of cells. 
 
Table 1.1. Advantages and disadvantages of microencapsulation and macroencapsulation 
techniques 
 Microencapsulation Macroencapsulation 
Advantages 
 Reduced diffusion barrier 
 Low transplant volume  
 Easy to retrieve transplant 
 Easy to incorporate 
biomolecules 
 Easy to characterize material 
properties 
Disadvantages 
 Difficult to retrieve 
transplants 
 Difficult to incorporate 
biomolecules 
 Difficult to characterize 
physical properties of 
materials 
 Hindered permeability 
 Higher transplant volume 
 
The global goal for this dissertation is to develop microencapsulation and 
macroencapsulation techniques for synthesizing biomimetic materials to overcome some 
of the challenges facing islet transplantation. Thiol-ene hydrogels formed by radical 
mediated photopolymerizations have emerged as a versatile biomaterial platform for 
controlled release and tissue engineering applications. Chapter 2 of this dissertaion 
includes the mechanisms and the applications of thiol-ene photopolymerization. During 
my graduate studies, I have developed a cytocompatible visible light mediated step-
growth thiol-ene polymerization scheme. The focus of this dissertation was to capitalize 
on this innovative gelation chemistry for the development of microencapsulation and 
macroencapsulation techniques to encapsulate β-cells. The following specific objectives 
are proposed: 
 
Objective 1: Establish a visible light mediated interfacial thiol-ene 
photopolymerization for microencapaulation of islets. In Chapter 3, a cytocompatible 
visible light-mediated interfacial thiol-norbornene photopolymerization scheme was 
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developed for creating hydrogel conformal coating on pancreatic islets. I investigated the 
tunability of this microencapsulation technique, as well as the viability and function of 
coated islets.  
 
Objective 2: Synthesize biomimetic and anti-inflammatory thiol-ene hydrogel for 
macroencapsulation of β-cells. To suppress the potential inflammatory response, I have 
developed thiol-ene hydrogel crosslinked by either thiolated β-cyclodextrin (βCD) 
derivative (Chapter 4). βCD derivatives were synthesized and characterized for the 
crosslinking of βCD-PEG hybrid hydrogels via radical-mediated thiol-ene 
photopolymerizations. Further investigation was conducted on the delivery of a model 
hydrophobic drug, and the testing of the cytocompatibility of these step-growth 
hydrogels. To introduce biofunctionality to the otherwise inert thiol-ene hydrogels, in 
Chapter 5, a laminin-derived peptide flanked with two cysteine residues were readily 
incorporated through orthogonal crosslinking to recapitulate islets extracellular 
microenvirnment to support β-cells survival. 
 
Objective 3: Investigate the effect of biomechanical stimulus on the survival of β-
cells. Utilizing thiol-ene hydrogel that contains chemically immobilized βCDs, the 
mechanical properties of the hydrogels could be tuned via host-guest interactions 
between βCD and adamantane functionalized PEG. The development and 
cytocompatibility of this hydrogel platform were included in Chapter 6. Most 
importantly, I evaluated the effect of biomechanical changes on the viability and 



















2.1  Abstract 
 
 Thiol-ene hydrogels formed by radical mediated photopolymerizations have 
emerged as a versatile biomaterial platform for controlled release and tissue engineering 
applications. In this step-growth photopolymerization scheme, multi-arm poly(ethylene 
glycol)-norbornene (PEGNB) reacts with dithiol or bis-cysteine containing cross-linkers 
to form chemically cross-linked hydrogels. Thiol-ene hydrogels can be prepared via UV 
light or visible light irradiation, depending on the type of photoinitiator used. Thiol-ene 
reaction is not oxygen inhibited, which yields a rapid gelation kinetics. The step-growth 
polymerization affords an idealized network structure with independently tunable 
biochemical and biophysical matrix properties. Thiol-ene hydrogels can be rendered 
completely non-degradable, degradable only by hydrolysis, proteolysis, photolysis, or by 
the combination of different mechanisms. If PEG-ester-norbornene (PEGeNB) is used, 
the gels can be degraded hydrolytically due to the presence of ester bonds within the 
macromer. On the other hand, the use of PEG-amide-norbornene (PEGaNB) renders the 
gels hydrolytically stable. If cell-mediated or user-controlled gel degradation is desired, 
bis-cysteine peptide linker containing enzyme-sensitive or photolabile sequence can be 
used to cross-linked the gels. The capability of thiol-ene hydrogels to undergo diverse 
gelation and degradation permits researchers to design versatile hydrogel matrices 
suitable for protein delivery and three dimensional (3D) cell culture. Due to the 
 
 
Chaper 2 here is as appeared in Chapter 12 by H. Shih and C. Lin, Biodegradable Polymers. Volume 2: 




orthogonal nature of the thiol-ene reaction, post-gelation modification in the presence of 
cells can be easily achieved, given that sufficient norbornene groups are available 
following the initial gelation. This attractive feature allows researchers to introduce 
biochemical motifs, in a spatial-temporally controlled manner, to guide cell 
morphogenesis in 3D. 
 
 
2.2  Introduction 
 
2.2.1  Photopolymerization to Prepare Hydrogels 
 
 Photo-initiated radical polymerizations have received significant attention for in 
situ cell encapsulation and controlled delivery of biological molecules, in large part due 
to rapid and ambient gelation conditions and the stability of the covalently crosslinked 
networks [25-30]. Synthetic macromers are increasingly developed for radical-mediated 
hydrogel synthesis. Depending on the reactivity of the macromer functional groups, 
hydrogels can be prepared from chain-growth, step-growth, or mixed-mode 
photopolymerization [31]. In chain-growth photopolymerization (Figure 2.1A), vinyl 
monomers/macromers are cross-linked into hydrogels due to propogation of carbonyl 
radicals across the unsaturated vinyl groups. In step-growth photopolymerization, cross-
linking occurs between two mutually reactive groups located on multi-functional 
macromers (Figure 2.1B). A mixed-mode polymerization is the combination of both 
chain-growth and step-growth polymerizations, given that the macromer used (e.g., 








Figure 2.1. Schematics of hydrogels formed by: (A) Chain-growth photopolymerization 
using linear homo-bifunctional macromer to produce a heterogeneous network. (B) Step-
growth photopolymerization of multifunctional and mutually reactive monomers. An 




2.2.2  Photoinitiation Systems for the Polymerization of Hydrogels 
 
 Radical-mediated photopolymerization is a well-established technique to prepare 
hydrogels for biomedical applications. Typically, a light source that emits lights in the 
cytocompatible wavelengths (e.g., λ > 365 nm) is used to excite photoinitiator molecules. 
Following light exposure, a type I or cleavage-type photoinitiator (Figure 2.2) readily 
absorbs photons from the light source and decomposes into two primary radicals to 
initiate gelation [33]. On the other hand, a type II photoinitiator abstracts hydrogen from 
a co-initiator, thus generating secondary radicals that initiate crosslinking [33-35]. 
Adequate solubility of a photoinitiator in an aqueous solution and sufficiently high molar 
absorptivity at cytocompatible wavelengths are major factors concerning the suitability of 
a photoinitiator to initiate photopolymerization for preparing cytocompatiblie hydrogel. 
Only a few photoinitiators fulfill these criteria, such as type I initiators Irgacure-2959 (I-
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2959, Figure 2.2A) [36, 37] and lithium arylphosphanate (LAP, Figure 2.2B) [38], as 
well as type II initiator eosin-Y [34, 35, 39]. Commercially available I-2959 has low 
water solubility (< 0.5 wt%) and low molar absorptivity at cytocompatible wavelengths 
(e.g., at 365nm , ε < 10 M-1cm-1).  In addition, I-2959 cannot be used in visible light-
mediated photocrosslinking due to its near zero molar absorptivity at wavelengths higher 
than 400 nm.  While LAP is highly water-soluble (> 5 wt%) and has high absorbance at 
365 nm (ε ~ 200 M-1cm-1), its excitability in visible light range is limited (ε ~ 30 M-1cm-1 
at 405 nm) [38]. On the other hand, type II photoinitiator such as eosin-Y is highly water 
soluble and can be readily excited by visible light (ε > 100,000 M-1cm-1 at 515 nm). 
Eosin-Y has been used to initiate the gelation of chain-growth poly(ethylene glycol) 
diacrylate (PEGDA) hydrogels. Unfortunately, a co-initiator (e.g., triethanolamine, TEA) 
is required for generating sufficient radicals and a co-monomer (e.g., 1-vinyl-2-
pyrrolidinone, NVP) is often used to achieve high and rapid functional group conversion. 
The adjustment of various gelation components can be complicated and this is perhaps 
why UV-mediated photopolymerizations, even with potential biosafety concerns, is still a 







          






Chain-growth polymerized network 
 Hydrogels crosslinked by radical-mediated chain-growth photopolymerization 
have been used for numerous drug delivery and tissue engineering applications. In 
general, any hydrophilic macromer with terminal or internal vinyl groups can be cross-
linked into hydrogel via chain-growth polymerization, as long as the vinyl groups are 
capable of undergoing homopolymerization. Poly(ethylene glycol) diacrylate or 
dimethacrylate (PEGDA or PEGDM, Figure 2.3) are among the most commonly used 
macromers for preparing chain-growth hydrogels. Typically, a cleavage type 
photoinitiator is used in conjunction with a UV light source to generate radicals for 
initiating the cross-linking process. This reaction can be carried out in aqueous solution 
and under mild reaction conditions, making it suitable for in situ protein or cell 
encapsulation. The crosslinking density of the chain-growth hydrogels can be tuned by 
adjusting light exposure time or by altering the concentrations of the starting macromers. 
However, free radicals initially generated from photoinitiators have long half-life in 
chain-growth polymerization due to the continuous propagation of the radical species 
along the vinyl groups [40]. When performing in situ cell or protein encapsulation, these 
radicals may increase cellular damage, protein denaturation, or undesired protein-
polymer reactions.  
 






Figure 2.3. Structures of PEGDA (A), PEGDM (B), and acryalted PLA-PEG-PLA (C). 
 
 Furthermore, these chain-growth hydrogels are typically non-degradable in a mild 
aqueous environment. Degradable hydrogels are particularly useful as provisional 
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matrices for tissue regeneration and as carriers for controlled protein delivery [41-44]. 
Among all degradation mechanisms, hydrolytic degradation of synthetic hydrogels has 
received significant attention due to the simplicity of hydrolysis mechanism and well-
defined polymer chemistry [45-47]. Although it is possible to render PEG hydrogels 
degradable, it requires the synthesis of macromers with build-in degradability. For 
example, hydrolytically degradable block co-polymer such as PLA-PEG-PLA (PLA: 
polylactic acid) can be synthesized through ring-opening co-polymerization of PEG and 
lactide. After end-capping the linear co-polymer with acrylates, the resulting macromers 
(Figure 2.3C) can be polymerized into a chain-growth network with various degrees of 
hydrolytic degradability, depending on the number of lactide units incorporated in the 
PLA blocks. Hydrogels prepared from these block copolymers are hydrolyzed to form 
lactic acid and PEG [45, 46]. The hydrolytic degradation rate of these hydrogels could be 
tuned and predicted by using copolymers with different lengths of lactide repeating units 
[45, 46].  
In addition to the PLA-PEG-PLA copolymers, other hydrolytically labile 
hydrogels were prepared by incorporating ester bonds to the termini of PEG macromers 
prior to acrylation or methacrylation [48, 49]. Regardless of their degradability, 
homopolymerized vinyl-based hydrogels contain heterogeneous and dense hydrophobic 
polyacryalte kinetic chains (Figure 2.1A) that may cause adverse effects on the stability 
of the encapsulated molecules. These high molecular weight polyacrylate kinetic chains 
are not degradable [50], which could cause difficulty in clearance in vivo.  
 
Step-growth thiol-ene network 
In addition to chain-growth photopolymerized network, hydrogels can also be 
prepared via a radical mediated step-growth photopolymerization. Anseth and colleagues 
introduced a new class of PEG-based hydrogels formed by radical-mediated orthogonal 
thiol-ene photo-click reaction [38]. In this system, low intensity and long wavelength (5 – 
10 mW/cm2, 365 nm) UV light was used to generate thiyl radicals from thiol-containing 
molecules (e.g., bis-cysteine-containing oligopeptides). These thiyl radicals react with 
ene moieties on norbornene-functionalized multi-arm PEG to create orthogonal thiol-
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ether linkages and a step-growth network (Figure 2.4A). Central to this gelation scheme 
is the multi-arm PEG macromers, which can be synthesized through either esterification 
of hydroxyl-terminated multi-arm PEG with norbornene acid or amide bond formation 
between amine-terminated multi-arm PEG with norbornene acid. The thiol-ene hydrogels 
obtained from this thiol-ene photoclick chemistry can be degraded hydrolytically via 
ester bond hydrolysis if PEG-ester-norbornene (PEGeNB) is used to form thiol-ene 
hydrogels (Figure 2.4B). Conversely, the gels remain hydrolytically stable when PEG-
amide-norbornene (PEGaNB) is used (Figure 2.4C). This thiol-ene reaction scheme 
preserves all advantages offered by photopolymerizations, including rapid, ambient, and 
aqueous reaction conditions, as well as spatial-temporal control over gelation kinetics. 
Furthermore, step-growth thiol-ene photo-click reactions are not oxygen inhibited [51], 
which is beneficial for achieving rapid gelation compared with acrylate-based chain-
growth photopolymerizations at equivalent macromer functionality [52]. Comparing with 
step-growth Michael-type gelation, thiol-ene photo-click reactions have reduced disulfide 
bond formation due to radical-mediated cleavage [53],  thus increasing the extent of 
crosslinking and higher mechanical properties at a similar macromer content [38]. 
Furthermore, the orthogonal and step-growth nature of norbornene-sulfhydryl reaction 
permits dynamic modification of hydrogel biochemical and biophysical properties in the 
presence of cells [38]. Several cell types have been encapsulated successfully using thiol-
ene hydrogels, including human mesenchymal stem cells [54], fibroblasts [38, 55], 
fibrosarcoma [55], valvular insterstitial cells [56], and radical-sensitive pancreatic -cells 
[52]. Enzymatically degradable peptides could be utilized to crosslink thiol-ene hydrogels 
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Figure 2.4. (A) Mechanism of radical-mediated thiol-ene photo-click reaction. (B) 





 Early works on thiol-ene gelation have focused on the use of UV light and 
cleavage-type initiators. Recently, Lin and colleagues developed visible light mediated 
thiol-ene gelation using a type II photosensitizer eosin-Y as the sole photoinitiator [58, 
59]. Mechanistically, visible light (400-700 nm) excites eosin to abstract hydrogen atoms 
from thiol-bearing molecules, which generate thiyl radicals that cross-link with 
norbornene groups through the same radical-mediated thiol-ene photo-click reactions 
(Figure 2.4A). In this gelation scheme, no co-initiator or co-monomer is needed to 
achieve gelation, thus improves the cytocompatibility of the gelation system for in situ 
cell encapsulation (Shih and Lin, 2013). 
 
 
2.3  Thiol-ene Hydrogel Network Crosslinking 
 
2.3.1  Improved gelation kinetics and efficiency 
 
 Hydrogels can be prepared by photopolymerization through either a chain-growth 
or a step-growth mechanism. While conventional chain-growth radical 
photopolymerization is sensitive to inhibition by molecular oxygen, orthogonal thiol-
norbornene or thiol-ene photo-click reaction is not oxygen inhibited. Therefore, it yields 
rapid gelation kinetics and higher degree of functional group conversion [51, 60]. 
Experimentally, it was determined that at the same functional group concentration, the 
gelation of step-growth thiol-norbornene reaction occurs 20-time faster than acrylate-
based chain-growth photopolymerization (e.g., gel points of 3 to 7 seconds for thiol-
norbornene reaction and 1 to 2 minutes for acrylate-based homopolymerization). 
Hydrogels prepared from thiol-norbornene photopolymerization of PEG-based 
macromers also have higher gel fraction and stiffness compared with acrylate-based 
hydrogels with the same functional group concentrations [52]. For example, step-growth 
hydrogels prepared from PEG4NB and a peptide cross-linker Cys-Gly-Gly-Tyr-Cys 
exhibited consistently high gel fractions of 92-95%, whereas chain-growth hydrogels 
based on homopolymerization of PEGDA only yielded gel fractions of 63-84%. 
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Hydrogels with high gel fraction are desirable because the unreacted macromer 
components (due to lower gelation efficiency) may leach out from the hydrogels and 
complicated experimental results, especially for in vivo studies.  
 
2.3.2  Improved network ideality 
 
 While both are initiated from light-induced radical-mediated 
photopolymerization, step-growth thiol-norbornene hydrogels formed with multi-arm 
PEG-norbornene (e.g., PEG4NB) have a completely different network structure 
compared with chai-growth homopolymerization of PEGDA. Another hydrogel system 
formed by a step-growth reaction is the Michael-type addition reaction. For example, 
multi-arm PEG-acrylate or PEG-vinylsulfone reacts orthogonally with thiol-terminated 
cross-linkers to yield a step-growth hydrogel network [61]. Although these step-growth 
hydrogels are useful in in situ cell encapsulation and protein delivery, they are known to 
have slower gelation kinetics at a physiological pH (minutes to hours) as compared with 
radical-mediated step-growth thiol-ene gelation (seconds to minutes). Recently, Shih and 
Lin compared the gelation kinetics of PEG-based hydrogels formed by these two types of 
step-growth polymerized hydrogels, namely radical-mediated thiol-ene photo-click 
reaction and Michael-type conjugation addition [62]. In this study, 4-arm PEG-
norbornene (PEG4NB) and 4-arm PEG-acrylate (PEG4A) having the same molecular 
weight (MWA = 20 kDa) and functionality (fA = 4) were used as the macromers, while 
dithiothreitol (DTT) was used as a bi-functional (fB = 2) cross-linker in both systems. In 
situ rheometry was used to monitor the gelation kinetics. As shown in Figure 2.5, the 
radical-mediated thiol-norbornene gelation exhibited much faster (>250-fold faster) gel 
points when compared with gelation caused by Michael-type addition reaction. Michael-
type hydrogels formed from PEG4A and DTT also had a significantly lower shear 




A.       B.  
       
Figure 2.5. In situ rheometry of step-growth hydrogels: (A) Thiol−ene photoclick 
polymerization (4 wt % PEG4NB-DTT). UV light was turned on at 30 s. (B) Michael-
type addition (4 wt % PEG4A-DTT). Temperature reached 37 °C at 15 s [62]. 
 
Apart from the difference in gelation kinetics, these two step-growth gelation 
systems (i.e., thiol-norbornene and thiol-acrylate Michael-type) also exhibit different 
degrees of network non-ideality. In principle, hydrogels prepared from an orthogonal 
reaction should have the same network structure if there is no non-ideality in 
polymerization. Specifically, at an identical macromer concentration and without any 
structural defect, hydrogels crosslinked by these macromers should have the same degree 





      (2.1) 
where WSwollen is hydrogel swollen weight and WDry is the dried polymer weight.  
A perfectly crosslinked (or ‘ideal’) thiol-ene or Michael-type hydrogel network 
without defects can be estimated by means of hydrogel equilibrium swelling [63]. 
Considering the structural information of the step-growth hydrogels (i.e., macromer 
molecular weight and functionality), the average molecular weight between crosslinks 
(𝑀𝑐̅̅ ̅̅ ) is defined as [63]:  






)      (2.2) 
Here, MWA and MWB represent the molecular weight of PEG4NB (or PEG4A) 
and crosslinker, respectively. fA and fB are the number of reactive functionality for 
PEG4NB (or PEG4A) and crosslinker.  With a known 𝑀𝑐̅̅ ̅̅ , the ideal network crosslinking 
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density or density of elastically active chains (vc) and polymer volume fraction (v2) can 
be calculated based on the Flory-Rehner theory [64]:  
𝑣𝑐 =
𝑉1







          (2.3) 
Here,  𝑣2̅̅ ̅ is the specific volume of PEG (0.92 cm
3/g at 37 oC), V1 is the molar 
volume of water (18 cm3/mole) and ᵡ12 is the Flory-Huggins interaction parameter for a 
PEG-H2O system (0.45).  After obtaining v2, ideal hydrogel mass swelling ratio q can be 




      (2.4) 
where 𝑣1̅̅ ̅ is the specific volume of water (1.006 cm
3/g at 37 oC). 
Based on Equation (2.2), the molecular weight between crosslinks (𝑀𝑐̅̅ ̅̅ ) of these 
two step-growth hydrogel systems without defect should be identical (neglecting the 
minor difference in the molecular weight of norbornene and acrylate moiety) and was 
calculated as 10,154 Da (Table 2.1).  Thus, the ideal crosslinking density or density of 
crosslinked elastic chains (vc) for these step-growth hydrogels was estimated to be 
1.93×10-3 using Equation (2.3).  Accordingly, the mass swelling ratio of a perfectly 
crosslinked step-growth hydrogel (qeq, ideal) was calculated as 9.6 using Equations (2.3) 
and (2.4) (Table 2.1 and dashed line in Figure 2.6).  Experimentally, however, we found 
that thiol-ene hydrogels, when compared to Michael-type gels at identical macromer 
compositions, had lower mass swelling ratio (28.5 ± 2.2 vs. 44.5 ± 3.8) at the equilibrium 
state [62]. This indicates that radical mediated thiol-ene hydrogels exhibit higher degree 
of network ideality compared to gels formed from Michael-type addition. These results 
confirmed a previous notion that radical-mediated thiol-ene reaction, when compared to 
Michael-type conjugation reaction, produce step-growth hydrogels with faster gelation 
kinetics, less structural defects, higher degree of crosslinking, and improved gel 




Table 2.1. Characteristics of step-growth Michael-type and thiol-ene hydrogels [62] 
 𝑴𝒄̅̅ ̅̅  (Da) qeq, ideal qeq, actual 
PEG4A* (Michael-type) 10,154 9.6 44.5 ± 3.8 
PEG4NB* (Thiol-ene) 10,154 9.6 28.5 ± 2.2 
*4-arm PEG-derivatives (4 wt%, 20 kDa), crosslinked by DTT. 
 
 
2.3.3  Tunable crosslinking density of thiol-norbornene hydrogels 
 
 Based on the Flory-Rehner theory, an ‘ideal’ step-growth network with a fixed 
macromer composition and without defect should only have a single equilibrium swelling 
ratio [62]. With the same gel formulation, the swelling ratio should be independent of 
macromer concentrations at equilibrium swelling state. However, the experimental 
equilibrium mass swelling ratios of thiol-norbornene hydrogels exhibited high 
dependency on PEG4NB macromer concentration, indicating the existence of network 
non-ideality (Figure 2.6).  For instance, when the concentration of PEG4NB macromer 
was increased from 4 wt% to 20 wt%, swelling ratios decreased from ~29 to ~12 and 
approached ideal equilibrium swelling ratio (~9.6). Hydrogels with lower swelling ratios 
(at higher macromer contents) had higher elastic moduli. This inverse relationship was 
commonly observed in chain-growth polymerized hydrogel networks. The result 
suggested a higher possibility of network defects formed at lower PEG4NB contents. 
When cross-linked at a low macromer concentration, step-growth photopolymerization 
tends to yield more intramolecular reactions (i.e., primary cycles) [63, 66, 67] . On the 
other hand, at a higher macromer concentration, the probability of forming intermolecular 
cross-linking increases. The outcomes of increased intramolecular reactions at lower 
macromer concentrations include higher gel swelling and lower gel modulus (Figure 2.6). 
Although thiol-ene hydrogels contain network defects at lower polymer contents, the 
stiffness of these hydrogels is physiologically relevant (shear moduli between 1 to 10 






Figure 2.6. Effect of PEG4NB macromer concentration on thiol-ene hydrogel equilibrium 
swelling (left y-axis) and elastic modulus (right y-axis). Swelling ratio of an ideal 
network was calculated based on the molecular weight between crosslinks (𝑀𝑐̅̅ ̅̅ ) of given 
macromer molecular weights (MWPEG4NB = 20 kDa, MWDTT = 154 Da) and 
functionalities (fPEG4NB = 4, fDTT = 2) [62]. 
 
 
2.4  Degradation of Thiol-ene Hydrogel 
 
2.4.1  Hydrolytic degradation 
 
In addition to the chain-growth polymerized hydrogels, step-growth polymerized 
gels could also be rendered hydrolytically degradable. For example, Hubbell and co-
workers developed Michael-type addition hydrogels through nucleophilic reactions 
between acrylates on multi-arm PEG macromer and sulfhydryl groups on the crosslinkers 
[63]. Thioether-ester linkages formed between acrylate and sulfhydryl moieties were 
hydrolytically labile and the degradation rates of these hydrogels could be tuned by 
controlling macromer concentration and functionality. Bowman and colleagues 
performed experimental and theoretical investigations on hydrolytic degradation of step-
growth thiol-acrylate and thiol-allylether photopolymers [66, 70-72]. Degradation was 
readily tuned and predicted using monomers with different concentration, functionality, 
and degradability. Leach and colleagues developed hydrolytically degradable Michael-
type hydrogels based on 4-arm PEG-vinylsulfone (PEGVS) and PEG-diester-dithiol [73, 
74]. Degradation of these step-growth hydrogels was altered by tuning the number of 
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methylene groups between the thiol and ester moieties in the PEG-diester-dithiol linkers. 
In the above examples, acidic by-products (i.e., carboxylic acid) are obtained from the 
ester hydrolysis mechanism. 
 Due to the presence of thio-ester bond forming between thiol and backbone PEG, 
thiol-ene hydrogels can be rendered hydrolytically degradable. Metters and Hubbell 
previously established a statistical-co-kinetic model for predicting the hydrolytic 
degradation of step-growth Michael-type hydrogels. Due to structural similarities 
between step-growth Michael-type and thiol-ene hydrogels, Shih and Lin utilized this 
model to study the hydrolytic degradation of step-growth thiol-ene hydrogels and showed 
the high predictability of thiol-ene hydrogels. Based on this model, the degradation of 
thiol-ene hydrogels was assumed to be purely due to ester bond hydrolysis with a pseudo-
first order degradation kinetics [45, 46]. With this assumption, the fraction of hydrolyzed 
ester bonds (PEster) at any given time in the system is expressed as: 
𝑃𝐸𝑠𝑡𝑒𝑟 = 1 −
[𝐸𝑠𝑡𝑒𝑟]
[𝐸𝑠𝑡𝑒𝑟]0
= 1 − 𝑒−𝑘
′𝑡    (2.5) 
Here, k’ is the pseudo-first order ester bond hydrolysis rate constant [Ester] and 
[Ester]0 are the current and initial numbers of intact ester bonds in the system. 
  The fraction of intact elastic chains (i.e., crosslinkers such as DTT or bis-
cysteine containing peptides) within these crosslinked networks at any given time is 
expressed as: 
1 − 𝑃𝐶ℎ𝑎𝑖𝑛 = (1 − 𝑃𝐸𝑠𝑡𝑒𝑟)
𝑁 = 𝑒−𝑁𝑘
′𝑡   (2.6) 
where N is the number of degradable units (i.e., ester bonds) connected to one elastic 
chain (e.g., N = 2 for the case of PEG4NB-DTT hydrogels). 
To obtain the degree of crosslinking in the system, one must also consider the 
connectivity of multi-arm PEG macromers. For an ideal step-growth network, the 
fraction of fA-armed macromer with i arms still connected to the network at any time 






𝑖    (2.7) 






𝑖=3 )[𝐴]0     (2.8) 
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Here, i ≥ 3 because any fA-arm (fA ≥ 3) macromer with only two arms connected to intact 
elastic chains forms an extended loop, rather than a crosslink.  [A]0 represents the 
concentration of  fA-arm macromers (e.g., PEG4NB) in the equilibrium swelling state 





[𝐴]0      (2.9) 
When the functionalities of the macromer and crosslinker (fA = 4 and fB = 2) are 
taken into account, the crosslinking density of a perfectly crosslinked thiol-ene network 
in the equilibrium state could be derived from Equations (2.3) to (2.9) and expressed as:     
𝑣𝑐 = (6𝑒
−3𝑁𝑘′𝑡 − 4𝑒−4𝑁𝑘
′𝑡)[𝐴]0,𝑎𝑐𝑡𝑢𝑎𝑙   (2.10) 
 For gels with non-idealities or structural defects, [A]0,actual is obtained using actual 




[𝐴]0     (2.11) 
where vc,actual represents the experimental crosslinking density converted from 
experimental mass swelling ratio using Equations (2.3) and (2.4) and vc,ideal represent 
ideal crosslinking density calculated based on the molecular weight between cross-links: 
𝑀𝑐̅̅ ̅̅ . 
 The hydrolytic degradation of thiol-ene hydrogels was found to be pH-dependent.  
It was demonstrated that PEG4NB-DTT hydrogels incubated in acidic condition (pH 6.0) 
had an almost constant swelling ratio over a 45-day period, whereas hydrogels with the 
same compositions exhibited increasing swelling over time in slightly basic conditions 
(pH 7.4 and pH 8.0) (Figure 2.7). If the degradation follows the same ester hydrolysis 
mechanism at an elevated pH value (e.g., from pH 7.4 to pH 8.0), degradation profiles at 
different pH values could be described using a pseudo-first order equation [76]:  
[𝐸𝑠𝑡𝑒𝑟] = [𝐸𝑠𝑡𝑒𝑟]0𝑒
−𝑘′[𝑂𝐻−]𝑡    (2.12) 
Through experimental curve fitting, it was shown that the degradation of thiol-ene 
hydrogels was not solely governed by simple ester bond hydrolysis and other factors 
could also play a role on the degradation rate of these thiol-ene hydrogels. A potential 
explanation for this phenomenon is base-catalyzed oxidation of thioether bond forming 
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between norbornene and thiol groups, which may be promoted at higher pH values. 
Another possible reason for the lower-than-predicted degradation rate at higher pH values 
was that the degradation process produced acidic by-products, which decreased acidity 
and retarded the degradation.  
 
Figure 2.7. Effect of buffer pH on mass swelling ratio of 4 wt% PEG4NB-DTT 
hydrogels.  Symbols represent experimental data while dashed curves represent 
exponential curve fitting to the experimental data. The apparent degradation rate 
constants (khyd) for gels degraded in pH 7.4 and pH 8.0 were 0.024 ± 0.001 and 0.057 ± 
0.002 day-1, respectively.  Solid curves represent model predictions with best-fit kinetic 
rate constants: k’pH 7.4 = 0.011 day
-1 and k’pH 8.0 = 0.027 day
-1. No curve fitting or model 
prediction was made for gels degraded in pH 6.0 due to the stability of gels in acidic 
conditions. 
 
In addition to the influence of pH, degradation rate of thiol-ene hydrogels can be 
affected by other factors such as macromer concentrations. Theoretically, thiol-ene 
hydrogels formed at a higher macromer concentration have a higher degree of network 
crosslinking. The later property is directly correlated to the concentration of thiol-ether-
ester bonds formed in the network. Experimentally, it was demonstrated that given the 
same amount of time and hydrated environment, thiol-ene hydrogels with higher degree 
of network crosslinking would degrade slower. The degree of network crosslinking can 
also be altered by changing the ratio of thiol to ene. At higher thiol-to-ene ratio, higher 
network crosslinking (e.g., higher [A]0) led to slower rate of degradation.  Furthermore, 
hydrolytic degradation rate of thiol-ene hydrogels can be affected by the sequence of bis-
cysteine-bearing peptide linker. Hydrogels crosslinked by peptides containing aromatic 




























(e.g., Cys-Gly-Gly-Tyr-Cys or CGGYC) or hydrophobic (e.g., Cys-Gly-Gly-Leu-Cys or 
CGGLC) residues yielded slower degradation rates compared to gels crosslinked by 
peptide linker without side group (i.e, Cys-Gly-Gly-Gly-Cys or CGGGC), potentially due 
to steric hindrance and hydrophobic effect of tyrosine and leucine residues that retarded 
degradation [62].  
 
2.4.2  Enzymatic degradation 
 
 Thiol-ene hydrogels can be rendered enzymatic degradable when protease 
sensitive peptides are used as gel cross-linkers. The termini of these peptides are usually 
flanked with cysteine residues to provide sylfhldryl groups needed for the orthogonal 
thiol-ene photo-click reactions. Enzyme-sensitive thiol-ene hydrogels can serve as 
carriers for delivering therapeutic agents in response to specific enzymatic activity, which 
causes cleavage of the peptide cross-linkers. For example, Aimetti et al reported a human 
neutrophile elastase (HNE) responsive thiol-ene hydrogels for delivering therapeutic 
agents on demand [57]. Lin et al. reported a cymotrypsin degradable peptide (i.e., Cys-
Gly-Gly-Tyr-Cys, CGGY↓C) for enzyme responsive recovery of pancreatic β-cell 
aggregates from thiol-ene hydrogels [52]. In Figure 2.8, a linear relationship for hydrogel 
mass loss as a function of time suggests that the enzymatic degradation of thiol-ene 
hydrogels was governed by a surface erosion mechanism. A significantly faster rate of 
erosion was observed when hydrogels were incubated in solution with higher 
chymotrypsin concentration [52].  
In addition to utilizing a surface erosion mechanism to release drugs or cells, 
thiol-ene hydrogels can also be used to study cellular behaviors, such as proliferation and 
migration that are related to local enzymatic reactions. During these processes, cells can 
secrete enzymes such as the matrix metalloproteinases (MMPs). When a hydrogel is 
cross-linked with a peptide senstive to MMPs, the local protease activity can cause 
peptide cleavage and reduction in local gel cross-linking density. This process permits the 
cells to explore their neighboring matirx, which has been shown to improve tissue 
regeneration [77]. In particular, bis-cysteine MMP sensitive peptide (i.e.,  
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KCGPQG↓IWGQCK) has been used as a crosslinker for encapsulating cells in thiol-ene 
hydrogels [54]. It has been shown that cells, such as hMSCs or pancreatic cancer PANC-
1 cells, secrete MMPs to cleave thiol-ene hydrogels as they spread or proliferate [54, 78, 
79]. Although this type of enzymatic degradation is mostly restricted to local cellular 
activites, significant reduction in bulk gel mechanical properties could also be observed 
after prolong culture.  
 
Figure 2.8. Effect of chymotrypsin concentration on mass loss of PEG4NB-CGGYC 
hydrogel (4wt% PEG4NB, N = 3, mean ± SEM) [52].  
 
 
2.4.3  Photolytic degradation 
 
 There is a growing interest in the development of biomimetic materials with 
dynamically tunable gel properties during the course of the studies. For example, 
macromers with photolabile groups can be used to fabricate hydrogels with dynamically 
tunable cross-linking density. This will allow users to change gel biomechanical (i.e., 
reduction of gel cross-linking density) or biochemical properties (e.g., removal of 
pendent bioactive motifs) through additional light-mediated bond cleavage. Additionally, 
drugs or cells immobilized/entrapped within a photodegradable gel can be released on 
demand via light-induced matrix degradation. The cleavage of photolabile linkers can 
lead to the reduction of matrix stiffness that allow one to observe the influence of matrix 
properties on cell fate processes [80, 81].  
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Currently available photolabile units often contain an ortho-nitrobenzyl (o-NB) 
moiety that is highly susceptible to UV light. The absorbance of o-NB-containing 
macromers usually peaks between 280-400 nm [81-84]. When exposing to lights at these 
wavelengths, o-NB groups are effectively photo-lysed. This photolysis reaction liberates 
the initially immobilzied molecules or reduces the gel cross-linking density. Current 
methods to prepare photodegradable hydrogels are restricted to non-photo-mediated 
process, such as redox reactions, thermal polymerizations, Michael-type conjugations, or 
orthogonal ‘click’ chemistries [53, 75, 81, 85-87]. Photodegradable hydrogels can also be 
synthesized by photopolymerization, given that an appropriate photopolymerization 
system is utilized such that the photodegradable unit remain intact during network 
formation. Ki et al. recently reported the synthesis of photodegradable step-growth thiol-
ene hydrogels by visible light-initiated thiol-ene photo-click reactions. A visible light 
source was utilized to excite eosin-Y, which initiated the cross-linking of PEG4NB and 
linker dithiothreitol (DTT) [80]. This new step-growth hydrogel system preserves the 
favorable preoperties offered by photochemistry, including photopolymerization and 
photodegradtion. Visible light wavelengths (400-700nm) were used to photopolymerized 
the thiol-ene hydrogels, whereas an orthogonal wavelength (302nm and 365nm) was used 
to cleave the peptide linker (Cys-Gly-NPA-Gly-Cys) containing a photolabile amino 
acid, L-2-nitrophenylalanine (NPA) (Figure 2.9A). The rate of hydrogel degradation was 
easily manipulated by wavelength and UV light intensity. As shown in Figure 2.9B, 
shorter wavelength and higher light intensity resulted in faster rate of photolysis. The 
applications of this simple photodegradable thiol-ene hydrogel include patterning of 
bioactive motifs in a spatial-temporal fashion, and releasing of biomolecules that are 








Figure 2.9. (A) Schematic of visible light mediated photo-crosslinking and UV-mediated 
photodegradation of step-growth thiol-ene hydrogels crosslinked by PEG4NB and 
photolabile peptide CGOGC (O: L-2-nitrophenylalanine). (B) Effect of different 
wavelength UV lights (302 or 365 nm, 10 mW/cm2) on reduction of residual hydrogel 
mass (N = 3, mean  SEM) [80].  
 
 
2.4.4  Multifaceted degradation mechanisms 
 
 While the radical-mediated thiol-ene hydrogels can be designed to be degraded 
via hydrolysis, proteolysis, or photolysis, it is also possible to combine several 
degradation mechanisms into one hydrogel matrix. For instance, a simple dual-mode 
enzymatic and hydrolytic degradable hydrogel was created without altering hydrogel 
molecular structure or hydrophilicity [62]. As shown in Figure 2.10, thiol-ene hydrogels 
were cross-linked by non-cleavable CGGGC and chymotrypsin-sensitive CGGY↓C 
peptides at various compositions [62]. When these gels were exposed to chymotrypsin 
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solution, hydrogels containing high percentage of CGGYC cross-linker (100−75%) 
eroded in a surface erosion mechanism, evidenced by linearly increasing mass loss 
profiles with time. When the total content of CGGYC peptide was decreased to 50 and 
25%, chymotrypsin treatment led to increased gel mass (i.e., negative mass loss). This 
indicated the protease treatment led to a “loosened” gel structure and increased water 
uptake. Under this condition, the degradation mode was likely transitioned from a surface 
erosion mechanism to a bulk degradation mechanism. On the other hand, chymotrypsin 
treatment had no effect on the swelling or mass loss of thiol-ene hydrogels cross-linked 
by purely non-chymotrypsin sensitive linker (CGGGC). These results suggested that by 
combining peptide cross-linkers with various protease sensitivities, the degradation 
behaviors of thiol-ene hydrogels could be manipulated between surface erosion and bulk 
degradation for dynamically controlled growth factors or drug delivery. 
 
Figure 2.10. Effect of peptide crosslinkers on PEG4NB-peptide hydrogels 
erosion/degradation. PEG4NB hydrogels crosslinked by different percentage of 
chymotrypsin sensitive (CGGYC) and non-degradable (CGGGC) peptides. Figure 
legends indicate the percent molar ratio of CGGYC:CGGGC. (4 wt% PEG4NB-peptide 






























2.5  Applications of Thiol-ene Hydrogels in 
Controlled Release and Tissue Engineering 
 
2.5.1  Protein delivery 
 
 Protein therapeutics (e.g., gorwth factors, cytokines, chemokines, etc.) play an 
important role in promoting wound healing and tissue regeneration. In situ encapsulation 
of proteins in chemically cross-linked hydrogels has been a favorable option due to the 
simplicity of material prepration and drug loading process. Releasing proteins from a 
hydrgoel can positively affect the healing/regeneration process of a damaged or diseased 
tissue. When co-encapsulated with cells, the network-entrapped proteins can also direct 
cell fate processes within the hydrogels. However, maintaining the structural integrity 
and bioactivity of a protein-based biomacromolecule during network corss-linking has 
proven a challenging task, in large part due to the presence of reactive radical species [40, 
57]. For example, Lin and Metters demonstrated a significant reduction of structural and 
functional integrity of model proteins bovine serum albumin (BSA) and lysozyme in 
chain-growth photopolymerized PEGDA hydrogels, as well as the effect of 
photoinitiators on protein bioactivity [88]. McCall and Anseth later compared the 
influence of chain-growth and step-growth photopolymerized hydrogels on the stability 
of lysozyme and transforming growth factor β (TGFβ) [40]. A 1000-fold increase in 
bioactive protein recovery was observed in thiol-ene hydrogels compared to chain-growth 
PEGDA hydrogels. Results of this study demonstrated that thiol-ene click reactions are 
capable of forming a cross-linked network more rapidly at a lower initiator concentration 
and with little to no impact on protein bioactivity. The highly efficient and orthogonal 
thiol-ene reaction, together with its non-oxygen inhibited nature, preserves the structure 
and function of sensitive proteins.  
In addition to preserving the bioactivity of encapsulated proteins, thiol-ene 
hydrogels are also a class of versatile matrices for sustained and stimuli-responsive 
protein delivery. For example, Aimetti et al. have developed an enzyme-responsive thiol-
ene hydrogels with potential for delivering anti-inflammatory drugs in responding to 
human neutrophil elastase (HNE), a protease secreted by neutrophil [57]. The hydrogels 
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were cross-linked by low molecular weight PEGNB macromer and HNE-sensitive bis-
cysteine-bearing peptides. The sequences of HNE-sensitive peptide substrates were 
systematically altered, from which to identify appropricate sequences for rapid linker 
cleavage and subsequent liberation of the otherwise entrapped proteins. The release of 
model protein was purely governed by matrix cleavage and proceeded in a surface 
erosion manner. Ideally, this system can be used to release anti-inflammatory drugs upon 
the onset of inflammation.  
Thiol-ene hydrogels could also be formulated into microgels. Murphy and 
colleagues used aqueous two-phase separation, in conjunction with radical-mediated 
thiol-ene photopolymerization, to prepare micro-scale hydrogels [89]. Affinity peptides 
capable of sequestering vascular endothelial growth factor (VEGF) were also 
immobilized within the permeable hydrogels. This molecular sequestering approach 
increased the binding and sustained the release of VEGF in vitro, which affected the 
proliferation of human umbilical vein endothelial cells. More recently, Fraser et al. 
prepared microgels formed by visible light mediated thiol-ene photopolymerization using 
eosin-Y as the photoinitiator [90]. Through a sequential thiol-ene polymerization, a thin 
gel coating was formed on the core microgels. Although not demonstrated in that 
publication, the multilayer microgels can be used to regulate the rate of drug release.    
 
2.5.2  3D cell culture 
 
 In addition to the mild and rapid reaction kinetics, radical-mediated thiol-ene 
hydrogels have high cytocompatibility for cells derived from either mesenchymal or 
epithelial origins. Thiol-ene hydrogels have been used to encapsulate a host of 
mammalian cells, including fibroblasts [38, 55], valvular interstitial cells (VICs) [56], 
HT1080 fibroscarcoma [55], human mesnechymal stem cells [54, 78], pancreatic β-cells 
[52], pancreatic ductal epithelial cells [79, 91], and embryonic stem cells [92]. Thiol-ene 
hydrogels impreganated with bone morphogenic protein 2 (BMP2) have also been used to 
accelerate bone healing (as compared to commercially available BME-2 delivery matrix) 
in vivo. Although the cross-linking of thiol-ene hydrogels is initiated by light sensitive 
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photoinitiators, the concentration of radicals needed to initiate rapid gelation is orders of 
magnitude lower than that in chain-growth polymerization, in large part due to the non-
oxygen-inhibited nature of thiol-ene reaction. This is significant because during the 
encapsulation process, some cells are prone to damage induced by free radicals. Insulin 
producing β-cells are one type of radical-sensitive cells. Lin and colleagues compared the 
differentces in chain-growth PEGDA and step-growth thiol-ene hydrogels in terms of 
gelation kinetics and cytocompatibility using a pancreatic β-cell line, MIN6. It was found 
that thiol-ene hydrogels were more cytocompatible than conventional PEGDA hydrogels 
for MIN6 cells. Furthermore, β-cells were able to proliferate into spheroids within these 
thiol-ene hydrogels [52, 59]. The cell spheroids could be recovered upon enzymatic-
mediated cleavage of the step-growth hydrogel network.  
Using PEG-norbornene macromers and protease-sensitive peptides as the gel 
cross-linkers, local matrix remodeling can be dictated by local cellular activity. Thiol-ene 
hydrogels can also be prepared to be degradabled hydrolytically and/or proteolytically, or 
completely non-degradable (Figure 2.11). The tunable degradability of the thiol-ene 
hydrogels allows one to examine the influence of microscale network properties on the 
encapsulated cell fate. For example, Anseth and colleages utilized thiol-ene hydrogels 
with different degree of matrix metalloproteinase (MMP) degradability to evaluate the 
potential of thiol-ene hydrogels as a 3D cell culture platform. MMP-sensitive peptide 
flanked with terminal cysteines (e.g., KCGPQGIWGQCK) was mixed with non-labile 
PEG-dithiol in different ratios [54]. The resulting thiol-ene hydrogels exhibited different 
degrees of protease sensitivity. The facile incorporation of CRGD motifs rendered the gel 
adhesive to the encapsulated human mesenchymal stem cells (hMSCs). Results showed 
that thiol-ene hydorgels were highly suitable for culturing and differentiate hMSCs. 
Following Anseth’s work, a recent study utilized two PEGNB macromers that are 
hydrolytically labile or hydrolytically stable to evaluate the effects of single-mode 
(purely hydrolytic or enzymatic) or dual-mode (hydrolytic and enzymatic) network 
degradation on hMSCs viability and morphology [78]. It was found that dual-mode 
degradable thiol-ene hydrogels provided a more cytocompatible environment for 
promoting cell survival, proliferation, and morphogenesis in 3D. The results in the study 
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demonstrated significant influence of network degradation and cell-mediated matrix 







Figure 2.11. (A) Schematics of a thiol-ene cross-link. Arrows indicate potential cleavage 
sites. (B) Different modes of thiol-ene hydrogel degradation. PEG-ester-norbornene (R = 
O) or PEG-amide-norbornene (R = NH) can be used to construct gels with different 
hydrolytic degradability (only one arm is shown). With a proper combination of 
macromer and cross-linker, thiol-ene hydrogels can undergo different modes of 
degradation and produce different degradation products. 
 
Recently, thiol-ene hyodrgels were used to study cancer cells in 3D. Lin and 
colleagues have established a highly tunable biomimetic thiol-ene hydrogel platform for 
studying the growth and morphogenesis of pancreatic ductal epithelial cells in 3D [79, 
91]. The thiol-ene hydrogels were tuned to render the otherwise inert PEG environment 
responsive to epithelial cell morphogenesis. The growth and morphological changes in 
PANC-1 cells, a pancreatic ductal adenocarcinoma cell line, were affected by macromer 
molecular weight, gel stiffness, cross-linker chemistry, and additional cell-matrix 
interaction. The use of MMP-sensitive or RGDS-immobilized gels promoted the 
formation of cyst-like cell clusters, whereas the cell clusters proliferated from single cells 
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were more compact and exhibited epithelial cell phenotype in non-MMP sensitive or 
YIGSR-immobilized gels [79]. Furthermore, thiol-ene PEG-peptide hydrogels serve as a 
promising platform for evaluating the efficacy of peptide drugs toward pancreatic cancer 
cells in 3D. The viability of PANC-1 cells under the influence of epidermal growth factor 
receptor (EGFR) inhibition was altered by the dosage of the inhibitor and by the 
conditions of the matrix in which the cells reside [91]. The use of 3D hydrogel matrices 
with adaptable and well-defined biophysical and biochemical properties may facilitate the 
identification of anti-cancer drugs that are effective in tumor tissues but with minimal 
side effects to normal tissues. 
 
 
2.6  Conclusion 
 
In summary, thiol-ene hydrogels formed by radical mediated 
photopolymerizations have emerged as a versatile biomaterial platform for controlled 
release of therapeutics and tissue engineering applications. Thiol-ene hydrogels have 
improved network crosslinking than the conventional chain-growth PEGDA and step-
groth Michael-type addition hydrogels. Depending on the type of photoinitiator used, 
thiol-ene hydrogels can be prepared via UV light or visible light irradiation. Thiol-ene 
hydrogels can be rendered completely non-degradable, degradable only by hydrolysis, 
proteolysis, photolysis, or by the combination of different mechanisms. The diverse 
gelation and degradation of thiol-ene hydrogels offer  researchers a new platform to 
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3.1  Abstract 
 
 A visible light-mediated interfacial thiol-ene photopolymerization scheme 
was developed for creating an immunoisolation coating on islets. Islets were stained 
with photoinitiator eosin-Y, followed by sequential incubations in macromer 
solutions. Upon visible light exposure, a step-growth thiol-ene hydrogel was formed 
around islets. The coated islets maintained viable in vitro. 
  
 
3.2  Introduction 
 
 Type 1 diabetes mellitus (T1DM) is an autoimmune disorder caused by auto-
reactive T-cells that destroy insulin-producing pancreatic β-cells in the islets of 
Langerhans [1, 93-95]. The direct outcome of β-cell destruction is hyperglycemia due to 
the lack of insulin secretion. Current gold standard of therapy to restore glucose 
homeostasis is insulin administration, such as insulin injections or implantation of insulin 
delivery devices [2]. However, tight glycemic control through insulin administration 
requires frequent monitoring of blood glucose levels, and all forms of exogenous insulin 
therapy cause various degrees of patient discomfort. While whole pancreas or islet 
transplantation can provide T1DM patients with insulin-independence, these approaches 




are reserved for diabetic patients with hypoglycemia unawareness due to a significant 
shortage of donor organs [3-5, 96, 97]. In addition, patients transplanted with allogenic 
islets are required to receive prolonged immunosuppressant therapy, which unfortunately 
cannot prevent instant blood mediated inflammatory response (IBMIR) that often 
destroys more than half of the transplanted islets shortly after surgery [6-8]. 
In a hope to improve the lifespan of transplanted islets, scientists and engineers 
have been developing encapsulation technologies to immunoisolate allogenic or even 
xenogenic islets from host tissues [9-18]. A few critical considerations of islet 
encapsulation are the cytocompatibility of the encapsulation process, the stability of the 
coating, and the permeability of the barrier. A successful permselective immune isolation 
barrier should be able to prevent infiltration of host immune cells while permitting facile 
exchange of nutrients and metabolites, including oxygen, glucose, and insulin [2]. 
Existing encapsulation technologies include macromolecular self-assembly [13, 15, 98], 
cell surface engineering [13], and covalent crosslinking of hydrogels [2, 99]. For 
example, islets can be encapsulated in polyplexes formed by layer-by-layer (LbL) self-
assembly between ionic macromolecules (e.g., polyanionic alginate with divalent barium 
or calcium cation) [100-102]. Recent work has explored multi-layer coatings formed by 
affinity binding between labeled macromers (e.g., biotinylated-PEG-N-
hydroxysuccinimide, streptavidin, and biotin-peptide) [103, 104], and hydrogen bonding 
between polar macromers (e.g., poly(N-vinylpyrrolidone) and tannic acid) [105]. The 
long-term stability of these physically assembled coatings depends highly on the micro-
environmental conditions in the transplantation site, such as pH and ionic strength [106, 
107]. Alternatively, islets can be encapsulated through cell surface engineering. In one 
example, islets were functionalized with hetero-bifunctional maleimide-poly(ethylene 
glycol)-lipid (maleimide-PEG-lipid), which was subsequently reacted with thiol-
containing molecules via thiol-maleimide Michael-type addition [20, 108, 109]. The 
drawbacks of this maleimide-based coating chemistry are slow gelation rate (from 
minutes to hours) [63, 73, 110], and potential cytotoxicity of maleimide moieties that 
may not be ideal for islet cell encapsulation [111].  
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Hubbell and colleagues pioneered an islet conformal coating technique based on 
visible light-initiated chain-growth photopolymerization [9, 19, 112-115]. The coating 
process starts with staining islets with a type II photoinitiator, eosin-Y.  The stained islets 
are then incubated in a precursor solution containing macromer PEG-diacrylate 
(PEGDA), co-initiator triethanolamine (TEA), and co-monomer N-vinylpyrrolidone 
(NVP). Upon exposure to a visible light source, eosin-Y on islet surface initiates 
interfacial photopolymerization. Thickness of the coating could be controlled by light 
exposure time, as well as the concentrations of PEGDA macromer, co-initiator, and co-
monomer [112]. Although this technique achieved early success in animal and non-
human primate models [116], the chain-growth polymerization scheme suffers from the 
potential cytotoxicity of co-monomer and co-initiator [117, 118], as well as the formation 
of a heterogeneous network containing hydrophobic polyacrylate kinetic chains [50]. 
Since the chain-growth polymerization is initiated from islet surface, the gelation yielded 
a dense hydrogel layer immediately adjacent to the cell surface [19]. The gradient of 
crosslinking density would complicate the permeability of nutrients, oxygen, and insulin 
[119], all of which are essential in maintaining islet survival and functions. 
 
 
3.3  Results and Discussion 
 
Unlike a chain-growth network that contains heterogeneous cross-links, the step-
growth thiol-norbornene photo-click reaction produces orthogonal cross-links with 
enhanced cytocompatibility [40, 52, 59]. We recently reported a visible light mediated 
step-growth thiol-ene hydrogelation without using co-monomer (NVP) and cytotoxic co-
initiator (TEA) [59]. We hypothesized that this visible light initiated orthogonal thiol-ene 
reaction could be adapted to form interfacial islet surface conformal coating. Prior to 
testing this hypothesis, we evaluated the cytocompatibility of this cell surface initiated 
thiol-ene photopolymerization. Here, we used MIN6 cell aggregates generated from 
rotating suspension culture as the cell model. These aggregates were cultured in high 
glucose DMEM supplemented with 50 μM β-mercaptoethanol, 10 % fetal bovine serum 
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(FBS, Gibco), and 1× antibiotic-antimycotic (Invitrogen) and maintained at 37 oC and 5 
% CO2. Since different compositions are required for chain-growth and step-growth 
coating chemistries, in this study, we used non-gelling components (e.g., PEGMA or 
PEGdNB) to examine the cytocompatibility of these coating chemistries (Figure 3.1A) 
under similar radical concentrations. After 10 days in culture, MIN6 β-cell aggregates 
(average aggregate diameter ~100 μm) were retrieved from media, washed with HBSS 
and stained with 10 mM of eosin-Y (Fisher Scientific) for 5 minutes. After staining, 
aggregates were washed 3 times with HBSS to remove excess eosin-Y and were 
transferred to non-gelling precursor solutions containing: (i) 16 wt% PEGMA2kDa 
(Monomer-Polymer), 50 mM of TEA, and 9 mM of NVP, or (ii) 20 wt% PEGdNB10kDa 
[120] and dithiothreitol (DTT, Fisher Scientific) at a unity functional group molar ratio 
(R[thiol]/[ene] = 1).These tubes were exposed to visible light using a fiber optic microscope 
illuminator (wavelength: 400 to 700 nm, AmScope) for 1 minute. In Figure 3.1B and 
3.1C, aggregates were recovered in culture media for 1 hour, followed by staining with 
live/dead staining reagents (i.e., 0.25 μL/mL Calcein AM and 2 μL/mL Ethidium 
homodimer-3, respectively) for 1 hour before imaging with a confocal microscope 
(Olympus Fluoview, FV1000). Similar to our previous work on bulk cell encapsulation 
using UV-light irradiation [52], visible light-based chain-growth photopolymerization 
(initiated by eosin-Y/TEA/NVP) was less cytocompatible compared with the step-growth 
photopolymerization initiated by eosin-Y and DTT. As shown in Figure 3.1B (left), 
numerous dead cells were found on the surface of MIN6 cell aggregates in the visible 
light-based chain-growth polymerization system, which was attributed to the high 
concentrations of radical species in the chain-growth polymerization, [40] as well as the 
potential cytotoxicity of TEA [117, 118]. In contrast, the visible light-initiated orthogonal 
step-growth thiol-ene reaction caused less cell death (Figure 3.1B, right) [52, 59]. Due to 
technical difficulties in quantifying aggregates viability, aggregates viability is only 




Figure 3.1. (A) Schematic of visible light-initiated interfacial chain-growth (top) or step-
growth thiol-ene (bottom) photopolymerization (EY: eosin-Y). (B) Viability of 
aggregates after non-gelling interfacial photopolymerization reactions (Green: live cells. 
Red: dead cells. Scales: 100 μm). 
 
 Next, we prepared interfacial thiol-ene coating on MIN6 β-cell aggregates. MIN6 
β-cell aggregates were stained with 10 mM of eosin-Y for 5 minutes. Eosin-Y stained cell 
aggregates were washed three times with HBSS (centrifugation for 3 minutes at 500 rpm 
each), suspended in 50 μL of macromer solution contained 20 wt% 8-arm PEG-
norbornene (PEG8NB) with stoichiometric ratio of thiol from DTT (Figure 3.2A & 
3.3A), and exposed to bright visible light. Note that in all the coating experiments, 
aggregate density was fixed at approximately 500 aggregates/mL and more than 200 
aggregates were analysed. Representative phase contrast images (Nikkon Eclipse Ti) 
revealed the formation of a thin thiol-ene hydrogel coating on β-cell aggregates after only 
30 seconds of light exposure (Figure 3.3B, left). Furthermore, live/dead staining results 
showed that the coated β-cell aggregates remained viable (Figure 3.3C, left). This direct 
coating method (i.e., one-step incubation) produced a wider distribution of gel coating 
thickness, ranging from 20 μm to 60 μm (Figure 3.3D), which averaged to approximately 

















3.2 software. In addition, the one-step method only yielded a coating efficiency of 64 % 
(Figure 3.3F), and there was a strong dependency between the coating thickness and the 
size of the cell aggregates (Figure 3.3G). Here, coating efficiency is the percent fraction 
of coated aggregates over the sum of coated and non-coated aggregates. While the one-
step coating method is easy and cytocompatible to β-cell aggregates, it did not show high 
coating efficiency and consistency. Thus, it is essential to establish a coating strategy that 
provides high consistency and repeatability for isolated islets, which are heterogeneous in 
size (a few tens to a few hundreds micron) [121]. We hypothesized that the conformal 
coating results could be improved by providing additional thiols near the surface of the 
cell aggregates. These surface-anchored thiols could reduce the variability of coating 
thickness and increase coating/polymerization efficiency. Our recent work has shown that 
PEG exhibits affinity to eosin-Y [122]. Hence, we hypothesized that by incubating eosin-
Y stained aggregates with PEG-di-thiol (PEGdSH) would allow PEGdSH to anchor on 
the surface of cell aggregates via affinity binding to cell surface adsorbed eosin-Y (Figure 
3.2B). To test this hypothesis, stained aggregates were incubated in 20 wt% of PEGdSH 
for 5 minutes, and washed three times with HBSS before suspending in macromer 
solution containing PEG8NB with DTT (Figure 3.2B). After 30 seconds of light 
exposure, conformal hydrogel coating also formed on β-cell aggregates (Figure 3.3B, 
right). Two-step coating process is also cytocompatible to MIN6 aggregates (Figure 3.3C, 
right). More cell death observed in two-step coating potentially due to the increased in 
radical reactions on the surface of aggregates. This two-step incubation process produced 
thiol-ene conformal gel layer with a narrower distribution of coating thickness (Figure 
3.3D, ~20 to 40 μm) and a lower average coating thickness (Figure 3.3E, ~ 26 μm). More 
importantly, the two-step coating method yielded higher coating efficiency (Figure 3.3F, 
80 %) and a reduced dependency between coating thickness and the size of cell 




Figure 3.2. Schematic of visible light-mediated interfacial thiol-ene photopolymerization 
and conformal coating on β-cell aggregates or islets via: (A) one-step or (B) two-step 
coating method. 
 
Results shown in Figure 3.3 have demonstrated the benefits and importance of 
additional PEGdSH incubation in interfacial thiol-ene photopolymerization. Therefore, 
we further investigated the effect of PEGdSH on coating thickness and efficiency. In 
general, the thiol-ene coating thickness decreased with increasing molecular weight 
(MW) of PEGdSH (i.e., from 35 μm, 26 μm, to 13 μm for 2 kDa, 3.4 kDa, and 10 kDa 
PEGdSH, respectively, Figure 3.4A-D & 3.5A). The use of higher MW of PEGdSH 
resulted in decreased coating efficiency (Figure 3.5B, from 98 % to 64 %). It is worth 
noted that in these experiments, the concentration of PEGdSH (20 wt%) as well as the 
stoichiometric ratio of thiol (from DTT) and norbornene (from PEG8NB) in the precursor 
solution were maintained. PEGdSH at a lower MW has higher thiol content when 
comparing with its counterpart at a higher MW and at the same macromer concentration. 
Therefore, increased coating thickness and efficiency at a lower PEGdSH MW were 
likely due to increased availability of thiols near the surface of the aggregates, which 





























Figure 3.3. (A) Schematic of visible light-initiated step-growth orthogonal thiol-ene 
reaction to form idealized hydrogel network. (B) Representative phase-contrast images of 
the conformal coated aggregates. (C) Representative live/dead stained images of the 
conformal coated aggregates (Scales: 50µm). (d-f) Effects of coating methods on (D) the 
cumulative distribution of conformal gel coating thickness, (E) the average coating 
thickness, and (F) the percent of coated aggregates. (G) Effect of aggregate diameter on 
thiol-ene conformal coating thickness. (One-step: 20 wt% PEG8NB-DTT and 30 seconds 
of light exposure. Two-step: 20 wt% PEG8NB-DTT, 3.4 kDa PEGdSH and 30 seconds of 















































































































Figure 3.4. (A-C) Representative phase-contrast images of MIN6 cell aggregates with 
thiol-ene conformal gel coating (two-step coating method). PEGdSH MW: (A) 2 kDa, 
(B) 3.4 kDa, and (C) 10 kDa. Arrows and dashed lines indicate the boundary of the 
hydrogel coating (Scales: 50 µm). (D-F) Parameters affecting thiol-ene conformal coating 
thickness: (D) molecular weight of PEGdSH, (E) photopolymerization time, and (F) 
concentration of macromer PEG8NB. Coating conditions: (A-D) 20 wt% of PEG8NB-
DTT and 30 seconds of light exposure. (E) 3.4 kDa of PEGdSH and 30 seconds of light 

















































































Figure 3.5. Effects of molecular weight of PEGdSH on (A) cumulative distribution of 
conformal gel coating thickness, and (B) percent of coated aggregates. (20 wt% of 
PEG8NB-DTT, R[PEG8NB]:[DTT] = 1, 30 seconds of light exposure. Mean ± SEM) 
 
 
We also evaluated the influence of other parameters on the thiol-ene interfacial 
conformal coating. For example, when the polymerization time was increased from 20 to 
60 seconds, gel thickness was increased from 15 to 43 μm (Figure 3.4E & 3.6). Longer 
polymerization time resulted in increasing coating efficiency (Figure 3.6B, from 53 % to 
98 %) and the likelihood of encapsulating more than one aggregate per gel capsule (~20 
% at 60 seconds). In addition, when the concentration of PEG8NB in the precursor 
solution was increased from 10 wt% to 20 wt%, gel thickness increased from 14 to 26 μm 
(Figure 3.4F & 3.7A). The use of a higher PEG8NB concentration also increased coating 
efficiency (from 24 % to 84 %, Figure 3.7B).  Regardless of the coating thickness, our 
analysis showed that thiol-ene hydrogels have controllable mesh size depending on the 
concentration of PEG8NB used. Based on the Flory-Rehner theory of elasticity, the mesh 
size of a step-growth hydrogel with an ideal network (e.g., PEG8NB-DTT hydrogel, 
MWPEG8NB = 20 kDa, MWDTT = 154 Da, and fPEG8NB = 8 and fDTT = 2) is 9.1 nm 
(Equation 3.1 to 3.6) [123]. The mesh sizes of all thiol-ene hydrogels prepared here 
(Figure 3.8, from 15.1 nm to 9.9 nm for 5 to 20 wt% of PEG8NB, respectively) were all 
larger than the hydrodynamic radius (2.0 nm) and diameter (4.0 nm) of insulin [124]. 
This indicates that the diffusion of insulin from thiol-ene gel coating will not be 
significantly retarded. 





























































Figure 3.6. Effects of PEG8NB concentration in the precursor solution on (A) cumulative 
distribution of conformal gel coating thickness, and (B) percent of coated aggregates. 






Figure 3.7. Effects of polymerization time on (A) cumulative distribution of conformal 
gel coating thickness, and (B) percent of coated aggregates. (MW of PEGSH = 3.4 kDa, 
20 wt% of PEG8NB-DTT, R[PEG8NB]:[DTT] = 1. Mean ± SEM) 
  

















































































































 Following the optimization of interfacial thiol-ene photopolymerization 
conditions using MIN6 aggregates, we prepared orthogonal thiol-ene hydrogel conformal 
coating on isolated islets. CD1 mice (7- to 8-week old) were obtained from Charles River 
and islets were isolated from CD1 mice following established protocol [125]. Permission 
for animal studies was approved by Indiana University School of Medicine IACUC 
(protocol #10235-MD/R). CD1 murine islets were used in this study while the main 
macromer was replaced with hydrolytically stable 8-arm PEG-amide-NB (PEGa8NB, 
Figure 3.9A) [59]. It is worth noted that thiol-ene hydrogels formed from PEGa8NB have 
similar degree of cross-linking efficiency (i.e., gel fraction above 90 %) and swelling (up 
to 2 weeks) when compared with hydrolytically labile ester-containing PEG8NB (Figure 
3.9). Specifically, hydrogels formed from hydrolytically labile PEG8NB showed 
significant degradation after three weeks. During the month-long incubation, no 
significant gel degradation was observed in gels formed from hydrolytically stable 
PEGa8NB (Figure 3.9C). As shown in Figure 3.10A, coated islets remained viable 24 
hours post coating. Furthermore, the coated hydrogel layer maintained its stability 
throughout 2 weeks of in vitro culture (Figure 3.10B, 3.10C & 3.10D). The average 
thickness of coating was ~30 μm with 90% of coating efficiency (data not shown). In 
long-term in vitro culture of primary islets, the production of cellular debris and the 
darkening of islets core are common phenomena, likely due to necrosis in the isolated 
islets (Figure 3.10D) [126].  Clearly, the cellular debris was free floating in culture media 
with the non-coated islets. On the other hand, the dark debris was ‘trapped’ within the 
conformal coating layer on the coated islets. These results suggest that the coating serves 
as a bi-directional immuoisolation barrier as it not only blocks the infiltration of host 
immune cells, but also prevents the liberation of graft debris to the transplantation site 
that would otherwise trigger host immune response [127, 128]. To examine insulin 
secretion from the coated islets, glucose-stimulated insulin secretion (GSIS) was 
performed at day 2 and day 14 (Figure 3.10E & 3.10F). Here, glucose solution was 
prepared (2.5 or 25 mM of glucose) with Krebs-Ringer bicarbonate (KRB) buffer 
containing sodium chloride (23 mM), potassium chloride (1 mM), sodium bicarbonate 
(4.8 mM), magnesium chloride hexahydrate (0.2 mM), calcium chloride dehydrate (0.2 
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mM), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES, 0.5 mM) and bovine 
serum albumin (BSA, 0.1 vol%). The temperature of glucose solutions were equilibrated 
to 37 oC. Coated or non-coated islets were washed with HBSS, hand-picked and 
transferred into micro-centrifuge tube (30 islets per tube, N = 4 tubes per sample group). 
Islets were primed with 500 μL of low glucose solution for 1 hour at 37 oC and 5 % CO2. 
Then, islets were incubated with 500 μL of low or high glucose solution (at 37 oC, 5 % 
CO2) for 2 hours each. The glucose solution was collected after each glucose treatment. 
After glucose stimulation, islets were lysed with acid ethanol extraction buffer (75 vol% 
of ethanol, 1.5 vol% 1N hydrochloric acid and 23.5 vol% ddH2O) and the samples were 
diluted accordingly with KRB mixture [129]. The amounts of insulin were quantified by 
mouse insulin ELISA kit (Mercodia) and normalized to their corresponding total insulin 
content (i.e., the sum of intracellular and secreted insulin). We found that the amounts of 
insulin secreted from the thiol-ene hydrogel coated islets were not statistically different 
from the non-coated islets. Within each non-coated or coated islets group, statistically 
significance (p < 0.05) was found between insulin secretion at 2.5 mM and 25 mM 
glucose. The GSIS index, which is the ratio of insulin secretion in high glucose buffer to 
low glucose buffer, showed no statistical significance between coated and non-coated 
islets throughout 2 weeks of in vitro culture (Figure 3.11). These results suggest that, 
after the thiol-ene interfacial coating process, the thiol-ene conformal gel coated islets 














Figure 3.8. (A) Effect of PEG8NB concentration on the mesh size (ξ) of hydrogels. The 
mesh size of an ideal network (ξideal) was determined by Flory-Rehner equations 
(Equation 3.1 to 3.6). The experimental mesh size (ξexp) was calculated from the swelling 
ratio of PEG8NB-DTT hydrogels at different macromer contents (Equation 3.4, 3.5 & 
3.6). Diameter of insulin was obtained from reference [124]. (B) Effect of PEG8NB 
concentration on the diffusion coefficient (Dg) of insulin in swollen hydrogel. The 
diffusion coefficient of insulin in pure solvent is obtained from reference [6] and the 
calculation of Dg was based on Lustig-Peppes model in reference [130]. (PEG8NB-DTT, 













































































Figure 3.9. (A) Schematic representation of thiol-ene hydrogels formed by hydrolytically 
degradable PEG8NB and non-degradable PEGa8NB. Effects of PEG macromer on (B) 
gel fraction, and (C) hydrolytic degradability of hydrogels. (20 wt% PEG8NB or 






















































Figure 3.10. (A) Representative live/dead stained images of non-coated and coated CD1 
mice islets (24 hours after coating). (B-C) Representative phase contrast images of non-
coated (top) and coated (bottom) CD1 mice islets on day 2 (B), and day 14 (C). Arrows 
and dashed lines in (B-C) indicate the boundary of the hydrogel coating (Scales: 50 µm). 
(D-E) In vitro glucose stimulated insulin secretion (GSIS) of isolated islets on (D) day 2 
and (E) day 14. Asterisks indicate statistical significance between 2.5 and 25 mM of 
glucose within each group (Mean ± SEM, p < 0.05). Coating conditions: 3.4 kDa 































































Figure 3.11. In vitro glucose stimulated insulin secretion (GSIS) index of CD1 murine 
islets. GSIS index is the normalization of insulin secreted at high glucose to low glucose. 
(Coating conditions: 3.4 kDa PEGdSH, 20 wt% PEGa8NB-DTT and 25 seconds light 
exposure. Mean ± SEM) 
 
 
3.4.  Materials and Methods 
 
Materials: Eosin-Y disodium salt and DTT were purchased from Fisher Scientific. 8-arm 
PEG-hydroxyl (MW: 20 kDa) and 8-arm PEG-amine (MW: 20 kDa) were purchased 
from JenKem Technology USA. PEG-monoacrylate (MW: 2 kDa) was purchased from 
Monomer-Polymer. Linear raw PEG-hydroxyl (MW: 2, 3.4 or 10 kDa) and all other 
chemicals were obtained from Sigma-Aldrich unless noted otherwise. CD1 mice (7- to 8-
week old) were obtained from Charles River as islet donors. Permission for animal 
studies was approved by Indiana University School of Medicine IACUC (protocol 
#10235-MD/R). 
 
Synthesis of Poly(ethylene glycol)-ester-norbornene (PEGNB) macromer: Linear or 8-
arm PEGNB was synthesized by reacting linear or 8-arm hydroxyl-terminated PEG with 
5-norbornene-2-carboxylic acid (5-fold excess to hydroxyl group) in anhydrous 





















a coupling reagent. Norbornene acid was mixed with DCC and stirred at room 
temperature for 1 hour.  The resulting norbornene anhydride was filtered into an addition 
funnel and added drop wise into a flask containing linear (10 kDa) or 8-arm PEG (20 
kDa), 4-(dimethylamino) pyridine (DMAP, 0.5-fold excess), and pyridine (5-fold excess) 
in anhydrous DCM.  The flask was kept in an ice bath and the mixture was reacted for 
overnight in dark.  The product was filtered and precipitated in cold ethyl ether on ice. 
After drying in vacuuo, PEGNB product was re-dissolved in water and dialyzed for 2 
days (in pH 6 ddH2O). 
1H NMR (Bruker 500) was used to confirm the degree of PEG 
functionalization (> 90 %). 
 
Synthesis of Poly(ethylene glycol)-amide-octa-norbornene (PEGa8NB) macromer: 
Norbornene acid (5-fold excess to amine groups) was activated by HBTU/HOBT (5.5-
fold excess to amine group) in dimethylformamide (DMF) for 3 minutes. With nitrogen 
gas purging, N,N-Diisopropylethylamine (DIEA, 6-fold excess to amine group) was 
added to the activated norbornene acid solution and stirred for 5 minutes.  The solution 
was added drop wise to a two-neck flask containing PEG-octa-amine in DMF. After 
overnight reaction at room temperature, the product was precipitated in cold ethyl ether. 
After drying in vacuuo, PEGaNB product was re-dissolved in water and dialyzed for 2 
days .  1H NMR (Bruker 500) was used to confirm the degree of PEG functionalization (> 
90 %). 
 
Synthesis of PEGdSH macromer: PEGdSH was synthesized following established 
protocol. In brief, linear PEG (2, 3.4 or 10 kDa) was dissolved in anhydrous toluene and 
dried by evaporating toluene. Dried PEG was re-dissolved in anhydrous tetrahydrofuran 
(THF), to which sodium hydride (1.5-fold excess of hydroxyl group) was added slowly 
and the mixture was stirred until no hydrogen gas bubble was visible, the set up was 
purged with nitrogen gas in an oil bath at 40 °C. Allyl bromide (6-fold excess of hydroxyl 
group) was added drop wise to the PEG solution and the reaction was allowed to continue 
overnight in dark. Sodium bromide salt was filtered off to obtain a clear solution 
containing PEG-allylether (PEGdAE), which was precipitated out in cold ethyl ether, 
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filtered, and dried in vacuuo. Next, thiolacetic acid (2-fold excess to allylether group) was 
added slowly to dichloromethane (DCM) solution containing PEGdAE and photoinitiator 
Irgacure I-2959 (0.5 wt%). Photoconjugation was initiated by UV-light exposure 
(Omicure S1000, 365 nm and 10 mW/cm2) for 15 minutes and continued for another 30 
minutes after supplementing with another portion (0.5wt%) of I-2959. Linear PEG-
thiolacetate was precipitated in cold ethyl ether, filtered, and dried in vacuuo. After re-
dissolving PEG-thiolacetate in ddH2O (30 mL), 15 mL of sodium hydroxide (2N) was 
added to the solution for 5 minutes. Then, equal amount of hydrochloride acid (2N) was 
added to neutralize PEG-thiolacetate solution. After dialysis for 2 days at room 
temperature, PEGSH was obtained from lyophilization. The purity (> 90 %) was 
characterized with H1NMR Bruker 500). 
 
Cytocompatibility of interfacial thiol-ene photopolymerization on β-cell aggregates or 
islets: MIN6 β-cell aggregates were formed on an orbital shaker in a non-treated tissue 
culture plate. These aggregates were cultured in high glucose DMEM supplemented with 
50 μM β-mercaptoethanol, 10 % fetal bovine serum (FBS, Gibco), and 1× antibiotic-
antimycotic (Invitrogen) and maintained at 37 oC and 5 % CO2. After 10 days in culture, 
MIN6 β-cell aggregates (average aggregate diameter ~100 μm) were retrieved from 
media, washed with HBSS and stained with 10 mM of eosin-Y for 5 minutes. After 
staining, aggregates were washed 3 times with HBSS to remove excess eosin-Y and were 
transferred to non-gelling precursor solutions containing: (i) 16 wt% PEGMA2kDa,  50 
mM of TEA, and 9 mM of NVP, or (ii) 20 wt% PEGdNB10kDa and DTT at a unity 
functional group molar ratio (R[thiol]/[ene] = 1). These tubes were exposed to visible light 
using a fiber optic microscope illuminator (wavelength: 400 to 700 nm, AmScope) for 1 
minute. Aggregates were recovered in culture media for 1 hour, followed by staining with 
live/dead staining reagents (i.e., 0.25 μL/mL Calcein AM and 2 μL/mL Ethidium 
homodimer-3, respectively) for 1 hour before imaging with a confocal microscope 
(Olympus Fluoview, FV1000). Pancreatic islets were isolated from CD1 mice following 
established protocol [125]. These islets were cultured in RPMI media supplemented with 
10 % fetal bovine serum, and 1× antibiotic-antimycotic. In a similar manner as described 
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above, islets were stained with live/dead dyes and evaluated viability with a confocal 
microscope. 
Coating of β-cell aggregates or pancreatic islets: MIN6 β-cell aggregates or isolated 
CD1 islets were stained with 10 mM of eosin-Y for 5 minutes. For the one-step coating 
method, aggregates were washed three times with HBSS (centrifugation for 3 minutes at 
500 rpm each) and suspended in 50 μL of macromer solution contained 20 wt% PEG8NB 
with stoichiometric ratio of thiol (from DTT) (Figure 3.2A). For the two-step coating 
method, stained aggregates/islets were incubated in 20 wt% of PEGdSH for 5 minutes, 
and washed three times with HBSS before suspending in macromer solution containing 
PEG8NB or PEGa8NB with DTT (Figure 3.2B). The mixture containing macromer 
components and stained aggregates/islets was exposed to visible light (between 20 to 60 
seconds). In these experiments, aggregate/islet density was fixed at approximately 500 
aggregates/mL. Coated aggregates or islets were imaged with phase-contrast microscope 
(Nikkon Eclipse Ti) and coating thickness was quantified by estimating circular diameter 
using NIS-Elements BR 3.2 software. 
 
Glucose stimulated insulin secretion (GSIS) and ELISA: Glucose solution was prepared 
(2.5 or 25 mM of glucose) with Krebs-Ringer bicarbonate (KRB) buffer containing 
sodium chloride (23 mM), potassium chloride (1 mM), sodium bicarbonate (4.8 mM), 
magnesium chloride hexahydrate (0.2 mM), calcium chloride dehydrate (0.2 mM), 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES, 0.5 mM) and bovine serum 
albumin (BSA, 0.1 vol%). The temperature of glucose solutions were equilibrated to 37 
oC. Coated or non-coated islets were washed with HBSS, hand-picked and transferred 
into micro-centrifuge tube (30 islets per tube, N = 4 tubes per sample group). Islets were 
primed with 500 μL of low glucose solution for 1 hour at 37 oC and 5 % CO2. Then, islets 
were incubated with 500 μL of low or high glucose solution (at 37 oC, 5 % CO2) for 2 
hours each. The glucose solution was collected after each glucose treatment. After 
glucose stimulation, islets were lysed with acid ethanol extraction buffer (75 vol% of 
ethanol, 1.5 vol% 1N hydrochloric acid and 23.5 vol% ddH2O) and the samples were 
diluted accordingly with KRB mixture. The amounts of insulin were quantified by mouse 
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insulin ELISA kit (Mercodia) and normalized to their corresponding total insulin content 
(i.e., the sum of intracellular and secreted insulin). 
Hydrogel fabrication and swelling: Step-growth thiol-ene hydrogels were formed by 
radical-mediated photopolymerization using 0.1 mM of eosin-Y under visible light 
exposure at an intensity of 70,000 Lux using a fiber optic microscope illuminator 
(AmScope) for 5 minutes. To quantify hydrogel swelling, circular hydrogel discs were 
prepared from 50 μL precursor solution.  Immediately after gelation, hydrogels were 
incubated in ddH2O at 37 
oC on an orbital shaker for 24 hours to remove sol fraction. 
Gels were then dried and weighed to obtain dried polymer weights (WDry).  The dried 
polymers were incubated in 5 mL of buffer solution (pH 7.4 PBS) at 37 oC on an orbital 
shaker.  At specific time points, hydrogels were removed from the medium, blotted dry 
with Kimwipe, and weighed to obtain swollen weights (WSwollen).  Hydrogel mass 
swelling ratios (qexp) were determined by a ratio of WSwollen to WDry. 
 
Hydrogel mesh size: For an ‘ideal’ thiol-ene hydrogel network containing no structural 
defects, the ideal mesh size was determined with structural information. First, the average 
molecular weight between crosslinks (𝑀𝑐̅̅ ̅̅ ) is defined as [129]: 






)     (3.1) 
Here, MWA and MWB represent the molecular weight of PEG8NB and crosslinker DTT, 
respectively. fA and fB are the number of reactive functionality for PEG8NB and DTT, 
which were 8 and 2, respectively.  With a known 𝑀𝑐̅̅ ̅̅ , the ideal network crosslinking 
density or density of elastically active chains (vc) and polymer volume fraction (v2) can 
be calculated based on the Flory-Rehner theory [63]: 
𝑣𝑐 =
𝑉1







          (3.2) 
Here, 𝑣2̅̅ ̅ is the specific volume of PEG (0.92 cm
3/g at 37 oC), V1 is the molar volume of 
water (18 cm3/mole) and ᵡ12 is the Flory-Huggins interaction parameter for a PEG-H2O 
system (0.45).  After obtaining v2, ideal hydrogel mass swelling ratio qideal can be 




      (3.3) 
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where 𝑣1̅̅ ̅ is the specific volume of water (1.006 cm
3/g at 37 oC). 
 The polymer volume fraction in the swollen state (v2,s) was obtained using the 









                                        (3.4) 
where ρ1 and ρ2 are the densities of the solvent and polymer, respectively. Here, q was 
either qideal or qexp. 
Second, the root-mean-squared end-to-end distance of network chains between 
two crosslinks in the neutral state or (𝑟0









2          (3.5) 
Here, Cn is the Flory characteristic ratio, l is the average bond length along the polymer 
backbone, and n is the number of chemical bonds within a repeating unit (e.g., n equals to 
3 for PEG). Mr is the molecular weight of the repeating units of the polymer chain. 
With calculated v2,s and (𝑟0
2)1/2, mesh size of the hydrogel (𝜉) was obtained as the 







2      (3.6) 
 
Diffusion coefficient of insulin: To estimate the diffusivity of insulin in a swollen 









)]    (3.7) 
where Dg is the insulin diffusion coefficient in the swollen thiol-ene hydrogel, D0 is the 
diffusion coefficient of insulin in pure solvent (1500 µm2/second) [131], and rs is the 
hydrodynamic radius of insulin (2 nm) [124]. Here, Y is assumed to be 1 which is the 
ratio of the critical volume required for a successful movement of insulin and the average 
free volume per molecule of solvent. 
Data Analysis: Data analysis was performed on Prism 5 software. Unless otherwise 
noted, all experiments were conducted independently for three times and the results were 
reported as mean ± SEM. Student’s t-test was conducted for statistical analysis where 
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significance was reported for p < 0.05. For coating thickness characterizations, at least 
200 aggregates were analyzed per experimental condition. 
 
 
3.5  Conclusion 
 
 In summary, we have developed a visible light-mediated thiol-norbornene 
interfacial coating process to prepare step-growth conformal hydrogel coating on islet 
surface. Using MIN6 -cell aggregates as a model, we evaluated the parameters critical 
in determining coating thickness (e.g., MW of PEGdSH, polymerization time, and 
macromer concentration). The results of live/dead staining and GSIS demonstrated high 
cytocompatibility of thiol-norbornene hydrogel coating on murine islets. This visible 
light mediated thiol-norbornene interfacial photopolymerization provides an alternate 
coating option and should be of great interest to the field of islet transplantation. Future 
work will focus on modifying thiol-norbornene gel formulation to create multi-functional 
immuno-isolation barrier, and on determining the inflammatory response and long-term 








PHOTO-CLICK HYDROGELS PREPARED  
FROM FUNCTIONALIZED CYCLODEXTRIN AND  
POLY(ETHYLENE GLYCOL) FOR DRUG DELIVERY  




4.1  Abstract 
 
 Polymers or hydrogels containing modified cyclodextrin (CD) are highly useful in 
drug delivery applications as CD is a cytocompatible amphiphilic molecule that can 
complex with a variety of hydrophobic drugs. Here, we designed modular photo-click 
thiol-ene hydrogels from derivatives of βCD and poly(ethylene glycol) (PEG), including 
βCD-allylether (βCD-AE), βCD-thiol (βCD-SH), PEG-thiol (PEGSH), and PEG-
norbornene (PEGNB). Two types of CD-PEG hybrid hydrogels were prepared using 
radical-mediated thiol-ene photo-click reactions. Specifically, thiol-allylether hydrogels 
were formed by reacting multi-arm PEGSH and βCD-AE, and thiol-norbornene 
hydrogels were formed by cross-linking βCD-SH and multi-arm PEGNB. We 
characterized the properties of these two types of thiol-ene hydrogels, including gelation 
kinetics, gel fractions, hydrolytic stability, and cytocompatibility. Compared with thiol-
allylether hydrogels, thiol-norbornene photo-click reaction formed hydrogels with faster 
gelation kinetics at equivalent macromer contents. Using curcumin, an anti-inflammatory 
and anti-cancer hydrophobic molecule, we demonstrated that CD-crosslinked PEG-based 
hydrogels, when compared with pure PEG-based hydrogels, afforded higher drug loading 
efficiency and prolonged delivery in vitro. Cytocompatibility of these CD-crosslinked 
hydrogels were evaluated by in situ encapsulation of radical sensitive pancreatic MIN6 β-
cells. All formulations and crosslinking conditions tested were cytocompatible for cell 
Chaper 4 here is as appeared in H. Shih and C. Lin, Biomacromolecules, 2015(16) 1915-1923 
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encapsulation. Furthermore, hydrogels crosslinked by βCD-SH showed enhanced cell 
proliferation and insulin secretion as compared to gels crosslinked by either dithiothreitol 
(DTT) or βCD-AE, suggesting the profound impact of both macromer compositions and 
gelation chemistry on cell fate in chemically crosslinked hydrogels. 
 
 
4.2  Introduction 
 
 As defined by the Food and Drug Administration (FDA), amphiphilic 
cyclodextrins (CDs) are a class of ‘Generally Recognized as Safe (GRAS)’ 
macromolecules [132-134]. The hydrophobic cavity of CD can accommodate a broad 
range of poorly soluble drugs through host-guest complex formation, whereas the 
hydrophilic surface of CD facilitates the dissolution of the CD-drug complex in aqueous 
solutions [135]. Three types of CD, α-, β-, and γ-CD (with 6, 7, and 8 repeating units of 
glycopyranose, respectively), are commonly used for increasing the solubility of 
hydrophobic drugs [136]. In addition to serving as a drug-dissolving agent, CDs can be 
easily modified for forming multifunctional macromolecules, including linear polymers 
and network hydrogels [137-139]. For example, hydroxyl groups of βCD could be 
functionalized with acrylate for crosslinking into hydrogel for binding and releasing anti-
cancer drug, such as chlorambucil. The release rate was controlled by adjusting pH or 
degree of network crosslinking [140]. CD could also be functionalized with azide for 
chemical crosslinking with PEG-di-alkyne via the copper-catalyzed azide-alkyne 
cycloaddition (CuAAC) [141]. Unfortunately, copper is a cytotoxic metal that induces 
oxidative damage to cells [142]. Hence, CuAAC is mostly not compatible with live cell 
experiments [143]. Recently, Sanyal et al. reported the formation and characterization of 
Michael-type thiol-maleimide hydrogels using hepta-thiol-substituted βCD (βCD-SH7) 
and linear poly(ethylene glycol)-maleimide (PEG-maleimide) [144]. However, 
maleimide group deprives topoisomerase II catalytic activity of cells that can lead to cell 
apoptosis [145] and the presence of unreacted maleimide might create adverse effects on 
cell viability [145, 146]. In addition, thiol-maleimide gelation proceeds via a nucleophilic 
56 
 
reaction that does not allow one to easily control polymerization kinetics. In this regard, 
Arslan et al. prepared CD-PEG hybrid hydrogels through photo-crosslinking of 
commercially available βCD-SH7 and PEG-allylether and the hydrogels were used to 
deliver hydrophobic puerarin [147]. This hydrogel crosslinking, however, was carried out 
in an organic condition using dimethylformamide (DMF) as the solvent. As a result, this 
system was not compatible for in situ cell encapsulation. 
 In the past few years, we and other groups have explored the aqueous-based step-
growth thiol-norbornene photo-click chemistry to prepare highly cytocompatible and 
tunable hydrogels for tissue engineering applications [148]. The gelation of thiol-
norbornene hydrogels can be initiated by type I photoinitiator (e.g., Irgacure-2959 or 
lithium arylphosphinate (LAP)) under long wavelength, low intensity ultraviolet (UV) 
light irradiation (365 nm, 5–10 mW/cm2). Thiol-norbornene gelation could also be 
initiated by visible light (400-700 nm) exposure with type II photoinitiator (e.g., eosin-Y 
or rose bengal) as the sole photosensitizer [58, 59]. The advantages of step-growth thiol-
norbornene photopolymerization include rapid, ambient, and aqueous reaction conditions, 
as well as spatial-temporal control over gelation kinetics [36, 37, 120]. More importantly, 
thiol-norbornene hydrogels are highly cytocompatible even for radical-sensitive 
pancreatic β-cells [52, 149]. In addition to PEG-norbornene, other macromers containing 
non-homopolymerizable ‘ene’ moieties have been explored for forming step-growth 
thiol-ene hydrogels. For example, Kloxin and colleagues recently reported an aqueous 
thiol-allylether reaction to form thiol-ene hydrogel for in situ cell encapsulation. The 
radical-mediated thiol-allylether hydrogel was formed between multi-arm PEG-thiol 
(PEGSH) and bis-allyloxycarbonyl functionalized peptides [150]. This thiol-allylether 
gelation produced hydrolytically stable hydrogels that were cytocompatible for 
encapsulation of human mesenchymal stem cells (hMSCs). 
 Thiol-ene hydrogels have been exploited as platforms for encapsulating 
hydrophilic biomolecules, drugs, and cells. Since CDs are capable of increasing the 
solubility of poorly soluble molecules, a CD-crosslinked thiol-ene hydrogel can 
potentially be used to encapsulate and to deliver both hydrophilic and hydrophobic 
biomolecules. Furthermore, CD can be used to form supramolecular association with 
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selected hydrophobic molecules, such as adamantane. A CD-immobilized hydrogel 
formed by the aqueous thiol-ene photo-click reaction will not only permit in situ cell 
encapsulation, but may also allow researchers to create hydrogels with dynamically 
tunable properties in the presence of cells. As the first step toward achieving this goal, we 
report here the synthesis and characterization of βCD derivatives, the crosslinking of 
βCD-PEG hybrid hydrogels via radical-mediated thiol-ene photopolymerizations, the 
delivery of a model hydrophobic drug, and the cytocompatibility of these step-growth 
hydrogels. Specifically, a two-step synthesis procedure was developed for functionalizing 
βCD with the desired number of allylether, which could be used to form hydrolytically 
stable thiol-allylether photo-click hydrogel. Alternatively, allylether moieties could be 
further converted to thiols, which could be used to form thiol-norbornene hydrogels. Both 
thiol-ene gelation systems utilized a low concentration of LAP as the photoinitiator and 
the gelation was initiated via light exposure at 365 nm. We investigated the gelation 
kinetics and physical properties of these two types of thiol-ene hydrogels. Curcumin, a 
hydrophobic molecule with anti-inflammatory and anti-cancer potential, was used as a 
model drug to demonstrate the enhanced uptake and prolonged release of hydrophobic 
drug from CD-crosslinked thiol-ene hydrogels. Furthermore, the cytocompatibility of 
these step-growth CD-crosslinked thiol-ene hydrogels were evaluated via in situ 














4.3  Results and Discussion 
 
4.3.1  Preparation and characterization of βCD derivatives 
 
  A two-step process was employed to modify βCD with allylether moiety. 
First, NaH was added at different concentrations to activate hydroxyl groups on 
βCD (Figure 4.1A, step i). Following the secession of hydrogen gas, excess allyl 
bromide was added to the reaction mixture (Figure 4.1A, step ii) to afford βCD-
AE. 1H NMR results (Figure 4.1B) showed that allylether group was successfully 
introduced to βCD. Unexpected peaks between 4.1 to 4.3 ppm were likely due to 
regioisomerism. Peaks of similar intensities (i.e., 3.8 or 4.6 ppm) were likely due 
to the shifting of protons on βCD due to varied combinations of allylether 
positions. The modification was confirmed by mass spectroscopy analysis. The 
difference of the average molecular mass of βCD-AE and βCD was divided by the 
molecular mass of allylether (i.e., 40 Da) to estimate the degree of allylether 
functionalization. As the concentration of NaH or allylbromide to βCD was 
increased (from 0 to 11.3-fold, Figure 4.2), so was the detected mass of the 
modified βCD and the estimated degree of substitution (0, 1.5, 2.4 and 4.5, 
respectively). To obtain thiol-substituted βCD, βCD-AE was first photoconjugated 
with thioacetic acid via radical-mediated thiol-allylether addition (Figure 4.1A, 
step iii). The intermediate product, βCD-thioacetate, was hydrolyzed with sodium 
hydroxide, neutralized with hydrochloric acid, and purified via dialysis to obtain 
the final product, βCD-SH (Figure 4.1A, step iv). 1H NMR results confirmed that 
allylether was replaced with thiol group (Figure 4.1B, bottom panel). The presence 
of thiol on modified βCD was further quantified by Ellman’s assay (Figure 4.3). 
As the concentration of βCD-SH was increased from 0.02 to 1 mg/mL, the 
concentration of thiol detected increased linearly (R2 = 0.99) from 0.006 ± 0.001 to 













Figure 4.1. (A) Schematics of βCD modifications. (i) NaH, DMF, room 
temperature; (ii) allylbromide, DMF, room temperature; (iii) thioacetic acid, I-
2959, UV (365 nm, 10 mW/cm2), 30 min; (iv) sodium hydroxide (aq.), followed 
by neutralization with hydrogen chloride. 1H NMR of (B) βCD, (C) βCD-AE, and 




Figure 4.2. Mass spectroscopy of CD derivatives. (A) Mass-to-charge (m/z) for un-
modified βCD (B-D) βCD-AE with increasing feed ratio of NaH and allylbromide (B: 
























4.3.2  Preparation of thiol-ene photo-click hydrogels 
 
 We next demonstrated the crosslinking of CD-PEG hybrid hydrogels using 
PEG8SH (M.W. 20 kDa) and βCD-AE through a radical-mediated thiol-allylether photo-
click reaction (Figure 4.4) and the gelation was evaluated via in situ photorheometry 
(Figure 4.4B, 4.5). Specifically, 5 wt% of PEG8SH was cross-linked with different 
concentrations of βCD-AE (9 to 24 mg/mL). The gel points of all formulations evaluated 
were similar regardless of βCD-AE concentration in the precursor solution (gel point ~ 
17 to 22 seconds, Figure 4.5). However, the formulation afforded the highest elastic 
modulus (~2.5 kPa at 300 second) at 24 mg/mL of βCD-AE (Figure 4.4B). Further 
increasing βCD-AE concentration did not yield higher gel modulus (data not shown). 
Controlled experiment using unmodified βCD with PEG8SH showed no sign of gelation 
even after 300 seconds of light exposure in the presence of photoinitiator (Figure 4.4C), 
suggesting that the gelation was not due to disulfide bond formation. Since 24 mg/mL of 
βCD-AE yielded the highest shear modulus of thiol-allylether hydrogel, we examined the 
gelation of thiol-norbornene hydrogel (Figure 4.4D) using this concentration (24 mg/mL) 
of thiol-substituted βCD (i.e., βCD-SH) and 5 wt% of 8-arm PEG-norbornene (PEG8NB, 
M.W. 20 kDa). Even with slightly lower degree of functionalization (~85 % on 
PEG8NB), the gelation of βCD-SH with PEG8NB still afforded a 5-fold faster gel point 
(Figure 4.4E, gel point ~3 seconds). However, the final shear modulus of thiol-
norbornene hydrogel formed with βCD-SH and PEG8NB only reached about 1.1 kPa 
(Figure 4.4E). Control experiment showed that gelation was not possible when 
unmodified βCD was mixed with PEG8NB (Figure 4.4F) and subjected to the same 
radical-initiation conditions, indicative of the lack of either PEG8NB 
homopolymerization or gelation due to supramolecular assembly (or threading) between 




Figure 4.4. (A) Scheme of light and radical mediated thiol-allylether gelation. (B) In situ 
photorheometry of thiol-allylether photopolymerization (G’: storage modulus; G”: loss 
modulus) between PEG8SH and βCD-AE. (C) In situ photorheometry of solution 
containing PEG8SH and βCD. (D) Scheme of light and radical mediated thiol-norbornene 
gelation. (E) In situ photorheometry of thiol-norbornene photopolymerization PEG8NB 
and βCD-SH. (F) In situ photorheometry of solution containing PEG8NB and βCD (5 
wt% PEG8SH or PEG8NB, 24 mg/mL of βCD-AE or βCD-SH, 1 mM LAP). Light (365 
nm, 10 mW/cm2) was turned on at 30 seconds (dotted line). N = 3, error bars were 





Figure 4.5. In situ photorheometry showing the evolution of storage modulus (G’) and 
loss modulus (G”) of thiol-allylether photopolymerization at 5 wt% PEG8SH and various 
CD-AE concentration in the precursor solution (1 mM LAP, 365nm light at 10 mW/cm2). 
Light was turned on at 30 seconds (dotted line). N = 3, error bars were omitted for clarity. 
 
The fast thiol-ene gelation using macromers functionalized with norbornene, a 
strained ene, is well-documented in the literature. For example, we have shown that PEG-
peptide thiol-norbornene gelation could be achieved rapidly (gel point ~ 2-3 seconds) 
using low PEGNB and photoinitiator concentrations (e.g., 4 wt% PEG4NB20kDa with 
DTT or bis-cysteine peptides and 1 mM LAP) [62]. On the other hand, Kloxin and 
colleague designed a radical-mediated (1.1 mM of LAP) thiol-allylether hydrogel system 
using 10 wt% of PEG4SH (M.W. 20 kDa) with alloc-functionalized peptides and 
obtained a gel point of about 15 seconds [150]. While both allylether and norbornene 
react with thiol via a strictly step-growth mechanism (i.e., no homopolymerization 
between the ene groups) [151], the polymerization rate of thiol-norbornene is six times 
faster than that of thiol-allylether due to the unity ratio of thiyl radical propagation to 
chain transfer kinetic parameters (kpSC /kCT) [151]. It is worth noting that, while thiol-
norbornene gelation was one order of magnitude faster than thiol-allylether gelation, the 
final gel shear modulus of the former was only about half of the latter. This could be 
explained by the fact that PEG8NB, which was synthesized in house, was lower in the 
degree of functionalization (85%, per 1H NMR) as compared with commercially 
acquired PEG8SH (>95%, per manufacturer’s certificate of analysis, respectively). 

























Furthermore, since βCD-SH was modified from βCD-AE, it would make sense that gels 
crosslinked by βCD-SH would have a lower degree of crosslinking, and hence lower 
shear modulus, as compared with gels crosslinked by βCD-AE.   
  CD has been shown to assist the assembly of physical ‘pseudo-
polyrotaxane’ hydrogel through interactions with PEG or block co-polymers of 
polypropylene oxide (PPO) and polyethylene oxide (PEO) (e.g., Pluronic). 
Previously, Cooper-White and colleagues reported supramolecular gelation of 
αCD with Pluronic co-polymers and concluded that the ‘threading’ induced 
gelation would only occur in the presence of ‘poly-CD’ aggregates, which was 
only apparent at a sufficiently high concentration of CD (at least 50-70 mg/mL) 
[152]. The gelation in the work presented here was purely based on thiol-ene 
photochemistry since the CD concentrations used in this study were less than 40 
mg/mL and the fact that no gelation was observed by simply mixing unmodified 
βCD with PEGNB (Figure 4.4C). Another relevant work reported by Elisseeff and 
colleagues showed a tunable CD/PEG hybrid hydrogel crosslinked by chain-
growth photopolymerization. It is worth noting that the functionalized βCD motifs 
were ‘threaded’ onto PEG-diacrylate after overnight incubation[153]. We believe 
that the threading of CD to PEG chains was minimal, if any, since we added βCD 
into the mixture right before photopolymerization in all experiments. Another 
potential complication is the formation of LAP/βCD complex. We performed 
isocratic HPLC using acetonitrile/phosphate buffer (35/65) containing βCD (0 to 
10 mM) as the mobile phase. While the elution of LAP shifted slightly (Figure 
4.6A), the elution time of injected LAP (0.1 mM) was not significantly different 
from each other regardless of βCD concentration (Figure 4.6B). Since the gelation 
was accomplished within 5 minutes, it is unlikely that the association between 
LAP and βCD, if any, would impede light-induced initiator breakdown and 
gelation. Furthermore, the potential association would also decrease after the 




Figure 4.6. Evaluation of potential LAP/CD complex formation using reverse-phase 
HPLC. (A) 0.1mM LAP was injected into C18 analytical column using 
acetonitrile/phosphate buffer (35/65) as the mobile phase. The mobile phase also 
contained different concentrations of βCD as indicated. Absorbance was measured at 280 
nm. N = 3, error bars were omitted for clarity. (B) Elution time corresponds to maximum 
absorbance of LAP. (Mean ± SD, N = 3) 
 
4.3.3  Effects of macromer functionality and  
molecular weight on gelation kinetics 
 
 Since thiol-norbornene reaction exhibits faster gelation kinetics than thiol-
allylether reaction, we evaluated the effects of PEGNB macromer functionality and 
molecular weight on the gelation of CD-based thiol-norbornene hydrogels (Figure 
4.7). PEG4NB (M.W. 20 kDa, Figure 4.7A) and PEG8NB (M.W. 40 kDa, Figure 
4.7B) were selected as these two macromers provided the same total concentration 
of norbornene at the same weight percentage (i.e., 10 mM at 5 wt%). Note that the 
molar ratio of norbornene to thiol was maintained at one, whereas the 
concentration of thiol from βCD-SH was determined by Ellman’s assay (Figure 
4.3). Since the average molecular weight per arm in these two macromers was the 
same (i.e., 5 kDa), the average molecular weight between crosslinks (𝑀𝑐̅̅ ̅̅ ) of the 
two was also the same (Eq. 3). This implied that the two sets of hydrogels would 
have the same ideal crosslinking efficiency (Eq. 4). Experimentally, however, we 
found that thiol-norbornene hydrogels cross-linked by PEG4NB (20 kDa) had a 
slightly slower gel point (~6 seconds) and a lower shear modulus (~1 kPa) when 

































































compared with gels crosslinked by PEG8NB (40 kDa) (~4 seconds and ~3 kPa). 
These results was consistent with the trend found in previously reported step-
growth Michael-type hydrogels [154]. Theoretically, step-growth hydrogels with 
the same 𝑀𝑐̅̅ ̅̅  (Eq. 3) should have identical mesh size (Eq. 4) regardless of the 
macromer concentration. Experimentally, however, macromer with lower 
functionality formed hydrogel with higher swelling ratio compared with macromer 
with higher functionality [62, 63]. The phenomenon was attributed to network 
defects and inefficient cross-linking at lower macromer functionality. We also 
compared gelation kinetics of CD-based thiol-norbornene hydrogels using 
macromer PEG8NB with different molecular weight (Figure 4.7B & 4.7C). The 
gel point of hydrogel cross-linked by 20 kDa PEG8NB was 2.2–fold faster, and the 
elastic modulus was 1.5–fold higher, than the gels cross-linked by 40 kDa 
PEG8NB. These results were also expected because of the higher molarity of 




Figure 4.7. In situ photorheometry of thiol-ene hydrogels crosslinked by βCD-SH and 
(A) PEG4NB (20 kDa), (B) PEG8NB (40 kDa) or (C) PEG8NB (20 kDa). (5 wt% 
PEGNB, [thiol] = [norbornene], 1 mM LAP). Light (365 nm, 10 mW/cm2) was turned on 




4.3.4  Effects of cross-linker on hydrogel properties 
 
 After examining the effect of CD-PEG macromer formulations on gelation, 
we evaluated the influence of crosslinker on the physical properties of selective 
groups of thiol-norbornene hydrogels. Three sets of macromers were used: (1) 
DTT with PEG4NB (labelled as DTT in Figure 4.8), (2) βCD-SH with PEG4NB 
(labelled as CD-SH), and (3) PEG4SH with βCD-AE (labelled as CD-AE). As 
shown in Figure 4.8A, the gel fraction was not significantly different between the 
three groups (86 ± 3 %, 79 ± 8 %, and 74 ± 6 % for DTT, CD-SH, and CD-AE gel, 
respectively). However, the DTT gel exhibited the highest equilibrium shear 
modulus when compared with gels crosslinked with CD-SH or CD-AE (Figure 
4.8B, ~7.1, 3.4, and 2.4 kPa for DTT, CD-SH and CD-AE gel, respectively). The 
differences in equilibrium shear moduli reflected the variation in network 
crosslinking density, which was affected by the types of thiol (i.e., DTT, CD-SH, 
or PEG4SH) and ene (i.e., norbornene or allylether) used in the formulations [62]. 
The lowest crosslinked CD-AE gels also had highest swelling ratio among the 
three groups (Figure 4.8D). Interestingly, even though the modulus of DTT gel 
was higher than that of CD-SH gel (Figure 4.8B & 4.8C), the swelling ratio of 
DTT gel was also 2-fold higher than that of CD-SH gel (Figure 4.8D). This result 
was contradictory to the inverse scaling of modulus and swelling ratio in 
chemically crosslinked hydrogels. A significantly lower swelling ratio for CD-SH 
gel might be a result of higher CD-SH concentration and mass (48 mg/mL) 
required for this formulation. As a comparison, the concentration of DTT used was 
only 1.5 mg/mL. Inclusion of higher content of amphiphilic CD in the gel 




Figure 4.8. Effect of crosslinker on (A) gel fraction, (B) elastic modulus at 
equilibrium gel swelling, (C) shear modulus as a function of time, and (D) swelling 
ratio as a function of time. Asterisks indicate statistical significance (p < 0.05, 5 
wt% 20 kDa PEG8SH or PEG8NB, 1 mM LAP, 365 nm light, intensity at 5 
mW/cm2, mean ± SD, N = 3). 
 
 The step-growth thiol-norbornene hydrogels were known to degrade 
hydrolytically if ester bonds were presence in the PEGNB macromers [62]. We 
evaluated the hydrolytic stability of the three groups of thiol-ene hydrogels (i.e., 
DTT, CD-SH, and CD-AE gel). The hydrolytic degradation of these thiol-ene 
hydrogels in neutral buffer solution (pH 7.4) was not significant as the modulus 
and swelling ratio remained relatively stable over 10 days (Figure 4.8C & 4.8D). 





































































kPa and 3.4 kPa for DTT and CD-SH gel, respectively) or contained no 
hydrolytically labile bonds (e.g., CD-AE thiol-allylether gel). We also conducted 
an accelerated hydrolysis study (Figure 4.9) by incubating these hydrogels in basic 
buffer (pH 9). As expected, a decline in G’ over time was observed for DTT and 
CD-SH gels (both crosslinked with PEG4NB), indicative of base-catalysed 
hydrolysis of ester bonds in PEG4NB macromer (Figure 4.9). On the other hand, 
CD-AE gel remained intact over time (i.e., constant G’) since thiol-allylether 
hydrogels did not contain hydrolytic degradable moieties.  
 
Figure 4.9. Effect of crosslinker on shear modulus as a function of time in pH 9 
PBS. ( 5 wt% 20 kDa PEG8SH or PEG8NB, 1 mM LAP, 365 nm light, intensity at 
5 mW/cm2, mean ± SD, N = 3). 
 
 
4.3.5  Uptake and release of hydrophobic  
curcumin from thiol-allylether hydrogels 
 
 One potential application of the CD-PEG hydrogel system is to deliver 
hydrophobic drugs. Many anti-inflammatory drugs, such as curcumin [155], are 
hydrophobic and hence have lower bioavailability in vivo. Curcumin has also been a 
subject of intensive research interest in diabetes because of its blood glucose lowering 
effect [156]. Since thiol-norbornene hydrogels would be hydrolyzed in basic buffer [62], 
we chose thiol-allylether hydrogels crosslinked by CD-AE and PEG4SH as a model gel 
system to demonstrate the enhanced uptake and sustained release effect of curcumin from 



















CD-PEG hybrid hydrogels. Pure PEG hydrogels crosslinked by PEGAE and PEG4SH 
under the same gelation conditions were used as control. The two sets of gels (labeled as 
PEGAE and CD-AE in Figure 4.10) were incubated in ddH2O suspended with 
hydrophobic curcumin for 8 hours. As shown in the top panel of Figure 4.10A, hydrogels 
crosslinked with CD-AE appeared more yellowish when compared to hydrogels 
crosslinked with PEGAE, indicative of higher amount of curcumin (yellow in color) 
uptake due to the presence of chemically crosslinked CD in the gel. Subsequently, these 
gels were immersed in DMSO to completely liberate the curcumin. As shown in the 
bottom panel of Figure 4.10A, both sets of gels appear transparent and identical, 
indicating that all curcumin were released from the gels. The liberated curcumin was 
quantified via UV/vis absorbance measurement (Figure 4.10B). Compared to pure PEG 
hydrogels crosslinked with PEGAE and PEG4SH, hydrogels crosslinked with CD-AE 
were capable of loading twice as much curcumin (~9 and ~20 µg/gel for PEGAE and 
CD-AE gel, respectively).  
 
 
Figure 4.10. (A) Photographs of thiol-allylether hydrogels incubated in curcumin 
suspended ddH2O for 8 hours (top) and after DMSO-treatment (bottom). (B) Curcumin 
uptake in hydrogels formed by 5 wt% PEG8SH with 3.4 kDa of PEGAE or 24 mg/mL 































 Because the amount of curcumin loading in the control PEGAE gel was much 
lower than that in the CD-AE gel, it would be difficult to compare the release of 
curcumin from these two sets of gels. In order to form complex with βCD, Yadav et al 
employed the pH shifting method to solubilize curcumin in an alkaline solution with βCD 
[157]. Therefore, we believe that the alkaline condition did not affect the association of 
βCD and curcumin.To demonstrate the sustained delivery of curcumin from CD-
crosslinked hydrogels, we performed drug-loading in alkaline curcumin solution for 36 
hours (curcumin was dissolved in 0.5 N NaOH first, followed by diluting with pH 7.4 
PBS). Prior to drug loading the two sets of gels were equally transparent (Figure 4.11A, 
panel 1). After drug loading (Figure 4.11A, panel 2), the two sets of thiol-allylether 
hydrogels were equally opaque, suggestive of similar curcumin intake. The similar 
amount of curcumin absorbed in the gels were quantified by DMSO treatment as 
described earlier (Figure 4.11B, 6.6 ± 1.1 and 6.9 ± 0.4 µg/gel for PEGAE and CD-AE 
gel, respectively). The gels were then incubated in buffer solution for curcumin release. 
Significantly more curcumin was released from hydrogels crosslinked by PEGAE than by 
CD-AE (Figure 4.11C, 85 % and 42 % of curcumin was released from PEGAE and CD-
AE hydrogels after 10 hours, respectively). Over the course of first 100 hours, a 1.8-fold 
higher amount of curcumin was released from PEGAE-crosslinked gels than from CD-
AE crosslinked gels (Figure 4.11C, 87 % and 49 %, respectively\). After the release 
study, CD-AE gel appeared slightly darker than PEGAE gel (Figure 4.11A, panel 3), 
suggesting that a higher amount of curcumin was still retained in this gel. However, after 
DMSO treatment for an additional 100 hours, the remaining curcumin were completely 
released from both sets of hydrogels (Figure 4.11C) and the appearances of the gels were 






Figure 4.11. (A) Photographs of thiol-allylether hydrogels: (1) immediately after 
photopolymerization, (2) after incubating in curcumin solution for 36 hours, (3) after 100 
hours of release in pH 7.4 PBS, and (4) after an additional 100 hours of release in DMSO 
(scale: 5 mm). (B) Effect of crosslinker on curcumin uptake in the gel. (C) Curcumin 
release from thiol-allylether hydrogel formed by 5 wt% PEG8SH with 3.4 kDa of 





 The increase of curcumin solubility via guest-host interactions with CD is well 
documented [158-160]. In our study, CD-AE was employed as both a hydrogel 
crosslinker and a carrier for hydrophobic drug (i.e., curcumin). Compared to thiol-
allylether hydrogels crosslinked by PEGAE, gels crosslinked by CD-AE accommodated 
significantly more curcumin due to the formation of inclusion complex. The presence of 
CD/curcumin inclusion complex also resulted in delayed/sustained release of curcumin 
from the CD-AE hydrogel. Since all curcumin absorbed in the gel could be liberated by 
DMSO, we believe that the retention of curcumin was purely due to inclusion complex 
formation but not Michael-type reaction occurred between curcumin and nucleophilic 
thiols in the gels [161],[162] . For the purpose of proof-of-concept, current study only 
demonstrated post-loading of curcumin by CD/PEG hydrogels. Future study will focus on 
pre-complexing functionalized CD with curcumin, which can be used as crosslinker to 
simultaneously encapsulate drugs and cells in a single reaction.  
 
4.3.6  Cytocompatibility of CD-crosslinked thiol-ene hydrogels 
 
 Next, we evaluated the cytocompatibility of CD-crosslinked thiol-ene hydrogels 
using in situ encapsulation of pancreatic MIN6 β-cells at a relatively low cell density 
(2×106 cells/mL) [149]. Thiol-norbornene hydrogels crosslinked by DTT and PEG8NB 
(M.W. 20 kDa) were used as a control group as similar gelation formulation has been 
shown to be cytocompatible for radical-sensitive MIN6 β-cells [52]. One day after cell 
encapsulation, live/dead staining was performed and the results show that thiol-
norbornene hydrogels crosslinked by CD-SH were highly cytocompatible for MIN6 cells 
(Figure 4.12A, ~83 % live cells), while hydrogels crosslinked by DTT or by CD-AE 
contained slightly more dead cells (Figure 4.12A, ~72 % and 73 % live cells for gels 
crosslinked by DTT and CD-AE, respectively). Regardless of the cross-linker used, 
MIN6 -cells formed spherical aggregates in all hydrogels 10 days after cell 
encapsulation (Figure 4.12A, right panel). The average diameters of the spheroids were 
about 18 µm, 26 µm, and 32 µm for hydrogels crosslinked by DTT, CD-SH and CD-AE, 
respectively. We also quantified cell metabolic activity using CellTiter-Glo® (for 
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measuring intracellular ATP content) and AlamarBlue® regent (for measuring cell 
metabolic activity). In DTT or CD-AE crosslinked hydrogels, the intracellular ATP 
content increased from ~13 to 200 pmol of ATP per sample (Figure 4.13) from day 1 to 
day 10. The difference between DTT and CD-AE crosslinked hydrogels was not 
significantly on either day 1 or day 10. On the other hand, the amount of ATP increased 
from ~70 to 390 pmol per sample in hydrogels crosslinked by CD-SH (Figure 4.13). The 
increased in intracellular ATP was most likely due to the cell proliferation and the 
formation of multi-cell aggregates. Cell proliferation in CD-PEG hydrogels was verified 
by Alamarblue® reagent assay (Figure 4.12B) and the trends were consistent with 
live/dead staining and ATP assay.  
 
Figure 4.12. Effect of crosslinker on the cytocompatibility of thiol-ene hydrogels on 
MIN6 β-cells. (A) Representative confocal z-stack images of MIN6 cells stained with 
live/dead staining kit on day 1 and day 10. MIN6 cells were encapsulated (2×106 
cells/mL) in thiol-ene hydrogels crosslinked by DTT, CD-SH or CD-AE. (B) Cells 
viability as assessed by Alamarblue® reagent. (C) Normalized insulin secretion. All gel 
formulations contained 5 wt% 20 kDa PEG8SH or PEG8NB, 1 mM LAP, and 365 nm 




Figure 4.13. Effect of crosslinker on the intracellular ATP content of MIN6 β-cells 
encapsulated in thiol-ene hydrogels. ATP contents were measured by CellTiter-Glo® 
reagent (mean ± SD, N = 3). All gel formulations contained 5 wt% 20kDa PEG8SH or 
PEG8NB, 1 mM LAP, and 365nm light at 5 mW/cm2. 
 
 
 Studies have shown that softer matrix and hydrolytic gel degradation promoted 
the phenotype, function, and proliferation of MIN6 βcells in 3D [52, 163]. The thiol-
norbornene hydrogels in the current study were slightly stiffer (Figure 4.8B) and 
relatively stable at pH 7.4 over the course of 10 days (Figure 4.8C & 4.8D). Consistent 
with our published work using PEG-based thiol-norbornene hydrogels [62], the 
hydrolysis rate of CD-PEG hybrid hydrogels could be accelerated under basic condition 
(e.g., pH 9, Figure 4.9). On the other hand, thiol-allylether hydrogels remained 
hydrolytically stable (Figure 4.9). Therefore, compared to CD-SH crosslinked hydrogels, 
the slightly higher initial cell death (Figure 4.12A to 4.12C) in DTT-crosslinked 
hydrogels might be a result of higher gel stiffness. When we replaced PEG8NB with 
PEG4NB without changing macromer molecular weight (20 kDa) or content (5 wt%), the 
modulus of the hydrogels decreased by half (Figure 4.14, 3.1 kPa and 1.2 kPa for DTT 
and CD-SH cross-linked gels, respectively). Additional cell encapsulation studies using 
these softer gels showed improved viability of encapsulated MIN6 cells (Figure 4.15, top 
panel, >98 % viable cells). In addition to gel stiffness, the presence of active radicals 
could induce cellular damage during photo-encapsulation [164]. While thiol-allylether 



























by DTT (Figure 4.8B, ~2.4 kPa and 7.1 kPa for CD-AE and DTT gel, respectively), the 
viability of MIN6 cells was not much higher (Figure 4.12). We reason that the radical-
sensitive MIN6 cells were exposed to active radicals for a longer time during the thiol-
allylether gelation because of a much lower chain transfer kinetic constant, and hence the 
benefits of a softer gel on cell viability was offset by longer exposure of the cells to 
radical species.  
 
Figure 4.14. Effect of crosslinker on elastic modulus at equilibrium swelling. Asterisk  
indicates statistical significant between crosslinker βCD-SH and DTT, R < 0.05. (5 wt% 
PEG4NB20kDa, [thiol] = [norbornene] = 10 mM, 1 mM LAP, light intensity at 10 
mW/cm2, mean ± SD, N = 3) 
 
 Finally, we evaluated function of encapsulated cells with static glucose stimulated 
insulin secretion (GSIS, Figure 4.12C). Since the viability of MIN6 cells varied among 
different conditions, the amount of insulin was normalized to the amount of intracellular 
ATP, which scales with cell number at day 10. Compared with thiol-ene hydrogels 
crosslinked by DTT or CD-AE, the secretion of insulin by MIN6 cells encapsulated in 
thiol-ene hydrogel crosslinked by CD-SH was about 3-fold higher than thiol-ene 
hydrogel crosslinked by DTT and CD-AE (Figure 4.12C, about 0.04 CD-SH, and 0.01 for 
DTT and βCD-AE). This functional assay result also concurs with the notion that softer 



















Figure 4.15. Effect of crosslinker on the cytocompatibility of thiol-ene hydrogel on MIN6 
β-cells. (A) Representative confocal z-stack images of MIN6 stained with live/dead 
staining kit on day 1 and 10. MIN6 were encapsulated (2×106 cells/mL) in thiol-ene 
hydrogels crosslinked by βCD-SH (left column) or DTT (right column). MIN6 β-cells 
viability measured by (B) CellTiter-Glo®, and (C) Alamarblue® reagent (mean ± SD, N 
= 3). All gel formulations contained 5 wt% PEG4NB20kDa, [thiol] = [norbornene] = 10 
mM, 1 mM LAP, and light at 5 mW/cm2. (Scale: 100 μm).  
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4.4.  Materials and Methods 
 
Materials: 4-arm PEG (20 kDa), 8-arm PEG (20 kDa and 40 kDa) and 8-arm PEG-thiol 
(PEG8SH, 20 kDa) were purchased from JenKem Technology USA. βCD was purchased 
from TCI America. 5-norbornene-2-carboxylic acid, N,N’-dicyclohexylcarbodiimide 
(DCC), 4-(dimethylamino) pyridine (DMAP), sodium hydride, and allyl bromide were 
obtained from Sigma-Aldrich. Dialysis membranes with MWCO 500-1000 Da and 6000-
8000 Da were obtained from Spectrum Laboratories and Fisher Scientific, respectively. 
Other chemicals were purchased from Fisher Scientific unless noted otherwise. 
 
Synthesis of photoinitiator and PEG macromers: The synthesis of photoinitiator 
lithium arylphosphonate (LAP) was described as reported elsewhere [38]. PEG-
tetra-norbornene (PEG4NB, 20 kDa) and PEG-octa-norbornene (PEG8NB, 20 kDa 
and 40 kDa) were synthesized following an established protocol [120]. In brief, 5-
norbornene-2-carboxylic acid (5-fold excess of OH group) and coupling reagent 
DCC (2.5-fold excess of OH group) were added to anhydrous dichloromethane 
(DCM). The mixture was purged with nitrogen and stirred at room temperature for 
1 hour. The resulting norbornene anhydride was filtered into an addition funnel 
and added slowly to a flask containing PEG (4-arm or 8-arm), DMAP (0.5-fold of 
OH group), and pyridine (0.5-fold of OH group) dissolved in anhydrous DCM. 
The flask was purged with nitrogen, kept on ice and allowed to react overnight in 
dark. The product was precipitated in cold ethyl ether and collected by filtration. 
PEGNB product was re-dissolved in double distilled water (ddH2O) and proceed 
with dialysis (MWCO 6000-8000 Da) for 2 days using slightly acidic ddH2O (pH 
6.8) to prevent ester hydrolysis of PEGNB. The pure product was obtained from 
lyophilization (degree of norbornene substitution >85 %). PEGNB: 1H NMR 
(CDCl3, 500 MHz): δ – 4.25 (m, 2H), 5.98 (m, 1H), 6.23 (m, 1H). PEG-allylether 
(PEGAE) was synthesized following a published protocol. Briefly, linear PEG (3.4 
kDa) was dissolved in anhydrous toluene and dried with evaporation by reduced 
pressure. Dried PEG was re-dissolved in anhydrous tetrahydrofuran (THF). 
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Sodium hydride (1.5-fold excess of hydroxyl group) was added slowly to the PEG 
solution under continuous nitrogen purging at 40 °C. Upon complete liberation of 
hydrogen gas, allylbromide (6-fold excess of hydroxyl group) was added drop wise 
to the solution. After overnight reaction in dark, sodium bromide salt was filtered 
off to afford a PEG-allylether (PEGAE) solution. PEGAE was precipitated in cold 
ethyl ether, filtered and dried in vacuuo. The purity of PEGAE product was 
verified with H1 NMR in CDCl3 (96 %, Bruker 500). PEGAE: 
1H NMR (CDCl3, 
500 MHz): δ – 4.04 (m, 2H), 5.31 (m, 1H), 5.43 (m, 1H), 6.07 (m, 1H). 
 
Synthesis of allylether or thiol functionalized βCD: βCD-AE was synthesized 
following a published protocol with slight modification [165]. βCD was dried in 
vacuum oven overnight and dissolved in 40 mL of anhydrous dimethylformamide 
(DMF) in a flask. While purging the flask with nitrogen, desired amount of sodium 
hydride (i.e., 2.3, 4.5 or 11.3-fold of [NaH] and [allylbromide] to [βCD]) was 
added slowly and the mixture was stirred until no hydrogen gas bubbles were 
visible (Figure 4.1A, step i). Allylbromide was added drop wise to the βCD 
solution using an addition funnel and the reaction was allowed to continue 
overnight in dark (Figure 4.1A, step ii). Next, the volume of βCD-AE mixture was 
reduced using a rotary evaporator. βCD-AE was precipitated in cold acetone twice 
and dried in a vacuum oven. βCD-AE: 1H NMR ((CD3)2SO, 500 MHz): δ – 4.04 
(m, 2H), 5.31 (m, 1H), 5.43 (m, 1H), 6.07 (m, 1H). The exact mass of βCD-AE 
was determined by using mass spectroscopy (Agilent Technologies 6520 Accurate-
Mass Q-TOF LC/MS).  
  Next, thioacetic acid (2-fold excess to [βCD-AE]) was added slowly to 10 
mL of DMF containing 1 g of βCD-AE and photoinitiator Irgacure I-2959 (0.5 
wt%). Photo-conjugation was initiated by UV-light exposure (Omicure S1000, 365 
nm and 10 mW/cm2) for 15 minutes and continued for another 30 minutes after 
supplementing with another portion of 0.5 wt% I-2959 (Figure 4.1A, step iii). 
βCD-thiolacetate was precipitated in cold acetone, filtered, and dried in vacuum 
oven. After re-dissolving βCD-thioacetate in ddH2O (10 mL), while purging with 
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nitrogen, 5 mL of sodium hydroxide (2 N) was added to the solution for 5 minutes 
to hydrolyze the thioacetate group. The solution was neutralized by adding equal 
volume of hydrochloride acid (2 N) solution, followed by dialysis (MWCO 500-
1000) for 2 days at room temperature (Figure 4.1A, step iv). The product βCD-
thiol (βCD-SH) was obtained from lyophilization. βCD-SH: 1H NMR ((CD3)2SO, 
500 MHz): δ – 1.3 (s, 1H), 1.76 (m, 2H), 2.53 (m, 2H), 3.35 (m, 2H). Ellman’s 
assay was performed to determine the concentration of thiol in βCD-SH solution.  
 
Hydrogel fabrication and characterizations: Step-growth thiol-ene hydrogels were 
formed by light mediated photo-click reactions using the following macromers: (1) 
PEG8SH (20 kDa) and βCD-AE, (2) PEG8NB (20 kDa) and βCD-SH, or (3) 
PEG8NB (20 kDa) and DTT. To obtain the best crosslinking efficiency in each 
gelation formulation, the stoichiometric ratio of thiol to ene was maintained at one. 
The concentration of PEGNB was adjusted based on 1H NMR results to afford 
correct norbornene concentrations in the gelation mixtures. Photoinitiator LAP was 
added to the precursor solution (50 μL/gel) to afford a final concentration of 1 
mM. The precursor solution was injected in between two glass slides separated by 
1 mm thick spacers. Hydrogel slabs were prepared by exposing the solution to 365 
nm light at 5 mW/cm2 for 5 minutes. To characterize gel fractions, hydrogels were 
immediately dried in vacuuo after gelation. Dry mass (WDry,1) was measured and 
the dried polymers were incubated in ddH2O at 37 
oC on an orbital shaker for 24 
hours to remove uncrosslinked (sol fraction) species. The swollen gels were dried 
again in vacuuo and weighed to obtain dried polymer weights (WDry,2).  After 
swelling hydrogels in pH 7.4 PBS for two days, the swollen gel weights were 
measured (WSwollen). Gel fractions were obtained by the ratio of the two dry masses 
(i.e., WDry,1/WDry,2). Hydrogel swelling ratios (q) were defined as the ratio of 




Crosslinking efficiency of thiol-ene hydrogel: The average molecular weights 
between crosslinks (𝑀𝑐̅̅ ̅̅ ) of thiol-ene hydrogels can be obtained from the structural 
information of the macromers (i.e., molecular weight and functionality) [63]: 






)      (4.1) 
Here, MWA and MWB represent the molecular weight of PEGNB and βCD-SH, while fA 
and fB are the number of reactive functionality for PEGNB and βCD-SH, respectively. 
With a known 𝑀𝑐̅̅ ̅̅ , the ideal network crosslinking density or density of elastically active 
chains (vc) and polymer volume fraction (v2) can be calculated [64]: 
𝑣𝑐 =
𝑉1
𝑀𝑐̅̅ ̅̅ 𝑣2̅̅ ̅
         (4.2) 
Here, 𝑣2̅̅ ̅ is the specific volume of PEG (0.92 cm
3/g at 37 oC), V1 is the molar volume of 
water (18 cm3/mole) and ᵡ12 is the Flory-Huggins interaction parameter for a PEG-H2O 
system (0.45).  
  In situ photo-rheometry was performed at room temperature on a Bohlin 
CVO 100 digital rheometer equipped with a light cure cell. A macromer solution 
(100 µL) was placed on a quartz plate in the light cure cell and irradiated with light 
(Omnicure S1000, 365 nm, 10 mW/cm2) through a flexible light guide. Light was 
turned on 30 seconds after starting time-sweep measurement (10 % strain, 1 Hz 
frequency, and a gap size of 90 µm) using a 25 mm parallel plate geometry. Gel 
points (i.e., crossover time) were determined at the time when storage modulus 
(G’) surpassed loss modulus (G”).  
  Oscillatory rheometry in strain-sweep mode was used to obtain elastic 
modulus of the hydrogel. At equilibrium swelling (after 48 hours in pH 7.4 PBS), a 
biopsy punch was used to punch out circular gel discs (8 mm in diameter) from the 
gel slabs. Storage moduli of the hydrogels were measured using 8 mm parallel 
plate geometry with a gap size of 800 μm.  The elastic moduli from at least three 
hydrogels for each gel formulation were recorded from the average of the linear 




Uptake and release of curcumin: Thiol-ene hydrogel discs (25 μL; 4.8 mm dia. × 
1.1 mm height) were formed as described above using the following formulations: 
(1) PEG8SH (20 kDa) and βCD-AE, or (2) PEG8SH (20 kDa) and PEGAE (3.4 
kDa). After photo-crosslinking, hydrogels were incubated in 2 mL of curcumin 
suspended in ddH2O (2 mg/mL). After 8 hours, hydrogels were removed from the 
curcumin suspension, rinsed with ddH2O, and placed individually in 1.6 mL tube. 
Hydrogels were individually incubated in 500 µL of DMSO. A portion of DMSO 
(200 µL) was collected and fresh DMSO (200 µL) was added every 24 hours for 
one week. The amount of released curcumin in DMSO was characterized via 
measuring absorbance at 430 nm using a microplate reader (BioTek®, Synergy 
HT).  
  In another experiment, hydrogels were transferred to 4 mL scintillation vials 
containing 400 μL of curcumin solution, which was prepared by dissolving 
curcumin in 0.5 N sodium hydroxide and then diluting with pH 7.4 PBS to a final 
concentration of 2 mg/mL. This pH shifting method to dissolve curcumin was 
adapted from Yadav et al [157]. After incubating the gels at room temperature for 
36 hours, hydrogels were transferred to scintillation vials containing 400 μL of pH 
7.4 PBS to rinse off the curcumin adsorbed on gel surface for 10 minutes. The 
solution was removed from the vials and 1 mL of pH 7.4 PBS was added to each 
vial for curcumin release study. Scintillation vials containing hydrogels were 
placed on an orbital shaker (60 rpm) at room temperature. At specific time points, 
500 μL of solution was collected from each vial, and fresh 500 μL of pH 7.4 PBS 
was added back to the vial. After 48 hours, PBS was completely removed from the 
vials, and 1 mL of DMSO was added to each hydrogel to extract the remaining 
curcumin from the gels. At specific time points, 500 μL of DMSO was collected 
from each vial, and fresh DMSO was added back to the vial to maintain the total 
volume at 1 mL. The absorbance of all collected curcumin samples (from 
curcumin release and DMSO, 200 µL/sample) were measured using a microplate 
reader (BioTek®, Synergy HT) at 430 nm. Measured absorbance was blanked with 
either pH 7.4 PBS or DMSO, and correlated to standard curves with known 
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concentrations of curcumin. The cumulative uptake of curcumin per gel was the 
sum of curcumin released in PBS and DMSO.  
 
Cell encapsulation and viability assay: Mouse insulinoma cells (MIN6, final cell 
density in the gels at 2106 cells/mL) were suspended in polymer solutions 
containing 1 mM LAP and macromers, including: (1) PEG8NB20kDa with DTT, (2) 
PEG8NB20kDa with βCD-SH or (3) PEG8SH20kDa with βCD-AE. Precursor solution 
was exposed to light (365 nm, 5 mW/cm2) for 5 minutes to obtain cell-laden 
hydrogels (25 μl/gel), which were maintained in high-glucose DMEM 
supplemented with 10 % fetal bovine serum (FBS), 50 μM β-mercaptoethanol, and 
1× antibiotic-antimycotic. To characterize cell viability, cell-laden hydrogels were 
incubated in 500 μL Almarblue® reagent (10 % in cell culture medium) at 37 oC 
and 5 % of CO2. After 14 hours of incubation, 200 μl of media were transferred to 
a 96-well plate for fluorescence quantification (excitation: 560 nm and emission: 
590 nm). To obtain qualitative cell viability, cells were stained with a live/dead 
staining kit (Calcein AM stained live cells green and Edithium homodimer stained 
dead cells red) and imaged with confocal microscopy. In each stained hydrogel, 
three images were taken at a step size of 10 µm for a total depth of 100 µm per 
image. The viability of MIN6 cells was quantified as the percent of live cells over 
the total number of live and dead cells.   
 
Insulin secretion from MIN6 cells: Cell function was assayed by glucose 
stimulated insulin secretion (GSIS). Briefly, cell-laden hydrogels were rinsed with 
HBSS, followed by priming in Krebs-Ringer bicarbonate (KRB) buffer (23 mM 
sodium chloride, 1 mM potassium chloride, 4.8 mM sodium bicarbonate, 0.2 mM 
magnesium chloride hexahydrate, 0.2 mM calcium chloride dehydrate, 0.5 mM 4-
(2-hydroxyethyl)-1-piperazineethanesulfonic acid and 0.1 vol% bovine serum 
albumin) containing 2.5 mM glucose for 1 hour at 37 oC and 5 % CO2. Then, the 
gels were incubated with 500 μL of low (2.5 mM) or high (25 mM) glucose KRB 
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for 2 hours each. The high glucose buffer solution was collected and subjected to 
insulin ELISA (Mercodia). 
 
HPLC to evaluate potential LAP/CD complex formation: Isocratic HPLC was performed 
using acetonitrile and 0.05 M of pH 5 phosphate buffer at a ratio of 35 to 65 (vol.%) as 
the mobile phase. βCD was dissolved at different concentrations (0, 1, 5, and 10 mM) in 
the mobile phase. Photoinitiator LAP (dissolved at 0.1 mM in the same solvent as the 
mobile phase without βCD) was injected and run through an analytical C18 column at a 
flow rate of 1 mL/min. The elution of the samples were monitored at 280 nm.   
 
Data analysis & statistics:  All experiments were conducted independently for 
three times and results were reported as mean ± SD. Data was analyzed with 
student’s t-test or two way ANOVA using GraphPad Prism 5 (p < 0.05). 
 
 
4.5  Conclusion 
 
In summary, we have synthesized step-growth thiol-ene photopolymerized 
hydrogel using derivatives of βCD and PEG. We found that thiol-norbornene hydrogels 
crosslinked by CD-SH and PEGNB exhibited faster gelation kinetics and higher 
crosslinking efficiency when comparing with thiol-allylether hydrogels crosslinked by 
PEGSH and CD-AE. Furthermore, the gelation kinetics of thiol-norbornene depended 
highly on the functionality of macromer used. In addition, CD/PEG hydrogels afforded 
higher loading, as well as prolonged and sustained delivery, of hydrophobic curcumin. 
The results of live/dead staining, cell viability assay, and GSIS demonstrated that cell 
viability was maintained in these hydrogels, but in some cases affected by hydrogel 
properties (e.g., stiffness). Future work will focus on utilizing this CD-based radical-






IMPROVING GELATION EFFICIENCY AND 
CYTOCOMPATIBILITY OF VISIBLE LIGHT  
POLYMERIZED THIOL-NORBORNENE HYDROGELS  





 Hydrogels containing biomimetic or therapeutic peptides have been used widely 
for tissue engineering and drug delivery applications. An attractive technique to prepare 
peptide-immobilized hydrogels is photopolymerization, which offers rapid and spatial-
temporally tunable gelation kinetics. Recently, our lab introduced a visible light mediated 
step-growth thiol-norbornene gelation scheme, in which eosin-Y was used as the sole 
photoinitiator. Compared with conventional visible light mediated chain-polymerizations 
where multiple initiator components are required, step-growth photopolymerized thiol-
norbornene hydrogels are more cytocompatible for in situ encapsulation of radical 
sensitive cells, such as pancreatic β-cells. While prior work has demonstrated the efficient 
crosslinking of inert poly(ethylene glycol)-norbornene (PEGNB) hydrogels via visible 
light irradiation, no peptide linkers were used to render the otherwise inert hydrogel 
network bioactive. This contribution explored the crosslinking of various bis-cysteine 
containing peptides with macromer 8-arm PEGNB to form biomimetic hydrogels suitable 
for in situ cell encapsulation. Initial efforts to polymerize thiol-norbornene PEG-peptide 
hydrogels through visible light and eosin-Y mediated crosslinking encountered 
challenges in gelation efficiency. During the optimization processes, we found that the 
addition of soluble tyrosine during polymerization significantly improved the 
crosslinking efficiency of PEG-peptide hydrogels. In addition, soluble tyrosine drastically 
enhanced the cytocompatibility of the resulting PEG-peptide hydrogels, as demonstrated 
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 Ongoing efforts in biomaterials science and engineering are the design of 
bioactive or biomimetic hydrogels for drug delivery and tissue engineering applications. 
Towards this end, hydrogels have been fabricated from naturally derived materials such 
as alginate [166], glycosaminoglycans [167-170], fibrin [171, 172], chitosan [173-175], 
dextran [176], collagen [177], and gelatin [178, 179]. Although hydrogels derived from 
natural matrices are inherently bioactive, it is difficult to tune their bioactivity, 
mechanics, and degradation features [180]. On the other hand, hydrogels prepared from 
purely synthetic polymers, such as polyethylene glycol (PEG) and polyvinyl alcohol 
(PVA), have high tunability in mechanical properties but they do not possess bioactive 
features necessary for promoting cell viability and function [181-183]. Hence, 
biomimetic peptides are routinely used to render the otherwise inert synthetic hydrogel 
bioactive.   
A classical way of immobilizing peptides in synthetic hydrogel is through chain-
growth copolymerization of acrylated macromers and acrylated peptides [184]. 
Alternatively, cysteine containing peptides could be readily crosslinked with acrylated 
macromers through a mixed-mode photopolymerization [185]. For example, Lin and 
Anseth incorporated cysteine-bearing glucagon-like peptide 1 (GLP-1C) into PEG-
diacrylate (PEGDA) hydrogel to improve the viability and insulin secretion of 
encapsulated islets [186]. Alternatively, PEG-peptide hydrogel could be polymerized via 
Michael-type addition between nucleophilic macromers (e.g., acrylate, maleimide, or 
vinyl sulfone) and cysteine-containing peptides [73, 187-189]. For example, Garcia and 
colleagues synthesized bioactive PEG-peptide hydrogels using 4-arm PEG-maleimide 
with cysteine-containing protease-sensitive and integrin-binding peptides (i.e., CRGDS) 
to promote the performance of encapsulated islets in vivo [190]. While these PEG-peptide 
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hydrogels have found various successful applications, limitations and challenges exist.  
For instance, chain-polymerized hydrogels are known to form network containing 
heterogeneous and hydrophobic polyacrylate kinetic chains and high molecular weight 
degradation products [47, 191-193]. On the other hand, while Michael-type hydrogels 
were formed by orthogonal crosslinking, it is difficult to control gelation kinetics and the 
resulting gel network often contains high degrees of structural defects [63]. 
 To overcome some of the above-mentioned issues, Anseth and colleagues 
introduced a new class of PEG-peptide hydrogels formed by radical-mediated step-
growth thiol-norbornene photo-click reaction [38]. In this system, low intensity and long 
wavelength ultraviolet (UV) light (5–10 mW/cm2, 365 nm) is used to generate primary 
radicals from photoinitiator lithium acylphosphinate (LAP) [38]. The radicals deprotonate 
protons from bis-cysteine-containing peptides, thus forming thiyl radicals capable of 
adding to norbornene in a strictly orthogonal fashion. The replenished carbonyl radicals 
are terminated through abstracting additional hydrogens from other thiol-containing 
molecules, hence completing the step-growth cycle. Similar to other photopolymerization 
schemes, the advantages of step-growth thiol-norbornene reaction include rapid, ambient, 
and aqueous reaction conditions, as well as spatial-temporal control over gelation kinetics 
[36, 37, 120]. Furthermore, thiol-norbornene photo-click reaction is not susceptible to 
oxygen inhibition, providing rapid gelation when comparing to acrylate-based chain-
growth photopolymerizations at equivalent macromer concentration and functionality 
[51, 52]. Thiol-norbornene photo-click reactions also hinder disulfide bond formation due 
to radical-mediated cleavage [53], thus increasing the degree of crosslinking and 
improved mechanical properties [38].  
 While current thiol-norbornene hydrogels have shown to be cytocompatible for 
mammalian cells [38, 52, 54-56, 78, 79, 91, 92, 194], the use of UV-light still raised 
concerns of DNA and protein damage [195, 196]. Recently, our lab developed step-
growth thiol-norbornene photo-click PEG-based hydrogels using a visible light source 
(400 nm to 700 nm) and type II photoinitiator eosin-Y [59]. This reaction scheme not 
only preserves all advantages offered by photopolymerization, but also eliminates the use 
of potentially cytotoxic components (i.e., co-initiator and co-monomer) used in the 
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conventional visible light polymerized chain-growth hydrogels. We have shown that 
purely synthetic hydrogels (i.e., PEGNB crosslinked with dithiothreitol, DTT) prepared 
through this reaction are highly cytocompatible for in situ encapsulation of pancreatic β-
cells and human mesenchymal stem cells (hMSCs) [59]. In an attempt to create bioactive 
hydrogels using visible light thiol-norbornene photopolymerization, we replaced DTT 
with bis-cysteine-bearing peptides as the hydrogel crosslinker. However, we found that 
the gelation efficiency was influenced significantly on the sequence of the bis-cysteine 
peptides. During the optimization processes, we discovered that the addition of soluble 
amino acid containing aromatic side chain (e.g., tyrosine, and tryptophan) could improve 
the efficiency of cysteine deprotection to form thiyl radicals, implying that gelation 
efficiency would be different in the presence of soluble amino acids. To test this 
hypothesis, soluble tyrosine was added during visible light polymerization to form PEG-
peptide hydrogel. We systematically studied the gelation kinetics and physical properties 
of PEG-peptide hydrogel. In addition, we evaluated the cytocompatibility of PEG-peptide 
hydrogels to both pancreatic β-cells and isolated mouse islets. 
 
 
5.3. Results and Discussion 
 
5.3.1. Tyrosine-assisted crosslinking of  
thiol-norbornene PEG-peptide hydrogels 
 
 To evaluate the influence of soluble tyrosine on gelation kinetics of PEG-peptide 
hydrogels formed by visible light mediated thiol-norbornene polymerization, hydrogel 
was crosslinked from a bis-cysteine-containing peptide (i.e., CGGGC) and PEG8NB in 
the presence of photoinitiator eosin-Y and visible light exposure (400-700 nm at 70,000 
lux, Figure 5.1A). We found that PEG-peptide hydrogels crosslinked without soluble 
tyrosine had a gel point of about 100 seconds and an ultimate elastic modulus of ~100 Pa 
(Figure 5.1B). The poor gelation was unexpected as we had previously demonstrated 
rapid gelation using PEGNB with an inert crosslinker – DTT [59]. Since visible light-
mediated thiol-norbornene gelation starts with the deprotonation of thiol group by excited 
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eosin-Y, we suspected that the poor gelation efficiency shown in Figure 5.1B might be a 
result of insufficient deprotonation of thiol groups on cysteine residues, which are part of 
the peptide sequence. Furthermore, we found that gelation efficiency depends highly on 
the sequence of the bis-cysteine peptide crosslinkers (Figure 5.2). Indeed, the influence of 
amino acids (e.g., tyrosine, tryptophan) on the half-life of eosin-Y radicals has been 
documented in the literature [195, 197]. Therefore, we hypothesized the addition of 
soluble tyrosine might improve the crosslinking efficiency of visible light-based thiol-
norbornene hydrogels. To test this hypothesis, soluble tyrosine (e.g., 1 mM) was added 
during gelation, which was monitored by in situ photorheometry. With the addition of 
tyrosine, the gel point was five-fold faster (~22 seconds) than the gelation without 
tyrosine. Furthermore, the ultimate elastic modulus increased ten-fold to ~1000 Pa 
(Figure 5.1C). The significant improvement of gelation efficiency in the presence of 
soluble tyrosine was indicative of an accelerated deprotonation of peptide-bound cysteine 


























Figure 5.1. (A) Scheme of visible light and eosin-Y mediated thiol-norbornene gelation. 
(B, C) In situ photorheometry of thiol-norbornene photopolymerization  between 3wt% 
PEG8NB and 6mM CGGGC in the presence of 0 mM (B), and 1 mM of tyrosine (C). G’: 
storage modulus; G”: loss modulus. Eosin-Y: 0.1 mM. Light intensity: 70,000 lux. N = 3. 






















































Figure 5.2. In situ photorheometry of thiol-norbornene photopolymerization  between 
5wt% PEG4NB20kDa and 5 mM of DTT or di-cysteine containing peptide in the presence 
of 0.1 mM eosin-Y. G’: storage modulus. Light intensity: 70,000 lux. N = 3. Error bars 
were omitted for clarity. 
 
 
 To further examine the kinetics of tyrosine-assisted thiol-norbornene reaction, we 
characterized thiol and norbornene consumptions using precursor solution containing 
non-gelling components, including linear PEG-norbornene (PEGdNB. MW: 6 kDa), 
soluble cysteine, eosin-Y, and soluble tyrosine at different concentrations. After visible 
light exposure, the concentration of free thiol remaining in the solution was quantified by 
Ellman’s reagent. Figure 5.3 shows that the rate of thiol conversion was faster at higher 
soluble tyrosine concentrations. At 20 seconds (where gel point was previously 
determined, Figure 5.1C), thiol conversion increased from 22 to 48 % as the 
concentration of tyrosine was increased from 0 to 10 mM (Figure 5.3, right panel). This 
higher thiol conversion rate in the presence of soluble tyrosine could explain the faster 
gel point shown in Figure 5.1C. Regardless of the amount of soluble tyrosine added, all 
non-gelling formulations eventually reached similar thiol conversion (~95% at 300 
seconds of visible light exposure). Even though all non-gelling formulations had similar 
thiol conversion (Figure 5.3), hydrogels formed without soluble tyrosine showed lower 
ultimate elastic modulus than that formed in the presence of soluble tyrosine (Figure 
























5.1B). The faster gelation assisted by soluble tyrosine likely decreased network non-
ideality, and hence higher gel modulus. 
 
   
Figure 5.3. Thiol conversion quantified by Ellman’s assay. The right panel shows the 
shaded region in the left plot. (3.4 wt% PEGdNB6kDa, 12 mM L-cysteine, 0.1 mM eosin-
Y. Tyrosine was added at indicated concentration, N = 3) In collaboration with Hung-Yi 
Liu. 
 
In a separate experiment, we examined the consumption of norbornene in non-
gelling samples using 1H NMR. The areas under the norbornene signature peaks (Figure 
5.4 and 5.5A, norbornene peaks: δ 5.8-6.2 ppm) were used to represent norbornene 
conversion. As the concentration of soluble tyrosine was increased from 0 to 10 mM 
(Figure 5.4A and 5.5B, tyrosine peaks: δ 6.8-7.2 ppm), the area under the norbornene 
signature peaks decreased from 1.86 to 0.37 a.u. (Table 5.1). When compared with 
unreacted PEGNB (Table 5.1, area under norbornene peaks: 7.05 a.u.), the norbornene 
consumption increased from 74 to 95 % when the concentration of soluble tyrosine was 
increased from 0 to 10 mM (Table 5.1). Since the step-growth thiol-norbornene reaction 
is strictly orthogonal (i.e., no homo-polymerization between norbornene groups under 
current experimental conditions), the amount of norbornene consumed after the reaction 
could be attributed to thiol-norbornene coupling.  
 
 



































Figure 5.4. Effect of tyrosine on norbornene conversion determined by 1H NMR using 
non-gelling components: PEGdNB6kDa (3.6 wt%), soluble cysteine (12 mM), eosin-Y (0.1 
mM), and tyrosine from 0 mM to 10 mM (from top to bottom). All prepared with D2O (at 
4.8 ppm). The integration of the areas under the norbornene peaks are reported in Table 
5.1. 
 
Table 5.1. Area of norbornene peaks integrated from 1H NMR results (Figure 5.4). 
 
[Tyrosine] (mM) AreaNorbornene (a.u.) Norbornene conversion (%) 
(-) reaction 0 7.05 0 
(+) reaction 
0 1.86 73.6 
0.1 1.84 74.0 
1 0.70 90.1 










Figure 5.5. 1H NMR of (A) PEGdNB6kDa and (B) L-tyrosine methyl ester. All prepared 
with D2O (at 4.8 ppm). 
 
 
5.3.2. Effect of tyrosine on the 
spectrophotometric properties of eosin-Y 
 
In addition to the alteration of gel properties, we observed a decreased in the redness of 
hydrogels with increasing tyrosine used during gelation (Figure 5.6A). The color of the 
gels was due to the intrinsic color of eosin-Y sequestered within thiol-ene gel network 
during gelation [58]. Since the concentration of eosin-Y was the same across the four 
formulations, the disappearance of redness was potentially due to the quenching of eosin-
Y by tyrosine through a proton-coupled electron transfer process [198, 199]. To verify 
this, we evaluated the spectrophotometric properties of precursor solution containing 
non-gelling components. Before exposing solution to light, the UV/Vis spectra of these 








~0.5 at 516 nm, Figure 5.6B to 5.6D). However, after exposing the non-gelling solution 
to visible light, the reduction in peak absorbance (at 516 nm) with increasing 
concentration of tyrosine (Figure 5.6B to 5.6D, 0.25 to 0.18 a.u. for 0 mM to 10 mM of 
tyrosine, respectively) confirmed the quenching of eosin-Y by tyrosine.  
 
 
Figure 5.6. (A) Photograph of hydrogels at equilibrium swelling. UV-vis spectra of eosin-
Y before (thick blue) and after (thin red) visible light exposure for 5 minutes in the 
presence of PEGdNB, CGGGC, and varied concentrations of tyrosine. Tyrosine 
concentration: (B) 0 mM, (C) 0.1 mM, (D) 1 mM, and (E) 10 mM. Eosin-Y concentration 
in all measurements: 0.1 mM. (3.4 wt% PEGdNB6kDa or 3 wt% PEG8NB20kda, 6 mM 
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5.3.3. Effect of tyrosine, macromer content and  
thiol-to-norbornene ratio on hydrogel properties 
  
 We further investigated hydrogel properties with respect to the concentration of 
soluble tyrosine added during gelation. Here, CGGGC was used as a model peptide for 
gel characterizations. As we increased the concentration of soluble tyrosine from 0 to 1 
mM, gel fraction increased from 50 to 65 % (Figure 5.7A), elastic modulus increased 
from 1 to 3 kPa (Figure 5.7B), and equilibrium swelling ratio decreased from 16 to 10 
(Figure 5.7C). These metrics were indicative of an improved crosslinking in the presence 
of soluble tyrosine.  This implies that the network crosslinking density of these PEG-
peptide hydrogels could be tuned easily with the amount of tyrosine added during 
reaction. Interestingly, further increasing tyrosine from 1 to 10 mM led to a decreased in 
gel fraction, elastic modulus and an increased in swelling ratio. The negative impact of 
high tyrosine concentration on gel properties was unexpected as the results obtained from 
thiol and norbornene consumption (Figure 5.3 and 5.4) showed a monotonic increase of 
functional group conversion. We hypothesize that the increased network non-idealities at 
high tyrosine content (i.e., 10 mM) was likely due to steric inference caused by tyrosine. 
 
 
Figure 5.7. Effect of tyrosine on (A) gel fraction, (B) elastic modulus at equilibrium gel 
swelling, and (C) swelling ratio as a function of time. (3 wt% PEG8NB, 6 mM CGGGC, 
0.1 mM eosin-Y, 400-700 nm light, intensity at 70000 lux, mean ± SD, N = 3). In 
collaboration with Hung-Yi Liu. 
 
 




















































 In addition to tuning gel properties by varying the concentration of soluble 
tyrosine, the physical properties of gels could also tuned by varying PEG8NB 
macromer and the ratio of ene to thiol. As PEG8NB concentration was increased 
from 3 to 9 wt%, there was a 25–fold increase in elastic modulus at equilibrium 
swelling (Figure 5.8A, from 1.3 to 32 kPa). In addition, increasing ratio of 
norbornene to thiol from 0.6 to 1 led to a 26–fold increase in elastic modulus at 
equilibrium swelling (Figure 5.8B, 0.05 to 1.3 kPa). These studies demonstrated 
the high tunability of visible light polymerized step-growth PEG-peptide hydrogels 
[59, 62].  
 
 
Figure 5.8. Effect of macromer concentration (A), and the ratio of norbornene to thiol (B) 
on the elastic modulus of PEG-peptide hydrogels. (3 wt% PEG8NB, 6 mM CGGGC, 0.1 
mM eosin-Y, 400-700 nm light, intensity at 70000 lux, mean ± SD, N = 3). In 





































































5.3.4. Cytocompatibility of PEG-peptide hydrogels 
 
 Next, we evaluated the cytocompatibility of thiol-ene hydrogel crosslinked in the 
presence of soluble tyrosine using in situ encapsulation of pancreatic MIN6 β-cells. 
Thiol-norbornene hydrogels were crosslinked by laminin-derived peptide (i.e., 
KCYIGSRCK) and non-degradable 8-arm PEGNB (PEG8aNB, 20 kDa) with or without 
adding soluble tyrosine. Here, laminin-derived peptide was used to mimic β-cells 
extracellular microenvironment [200-202]. To ensure that matrix stiffness would not a 
confounding factor when evaluating cellular fate, cell-laden hydrogels were formulated to 
have similar modulus (Figure 5.9, ~2 kPa), which was achieved through adjusting 
stoichiometric ratio of thiol to norbornene (i.e., R[thiol]/[ene] = 1 for gelation without 
tyrosine and 0.85 gelation with 1 mM of tyrosine). Hydrogels crosslinked with PEG8aNB 
were hydrolytically stable throughout the course of study (Figure 5.9). One day after cell 
encapsulation, live/dead staining was performed and more than 90 % of cells were 
stained green indicating that hydrogels were cytocompatible for in situ encapsulation of 
β-cells. However, we observed slightly more dead cells (stained red) when encapsulation 
was performed without tyrosine (Figure 5.10A, top). Regardless of the initial cell 
viability, β-cells formed cell spheroids after 10 days of culture in both formulations 
(Figure 5.10A, bottom). In addition, AlamarBlue® reagent was used to quantify 
metabolic activity of the cells encapsulated within the hydrogels. Compared with cells 
encapsulated in the absence of tyrosine, cells encapsulated in the presence of tyrosine 
showed higher cell metabolic activity throughout the course of study (Figure 5.10B). 
Most importantly, β-cells encapsulated in the presence of tyrosine had higher insulin 
secretion than cells encapsulated without the addition of tyrosine (Figure 5.10C, 2-fold 
and 3-fold higher on day 1 and 10, respectively). We examined the expression of insulin 
(ins) and pancreatic duodenal homeobox-1 (pdx1) on the mRNA level. These two genes 
were chosen because of their importance in glycemic control and in proliferation of 
pancreatic β-cells [203, 204]. The mRNA expression of ins and pdx1 showed that the 
addition of tyrosine did not create adverse influence on β-cells (Figure 5.11). Together, 
the addition of soluble tyrosine increased cell viability, insulin secretion, and did not 
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negatively impact beta cell-related gene expression. These results were most likely due to 
faster gelation kinetics, which reduced exposure time of radicals on radical sensitive β-
cells.  
 
Figure 5.9. Effect of tyrosine concentration on the degradability of PEG-peptide 
hydrogels. All gel formulations contained β-cells at 5×106 cells/mL, 3.5 wt% PEG8aNB, 



































Figure 5.10. Effect of tyrosine on the cytocompatibility of MIN6 β-cells. (A) 
Representative confocal z-stack images of MIN6 cells stained with live/dead staining kit 
on day 1 (Scales: 100 μm). (B) Cells viability as assessed by Alamarblue® reagent. (C) 
Glucose stimulated insulin secretion (25 mM of glucose) normalized by cell metabolic 
activity. * indicates comparison between day 1 and day 10, while % indicates comparison 
between 0 to 1 mM of tyrosine, p < 0.05. All gel formulations contained β-cells at 5×106 
cells/mL, 3.5 wt% PEG8aNB, KCYIGSRCK, 0.1 mM eosin-Y, and 400-700 nm light at 























































































































Figure 5.11. Effect of tyrosine on the mRNA expression of MIN6 β-cells. mRNA level of 
(A) Ins and (B) Pdx1 evaluated by qPCR. Actβ was used as a house keeping gene. * 
indicates comparison between day 1 and day 10, while % indicates comparison between 0 
to 1 mM of tyrosine, p < 0.05. All gel formulations contained β-cells at 5×106 cells/mL, 
3.5 wt% PEG8aNB, KCYIGSRCK, 0.1 mM eosin-Y, and 400-700 nm light at 70000 lux. 
Ratio of [thiol] to [norbornene] was 1 and 0.85 for 0 mM and 1 mM of tyrosine, 
respectively.  
 
 In addition to encapsulate β-cells, in situ cell encapsulation was also performed on 
islets isolated from CD1 mice. One day post encapsulation, live/dead images of 
encapsulated islets showed a significant amount of cell death (cells stained red) when 
islets were encapsulated without tyrosine (Figure 5.12A). When islets were challenged 
with glucose, only islets encapsulated in the presence of tyrosine showed a significant 
enhancement in insulin secretion (Figure 5.12B, 4-fold increased with 1 mM of tyrosine 
used). Collectively, the decreased cell viability and insulin-secreting function was 



















































Figure 5.12. Effect of tyrosine on the cytocompatibility of CD1 mouse islets. (A) 
Representative confocal z-stack images of islets stained with live/dead staining kit on day 
1. (B) Glucose stimulated insulin secretion normalized by ATP content per gel (day 1). 
Gel formulations: 3.5 wt% PEG8aNB, KCYIGSRCK, 0.1 mM eosin-Y, and 400-700 nm 
light at 70000 lux (Scales: 100 μm). 
 
 
5.4. Materials and Methods 
 
Materials: 8-arm PEG and PEG-amide were purchased from JenKem Technology USA. 
Fmoc-protected amino acids, HBTU, and HOBT were purchased from AnaSpec. Linear 
PEG (6 kDa), 5-norbornene-2-carboxylic acid, N,N’-dicyclohexylcarbodiimide (DCC), 





































membranes and other chemicals were obtained from Fisher Scientific unless noted 
otherwise.  
 
PEGNB synthesis: Linear PEG-norbornene (PEGNB, 6 kDa) and PEG-octa-norbornene 
(PEG8NB, 20 kDa and 40 kDa) was synthesized following an established protocol [120]. 
In brief, 5-norbornene-2-carboxylic acid (5-fold excess of OH group) and coupling 
reagent DCC (2.5-fold excess of OH group) were added to anhydrous dichloromethane 
(DCM). The mixture was purged with nitrogen and stirred at room temperature for 1 
hour. The resulting norbornene anhydride was filtered into an addition funnel and added 
slowly to a flask containing PEG, DMAP (0.5-fold of OH group), and pyridine (0.5-fold 
of OH group) dissolved in anhydrous DCM. The flask was purged with nitrogen, kept on 
ice and allowed to react overnight in dark. The reaction was repeated for the second time 
to improve the functionalization of norbornene on PEG. The product was precipitated in 
cold ethyl ether and collected by filtration. PEGNB product was re-dissolved in double 
distilled water (ddH2O) and proceed with dialysis for 2 days using slightly acidic ddH2O 
(pH 6.8) to prevent ester hydrolysis of PEG8NB. The pure product was obtained from 
lyophilization (degree of norbornene substitution >85 %). PEGNB: 1H NMR (CDCl3, 500 
MHz): δ – 4.25 (m, 2H), 5.98 (m, 1H), 6.23 (m, 1H). 
 To synthesize hydrolytically stable PEG-amide-norbornene (PEGaNB), 
norbornene acid (5-fold excess to amine groups) was first activated by HBTU/HOBT 
(5.5-fold excess to amine group) in dimethylformamide (DMF) for 3 minutes. With 
nitrogen gas purging, N,N-Diisopropylethylamine (DIEA, 6-fold excess to amine group) 
was added to the activated norbornene acid solution and stirred for 5 minutes.  The 
solution was added drop wise to a two-neck flask containing PEG-octa-amine in DMF. 
After overnight reaction at room temperature, the product was precipitated in cold ethyl 
ether. After drying in vacuuo, PEGaNB product was re-dissolved in water and dialyzed 
for 2 days.  1H NMR (Bruker 500) was used to confirm the degree of PEG 




Peptide synthesis: All peptides were synthesized in an automated microwave-assisted 
peptide synthesizer (CEM Discover SPS attached with Liberty 1).  Crude peptides were 
cleaved from resins using phenol, trifluoroacetic acid (TFA), triisopropylsilane (TIS), and 
ddH2O. Cleaved peptides were precipitated in cold ethyl ether, collected through 
centrifugation, dried in vacuuo, and purified by reverse phase HPLC (PerkinElmer Flexar 
system). Peptide identity was confirmed by mass spectrometry (Agilent Technologies 
Model 1200-6520). 
 
Hydrogel fabrication and characterization: Step-growth thiol-norbornene hydrogels were 
formed by visible light mediated photo-click reactions using PEG8NB and di-cysteine 
peptide (i.e., Cys-Gly-Gly-Gly-Cys or CGGGC) in the presence of 0.1 mM of eosin-Y. 
L-tyrosine methyl ester (i.e., soluble tyrosine) was added in selected formulations. The 
concentration of PEG8NB was adjusted based on 1H NMR results to afford correct 
norbornene concentrations in the gelation mixtures. The precursor solution was injected 
in between two glass slides separated by 1 mm thick spacers or in 1 mL syringe mold 
with an open tip. Hydrogel crosslinking was initiated by exposing the solution to 400-700 
nm light at 70,000 lux (equivalence of 10mW/cm2 at 550nm) for 5 minutes. To 
characterize gel fractions, hydrogels were immediately dried in vacuuo after gelation. 
Dry mass (WDry,1) was measured and the dried polymers were incubated in ddH2O at 37 
oC on an orbital shaker for 24 hours to remove un-crosslinked (sol fraction) species. The 
swollen gels were dried again in vacuuo and weighed to obtain second dried polymer 
weights (WDry,2). Gel fractions were obtained by the ratio of the two dry masses (i.e., 
WDry,1/WDry,2). In selected experiments, gels were allowed to swell in pH 7.4 PBS for two 
days prior to obtaining swollen gel weights (WSwollen). Hydrogel swelling ratios (q) were 
defined as the ratio of swollen gel mass to the second dried polymer mass (i.e., 
WSwollen/WDry,2). 
 
Rheometry: In situ photo-rheometry was performed at room temperature on a Bohlin 
CVO 100 digital rheometer equipped with a light cure cell. A macromer solution (100 
µL) was placed on a quartz plate in the light cure cell and irradiated with the visible light 
106 
 
(400-700 nm, 70,000 lux) through a flexible light guide. Light was turned on 30 seconds 
after starting time-sweep measurement (5 % strain, 1 Hz frequency, and a gap size of 90 
µm) using a 25 mm parallel plate geometry. Gel points (i.e., crossover time) were 
determined at the time when storage modulus (G’) surpassed loss modulus (G”).  
  Oscillatory rheometry in strain-sweep mode was used to obtain elastic 
modulus of the hydrogel. At equilibrium swelling (after 48 hours in pH 7.4 PBS), a 
biopsy punch was used to punch out circular gel discs (8 mm in diameter) from the 
gel slabs. Storage moduli of the hydrogels were measured using 8 mm parallel 
plate geometry with a gap size of 750 μm. The elastic moduli from at least three 
hydrogels for each gel formulation were recorded from the average of the linear 
viscoelastic region (LVR, linear portion of G’ plotting against % strain). 
 
Thiol and norbornene consumption: Eosin-Y (at 0.1 mM) and various components (i.e., 
PEGdNB6kDa, L-cysteine HCl, and L-tyrosine methyl ester) were dissolved in PBS (pH 
7.4) and exposed to visible light (400-700 nm, 70,000 lux). Concentrations of the 
components were equivalent to those used in gelation studies (final concentration of 
norbornene and thiol = 12 mM). To determine thiol-consumption, portions of non-gelling 
solution throughout 5 minutes of light exposure were collected, and the content of the 
free thiol was immediately assayed with Ellman’s reagent buffer. The thiol concentration 
presented at the specific time was measured against a known standard (i.e., L-cysteine 
HCl). In a separate experiment, non-gelling precursor solutions (1 mL each) were 
lyophilized after exposing to light for 5 minutes. 1H NMR was used to evaluate the 
signature peaks for norbornene (D2O was used for dissolution). The areas of the 
norbornene peaks (δ 5.8-6.2 ppm) were obtained and all integrated areas obtained were 
further compared to the area under the norbornene peaks for pure PEGdNB at the same 
macromer concentration (Figure 5.5A and Table 5.1). Norbornene consumption was 
calculated using the difference in the area of the norbornene peaks before and after 




Spectrophotometric properties: Eosin-Y (at 0.1 mM) and various components (i.e., 
PEGdNB6kDa, L-cysteine HCl, and L-tyrosine methyl ester) were dissolved in PBS (pH 
7.4) and exposed to visible light for 5 minutes.  Non-gelling components were used (e.g., 
PEGdNB and L-cysteine) to prevent gelation and to facilitate solution-based UV/Vis 
spectrometric measurements.  Concentrations of the components were equivalent to those 
used in gelation studies (final concentration of norbornene and thiol = 12 mM). Using a 
microplate reader (BioTek Synergy HT) in UV/Vis absorption mode (wavelength 
between 400 and 700 nm at 2 nm increments), the absorbance spectra of the non-gelling 
solutions were measured before and after the exposure of light. To prevent saturation in 
absorbance, solution was diluted so the final concentration of eosin-Y is 0.02 mM. 
 
Cell encapsulation and viability: Mouse insulinoma cells (MIN6, final cell density in the 
gels at 5106 cells/mL) were suspended in polymer solutions containing 0.1 mM eosin-Y, 
PEG8aNB, and di-cysteine peptide (i.e., Lys-Cys-Tyr-Ile-Gly-Ser-Arg-Cys-Lys or 
KCYIGSRCK) with and without tyrosine. Precursor solution was exposed to the same 
visible light for 5 minutes to obtain cell-laden hydrogels (20 μl/gel), which were 
maintained in high-glucose DMEM supplemented with 10 % fetal bovine serum (FBS), 
50 μM β-mercaptoethanol, and 1× antibiotic-antimycotic. Similar procedure was 
performed to encapsulate isolated CD1 islets. CD1 mice (7- to 8-week old) were obtained 
from Charles River and islets were isolated following established protocol [125]. 
Permission for animal studies was approved by Indiana University School of Medicine 
IACUC (protocol #10235-MD/R). Islets encapsulated gels were maintained in RPMI-
1640 media supplemented with 10 % FBS, and 1× antibiotic-antimycotic. To 
characterize cell viability, cell-laden hydrogels were incubated in 500 μL Almarblue® 
reagent (10 % in cell culture medium) at 37 oC and 5 % of CO2. After specific hours of 
incubation (16 hours for MIN6), 200 μl of media were transferred to a 96-well plate for 
fluorescence quantification (excitation: 560 nm and emission: 590 nm). To obtain 
qualitative cell viability, cells were stained with a live/dead staining kit (Calcein AM 
stained live cells green and Edithium homodimer stained dead cells red) and imaged with 
confocal microscopy (Olympus FV-1000 Laser Scanning Biological Microscope). For 
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MIN6 encapsulated gels, three images were taken at a step size of 10 µm for a total depth 
of 100 µm per image. For islets encapsulated gels, images were taken at a step size of 5 
µm for a total depth of 50 µm per image.  
 
Insulin secretion from islets: To access glucose stimulated insulin secretion 
(GSIS), cell-laden hydrogels were rinsed with HBSS, followed by priming in 
Krebs-Ringer bicarbonate (KRB) buffer (23 mM sodium chloride, 1 mM 
potassium chloride, 4.8 mM sodium bicarbonate, 0.2 mM magnesium chloride 
hexahydrate, 0.2 mM calcium chloride dehydrate, 0.5 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid and 0.1 vol% bovine serum albumin) containing 2.5 
mM glucose for 1 hour at 37 oC and 5 % CO2. Then, the gels were incubated with 
500 μL of low (2.5 mM) or high (25 mM) glucose KRB for 2 hours each. The low 
and high glucose buffer solutions were collected and analyzed using mouse insulin 
ELISA kit (Mercodia). Cell viability was further quantified by CellTiter Glo® 
assay (Promega). Insulin secretion obtained from ELISA was normalized by the 
respective ATP content of the cell-laden hydrogels.  
 
mRNA isolation and rtPCR: In preparation for RNA isolation, cell-laden gels were 
rapidly frozen using liquid nitrogen and stored in -80 oC until use. Collected samples 
were processed following NucleoSpin® RNA protocols (Clontech). The concentrations 
of pure RNA were determined using NanoDrop 2000 Spectrophotometer (Thermo 
Scientific). RNA was reverse transcribed into cDNA using PrimeScriptTM RT Reagent 
Kit (Clontech). SYBR Premix Ex Taq II kit (Clontech) was used for quantitative real 
time PCR (Applied Biosystems 7500 Fast Real-Time PCR machine) for selected genes 
(Table 5.2). The results for gene of interests were internally normalized by a house 
keeping gene (i.e., β-actin), and further normalized to control (i.e., gels crosslinked 






Table 5.2. Mouse primer sequences used in real time PCR. 
 














Data analysis: All experiments were conducted independently for three times and results 
were reported as mean ± SD. Data was analyzed with student’s t-test using GraphPad 





In summary, we have synthesized visible light mediated step-growth thiol-
norbornene photopolymerized hydrogel using multi-arm PEGNB and di-cysteine 
containing peptides. We found that thiol-norbornene hydrogels crosslinked in the 
presence of soluble tyrosine exhibited faster gelation kinetics and higher crosslinking 
efficiency. Furthermore, the network crosslinking depended highly on the amount of 
tyrosine, concentration of macromer and the ratio of norbornene to thiol used. In addition, 
a series of cell viability tests revealed that hydrogels crosslinked in the presence of 
tyrosine preserved the viability and insulin secreting function of pancreatic β-cells and 
mouse islets. Together, this data show that PEG-peptide hydrogels formed by visible light 





TUNING STIFFNESS OF CELL-LADEN  




6.1  Abstract 
 
 We report a dynamic hydrogel system with on-demand tunable matrix stiffness. 
The hydrogels are formed by thiol-allylether photo-click reaction using thiolated 
poly(vinyl alcohol) (TPVA), 4-arm poly(ethylene glycol)-allylether (PEG4AE), and 
mono-functional β-cyclodextrin-allylether (βCDAE). Adamantane-functionalized 4-arm 
PEG (PEG4AD) is used to stiffen hydrogels, whereas unmodified βCD is used to induce 
gel softening. The stiffening and softening processes are fully reversible and these 
hydrogels are ideal for investigating the effect of matrix mechanics on cell fate processes. 
 
 
6.2  Introduction 
 
Dynamic cell-laden hydrogels are increasingly developed for studying the 
influence of matrix mechanics on cell fate processes [208]. For example, stiffness of a 
cell-laden hydrogel could be irreversibly decreased through user-controlled or cell-
mediated matrix degradation [62, 209-211]. On the other hand, the crosslinking density 
of some hydrogels could be increased irreversibly by applying secondary photo-
crosslinking in the presence of the primary cell-laden hydrogel network [212, 213]. One 
common feature of the aforementioned strategies is that the changes in matrix mechanics 
are irreversible, hence these matrices might not be ideal for studying the impact of 




dynamic matrix stiffening on cellular mechanobiology [214, 215]. Here, we report a 
dynamic cell-laden hydrogel platform with post-gelation tunability in matrix stiffness, 
which is achieved by providing reversible host-guest interactions within the cell-laden 
hydrogel network. The hydrogels are prepared by a single step light-mediated thiol-
allylether photo-click reaction using thiolated poly(vinyl alcohol) (TPVA), 4-arm 
poly(ethylene glycol)-allylether (PEG4AE), and β-cyclodextrin-allylether (βCDAE). The 
thiol-allylether photo-click gelation is compatible with in situ cell encapsulation and the 
stiffness of the hydrogel are tuned through non-covalent host-guest interactions between 
network-immobilized βCD and soluble 4-arm PEG-adamantane (PEG4AD) supplied on 
demand. The stiffening/softening processes are fully reversible by means of incubating 
gels in PEG4AD and βCD solutions, respectively. More importantly, the magnitude of 
the stiffness change can be tuned from several hundreds to a few kilo-Pascals, a range 
relevant to many cell fate processes [216]. 
The influence of matrix biomechanical properties on cell fate has been intensively 
studied in the past decade [214, 217-221]. In particular, the differentiation of 
mesenchymal stem cells (MSC) has been shown to depend on substrate stiffness [153, 
216, 217, 222]. Furthermore, mechanical properties of tissues have been implicated in 
invasion and drug resistance of cancer cells [214, 215, 223-225], as well as in 
myofibroblastic activation of hepatic stellate cells and valvular interstitial cells [68, 226-
228]. It is commonly accepted that a cell culture matrix should present relevant 
mechanical properties for maintaining appropriate cell phenotype [163, 229], and the 
ultra-stiff tissue culture plastics (TCP) fail to provide such a physiologically relevant 
context. On the other hand, commercially available three-dimensional (3D) cell culture 
matrices are mechanically unstable and with limited tunability in stiffness post-gelation 
[230]. In view of the challenges facing these cell culture platforms, the past decade has 
witnessed increasing interests in 3D cell culture matrices with tailor-made and 
dynamically tunable biophysical and biochemical properties [231, 232]. To affect cell 
fate processes in 3D, synthetic polymeric cell-laden hydrogels can be designed to 
undergo different modes of degradation, including hydrolytic, enzymatic, or photolytic 
degradation [62, 209-211]. Hydrogels can also be hardened through secondary radical-
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mediated chain-growth or step-growth photopolymerizations [212, 213]. For example, the 
presence of excess unreacted vinyl groups in the primary hydrogel network permits 
additional crosslinking reactions for network stiffening [212, 213]. Although this 
approach readily increases hydrogel crosslinking density and stiffness, additional radicals 
formed during secondary photocrosslinking might be a confounding factor. While these 
dynamic material systems have demonstrated improvements over the conventional static 
cell culture systems, the stiffness of these hydrogels can only be decreased or increased 
irreversibly.  
A hydrogel system with reversibly tunable matrix crosslinking and stiffness 
should be highly desirable in the study of cellular mechanobiology. An approach suitable 
for achieving reversible matrix crosslinking is the supramolecular host-guest interactions, 
which have been used extensively to enhance solubility of hydrophobic drugs and to 
design self-healing polymers [233-235]. For example, the hydrophobic cavity of 
macrocyclic molecules (e.g., CD, and cucurbit[8]uril) can reversibly bind to a variety of 
hydrophobic drug molecules (e.g., curcumin, paclitaxel, doxorubicin, etc.) [235-239]. In 
another example, light-responsive supramolecular hydrogels formed from azobenzene-
functionalized hyaluronan (Azo-HA) and CD-functionalized polymers were used to 
encapsulate proteins and cells when Azo is in trans conformation, which permits CD/Azo 
complexation and network formation [240, 241]. Upon light exposure, Azo undergoes 
trans-to-cis isomerization, resulted in the disruption of CD/Azo complexes and the 
liberation of proteins and cells [240, 241]. Supramolecular ’host-guest‘ interactions 
between adamantane (AD) and CD have also been exploited for forming cell-laden 
hydrogels exhibiting injectable and shear-thinning properties [242-245]. To the best of 
our knowledge, however, supramolecular chemistry and host-guest interactions have not 
been exploited to induce reversible post-gelation hydrogel stiffening and/or softening in 




Figure 6.1. (A) Schematics of thiol-allylether photo-click reaction using photoinitiator 
LAP and long-wave ultraviolet light exposure (365 nm, 10 mW/cm2). (B-D) Chemical 
structures of the major macromers used, including TPVA (B), PEG4AE (C), and βCDAE 
(D).  
 
Here, we report the design of cell-laden hydrogels with reversibly tunable 
stiffness by means of non-covalent and reversible host-guest interactions between 
pendant βCD and soluble PEG4AD. The primary hydrogel network was prepared from 
thiol-allylether photopolymerization (Figure 6.1A) using TPVA (Figure 6.1B) and 
PEG4AE (Figure 6.1C) as the macromolecular crosslinkers. βCD-allylether (βCDAE, 
Figure 6.1D) was co-polymerized in the primary hydrogel network as pendant ‘host‘ 
motifs that can form additional physical crosslinks in the presence of soluble PEG4AD. 
Thiol-allylether photopolymerization was used to create the primary hydrogel network 
due to its orthogonal crosslinking, as well as its facile and quantitative immobilization of 













































‘host’ molecules (i.e., βCDAE, Figures 6.1D and 6.2) interact with user-supplied ‘guest’ 
macromolecules (i.e., PEG4AD), resulting in increased hydrogel crosslinking density and 
elastic modulus. When needed, this ‘stiffened’ hydrogel can be ‘softened’ 
thermodynamically or through competitive binding provided by soluble βCDs. In 
principle, the process of hydrogel stiffening or softening can be repeated indefinitely if no 
other degradation mechanism exists. 
 
 
Figure 6.2. (A) 1H NMR of βCD (top), and βCD-AE (bottom). Prepared with D2O (at 
4.79 ppm).  (B) Mass spectroscopy of βCDAE.  
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6.3  Results and Discussion 
 
To demonstrate the efficient crosslinking of orthogonal thiol-allylether hydrogels, 
we conducted in situ photorheometry using TPVA and PEG4AE in the absence (Figure 
6.1E) or presence of βCDAE (Figure 6.1F). After the light was switched on, the thiol-
allylether (TPVA-PEGAE) gelation occurred very rapidly (gel point: ~3 seconds) and the 
time required to reach 95% of ultimate stiffness was only ~2 minutes. The addition of 
βCDAE in the precursor solution led to a higher ultimate gel elastic modulus (G’ ~ 2.4 
kPa) and higher gel fraction (Figure 6.3A). One potential explanation for the higher 
initial gel stiffness in the presence of βCDAE (Figure 6.1F) is that some βCDAE might 
have more than two allylether motifs that contribute to additional crosslinking (Figure 
6.2B). Another potential is that immobilized bulky βCDAE decreased chain flexibility of 
linear TPVA, thereby increasing hydrogel stiffness. It is worth noting that, compared 
with similar light-mediated step-growth gelation using PEG-thiol and PEG-allylether, the 
gelation using TPVA and PEG4AE was faster and with the use of a significantly lower 
macromer contents (i.e., 1.6 wt% of PEG4AE with 2.5 wt% TPVA) [150, 246]. This is 
likely due to the use of multi-functional TPVA (~10 thiol groups per molecule of 
PVA6kDa). Overall, the use of efficient thiol-allylether photoclick reaction produces a 
stable βCD-immobilized hydrogel network for subsequent evaluation of hydrogel 




Figure 6.3. Estimation of βCD-immobilization post-gelation: (A) gel fraction; (B) 
normalized thiol concentration measured by Ellman’s assay; and (C) ATR-FTIR 
characterization. 2.5 wt% TPVA at 0.8 mM PEG4AE and 27.6 mM βCDAE 




















































Wavenumber (cm-1) TPVA + CD TPVA + CDAE
a 3700-3000 27.3  1.5 39.8  0.8




To ensure that βCDAE was successfully immobilized within the TPVA-PEG4AE 
hydrogel network, we prepared hydrogels using off-stoichiometric ratio of allylether to 
thiol (i.e., R[allylether]/[thiol] = 0.8). When compared with gelation using unmodified βCD, 
significantly lower free thiol was detected in the presence of βCDAE, indicative of 
βCDAE immobilization in the primary hydrogel network post-gelation (Figure 6.3B). 
ATR-FTIR characterization results also confirmed the immobilization of βCDAE in the 
thiol-allylether hydrogel network (1.5-fold and 34-fold increase in the areas under alcohol 
and carbonyl peaks, respectively. Figure 6.3C). We also conducted additional in situ 
photorheometry experiments to show that the gelation was indeed due to orthogonal 
thiol-allylether reaction between TPVA and PEG4AE and not a result of 
homopolymerization of allylether-macromers (i.e., βCDAE and PEG4AE, Figure 6.4A) 
or supramolecular ‘threading’ of βCDAE/TPVA or βCDAE/PEG4AE (Figure 6.4B). 
Another affirmation that βCD/PVA threading did not occur in this thiol-allylether 
gelation system (completing within 5 minutes) is that the threading events are typically 
achieved under extreme conditions such as high temperature (e.g., 90 oC), high βCD 
concentration (e.g., 70 wt%) or long incubation time (e.g., 2-72 hours) [247-250]. 
 
 
Figure 6.4. In situ photorheometry showing storage modulus (G’) and loss modulus (G”) 
of thiol-allylether photopolymerization (A) at 2.5wt% TPVA and 27.6 mM βCDAE; and 
(B) at 0.8 mM PEG4AE and 27.6 mM βCDAE in the precursor solution (1 mM LAP, 
365nm light at 10 mW/cm2). Light was turned on at 30 seconds (dotted line).  













































We hypothesized that the reversible association and dissociation between 
network-immobilized βCD and soluble multi-functional PEG4AD (MW: 10kDa) 
macromer (Figures 6.5A) could increase the crosslinking density, and hence elastic 
modulus, of this hydrogel [235, 251]. We first investigated the tunability of hydrogel 
stiffness by incubating βCD-immobilized hydrogels in solution containing PEG4AD 
(Figure 6.5B) at different concentrations. Since these thiol-allylether hydrogels were 
stiffened via host-guest supramolecular assembly, the amount of soluble PEG4AD 
supplemented to the βCD-immobilized hydrogels would affect the extent of host-guest 
interactions, and hence the degree of stiffening (Figure 6.5C). As expected, hydrogel 
stiffness increased from 1.6- to 2-fold when the concentration of PEG4AD was increased 
from 2.5 wt% (i.e., 10mM AD) to 5 wt% (i.e., 20mM AD) (Figure 6.5D). However, 
further increasing PEG4AD content to 10 wt% (i.e., 40mM AD) did not yield an even 
higher degree of stiffening because the concentration of AD at this condition exceeded 
the total βCD concentration (i.e., 27.6mM). As a result, additional PEG4AD became 
‘pendant’ and did not contribute to the formation of additional crosslinking. We further 
evaluated the stiffening effect using TPVA-PEG4AE hydrogels with different initial gel 
stiffness. At a fixed TPVA content (2.5 wt%), increasing PEG4AE concentration yielded 
hydrogels with higher initial elastic modulus (Figure 6.5E, 0.9 kPa to 4 kPa for 0.6 mM 
to 1.1 mM of PEG4AE, respectively). These hydrogels were separately stiffened using 
PEG4AD solution. Regardless of the starting equilibrium shear modulus, the stiffening 
process yielded hydrogels with significantly increased final elastic moduli (Figure 6.5E, 
2.3 kPa to 6.5 kPa). To evaluate the elastic nature of these hydrogels, we conducted 
frequency sweep oscillatory rheometry after incubating gels in the absence (Figure 6.6A) 
or presence (Figure 6.6B) of soluble PEG4AD. Results show that gel storage modulus 
(G’) dominated loss modulus (G”) over the range of frequency tested, indicating the 










Figure 6.5. (A) Schematic of a reversible βCD/AD complex. (B) Chemical structure of 
PEG4AD. (C) In situ stiffening of hydrogel through incubating βCD-containing gel in 
PEG4AD solution. Gel softening could be achieved by incubating the stiffened gel in 
PBS or solution containing unmodified βCD. (D) In situ stiffening using PEG4AD (10 
kDa) at different concentration. (E) Tuning the initial stiffness and dynamic stiffening of 
hydrogels through adjusting the content of PEG4AE in the pre-polymer solution. (Mean 
± SD, N = 3, * indicates p<0.05). 
 












































Figure 6.6. Frequency sweep rheometry of thiol-allylether hydrogels before (A), and after 
(B) incubating in PEG4AD. Error bars omitted for clarity. 
 
Although results so far show that the range of elastic moduli of hydrogels before 
and after PEG4AD-stiffening could be tuned in a physiologically relevant range (i.e., 
elastic moduli ranging from 0.03 to 6 kPa) [216], it is necessary to determine the long-
term stability of the in situ stiffened hydrogels. As shown in Figure 6.7A, PEG4AD-
induced gel stiffening (from ~2 to 3.5 kPa) could be maintained for more than one month 
as long as the βCD-immobilized hydrogels were incubated in PEG4AD-containing 
solution. After one month, the moduli of PEG4AD-stiffened gels started to decrease, 
which could be attributed to the hydrolysis of ester bonds in PEG4AD macromers (Figure 
6.5B). In a separate group where the stiffened hydrogels were transferred back to PBS 
following in situ stiffening, elastic moduli of the stiffened hydrogel decreased gradually 
(Figure 6.7A, from 3.5 to 2.2 kPa in 48 days), most likely a result of the thermal 
relaxation of the host-guest interaction. Control experiments show that hydrogels 
incubated in either 4-arm PEG or PBS solution had minimal change in stiffness 
throughout the study, suggesting that the specificity of βCD/AD binding is essential in 
the stiffening of the hydrogels.  
 








































Figure 6.7. (A) Effect of gel treatment conditions on the elastic modulus of thiol-
allylether hydrogel. Right panel: timeline for the treatments of hydrogels. (B) Reversibly 
tuning the elastic moduli of thiol-allylether hydrogel. 5 wt% of PEG4AD (10 kDa) and 5 
wt% of 4-arm PEG (10 kDa), respectively. Right panel: timeline for the treatments of 
hydrogels (2.5 wt% TPVA, 0.8 mM PEG4AE and 27.6 mM βCDAE, Mean ± SD, N = 3, 
* indicates p<0.05).   
 
βCD/AD interactions are non-covalent, reversible, and can be disrupted through 
thermal relaxation or through a competitive kinetic binding process. We have 
demonstrated that PEG4AD-stiffened gels took weeks to soften when placed in PBS 
(Figure 6.7A). This softening effect could be attributed to the dissociation and removal of 
PEG4AD from pendant βCD over time. Alternatively, a faster gel softening could be 
achieved by incubating the PEG4AD-stiffened hydrogels in solution containing 
unmodified βCD. Soluble βCD competes with PEG4AD for binding to immobilized 
βCD. As a result, the elastic moduli of PEG4AD-stiffened hydrogels incubated in βCD 












































































solution decreased from 3.1 to 2.3 kPa within 40 hours (Figure 6.7B). When the in situ 
softened hydrogels were incubated in PEG4AD solution for another 40 hours, the 
hydrogels were stiffened again and the process of stiffening/softening was repeatable 
(Figure 6.7B). For gels incubated in either PBS or 4-arm PEG/βCD, the stiffness 
remained steady throughout the study (Figure 6.7B).  
 Comparing to other hydrogels with stiffening or softening potential [62, 209-213], 
our dynamic thiol-allylether hydrogel offers a wider range of stiffness tunability (i.e., 
from hundreds to thousands Pascals). For example, Rosales et al. prepared step-growth 
Michael-type hydrogels crosslinked with azobenzene-modified peptides that undergo 
trans-to-cis isomerization upon UV/visible light exposure [252]. The conformational 
change in azobenzene-containing peptide leads to changes in crosslinker length, and 
hence gel stiffness was controlled depending on light irradiation conditions. However, the 
magnitude of the elastic modulus change reported was about 100-200 Pa. Another 
difference between our approach and the light-responsive azobenzene-modified hydrogel 
or the secondary photo-crosslinking system was that the stiffening/softening of thiol-
allylether hydrogels is a more gradual process (i.e., hours in our system vs. minutes in 
previous stiffening processes) that should be more relevant to the time scale of most cell 




Figure 6.8. Effect of thiol-allylether hydrogel stiffness on the cytocompatibility of MIN6 
β-cells. (A) Representative confocal z-stack images of MIN6 cells stained with live/dead 
staining kit on day 1 and day 10. MIN6 cells were encapsulated (2×106 cells/mL) in thiol-
allylether hydrogels. (B) Cells viability as assessed by Alamarblue® reagent. (C) 
Normalized insulin mRNA expression on day 10. All gel formulations contained β-cells 
at 2×106 cells/mL, 2.5wt% TPVA, 0.6/0.8/1mM PEG4AE and 27.6 mM βCDAE, 1 mM 
LAP, and 365 nm light at 5 mW/cm2 (Scales: 200 μm).  
 
To evaluate the cytocompatibility of this dynamic thiol-allylether hydrogel 

























































cell density (2×106 cells/mL). This cell density was used because a previous work has 
shown that MIN6 cells encapsulated in radical-mediated chain-growth photopolymerized 
PEG-diacrylate hydrogels did not survive well if the cell density was below 5×106 
cells/mL [149]. We found that the step-growth thiol-allylether polymerization is highly 
cytocompatible for MIN6 β-cells as the encapsulated cells were viable regardless of the 
initial gel elastic modulus (0.6, 1.5 or 3.5 kPa, Figure 6.8A) [52, 246]. Furthermore, the 
encapsulated cells all formed multi-cell spheroids after 10 days of culture. While higher 
metabolic activity was detected in cells encapsulated in softer gel at day-10 post-
encapsulation (Figure 6.8B), insulin mRNA level was lower in these cells (Figure 6.8C). 
Specifically, insulin expression was ~1.7-fold and 3.5-fold for soft and stiff gel, 
respectively (1-fold: insulin expression in cells encapsulated in 0.6 kPa gels). Another 
interesting phenomenon is that the sizes of cell spheroids formed within the stiffer 
hydrogels were noticeably smaller than those formed in the softer hydrogels, most likely 
because the stiffer hydrogels have higher crosslinking density that restricts the growth of 
the cell spheroids. The difference in cell spheroid sizes might be another confounding 
factor affecting insulin expression. 
The higher insulin expression from cells encapsulated in stiffer hydrogel does not 
concord with a previous study conducted by Desai and colleagues, who cultured MIN6 β-
cells using polymeric microwells with various moduli [163]. The conclusion from that 
study was that softer microwells promoted insulin expression in MIN6 β-cells and 
isolated islets. The discrepancy between current study and the reported results was likely 
due to the difference in cell-matrix interactions, because microwell does not provide 
uniform matrix contact for the cells. Furthermore, the function of β-cells in static thiol-
allylether hydrogels might be affected by different amounts of radicals formed during cell 
encapsulation, different gel elastic moduli post-gelation, and/or different cell spheroids 
sizes.  
 Using the thiol-allylether dynamic hydrogel system, it is possible to study the 
influence of gel stiffness on cell fate without introducing additional radicals post cell 
encapsulation and without the confounding factor of cell spheroid sizes. Here, we 
encapsulated MIN6 β-cells in βCD-immobilized thiol-allylether hydrogels and cultured 
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the cells for 5 days to allow the formation of multi-cell spheroids (Figure 6.11A, 
condition ii). After in situ gel stiffening (Figure 6.9, from 1.8 kPa to 2.5 kPa), the 
viability of cells was evaluated using live/dead staining. Compared to cell-laden gels that 
did not undergo stiffening, cells encapsulated in PEG4AD stiffened gels had slightly 
more cell death as revealed by the confocal images of live/dead stained MIN6 β-cells 
(Figure 6.11A). Quantitative ATP assay showed a reduction (not statistically significant) 
in total intracellular ATP when cell-laden hydrogels were subjected to PEG4AD (Figure 
6.11B, ~250 and 220 pmol of ATP/gel with and without exposure to PEG4AD, 
respectively). Since the concentration of PEG4AD selected was within the non-cytotoxic 
range (Figure 6.10A) and cells remained viable post-stiffening (Figure 6.11A), it is 
highly plausible that the increased gel stiffness altered intracellular metabolism/signalling 
that led to a lower intracellular ATP content. More interestingly, MIN6 β-cells 
encapsulated in PEG4AD-stiffened gels had a 1.5-fold higher insulin mRNA level when 
compared with cells encapsulated in gels that did not undergo stiffening process (Figure 
6.11C). Results from control experiments show that PEG or PEG4AD did not induce up-
regulation of insulin mRNA (Figure 6.10B). The effect of softening on cell fate was 
evaluated by incubating PEG4AD-stiffened gels in media containing βCD for 3 days 
(Figure 6.9). Compared to control gels that were not exposed to PEG4AD or βCD (Figure 
6.11A, condition iii), MIN6 cells encapsulated in hydrogel that underwent 
stiffening/softening had similar viability (Figure 6.11A, condition iv) and ATP content 
(Figure 6.11B, ~180 pmol/gel). More importantly, there was a reduction in insulin 
mRNA expression after in situ softening (Figure 6.11C, from 1.5 to 1.2-fold for condition 
(ii) and (iv), respectively), suggesting that the effect of matrix mechanics on insulin 




Figure 6.9. Effect of PEG4AD and βCD on the stiffening and softening of thiol-allylether 
hydrogel via CD-AD interactions. All gel formulations contained 2×106 cells/mL β-cells, 
2.5 wt% TPVA, 0.8 mM PEG4AE and 27.6 mM βCDAE, 1 mM LAP, and 365 nm light 




Figure 6.10. (A) Effect of PEGAD on the cytocompatibility of MIN6 β-cells. Cells 
viability as assessed by MTT. PEGAD (10 kda) was used. (B) Effect of PEG4AD (10 
kDa) on the Ins mRNA expression. Cells were all cultured on 2D TCP. 














































































Figure 6.11. Effect of PEG4AD stiffening and βCD softening on the cytocompatibility 
and functions of MIN6 β-cells. (A) Representative confocal z-stack images of MIN6 cells 
stained with live/dead staining kit on day 8 with or without PEG4AD stiffening (i & ii) 
and on day 11 with or without βCD softening (iii & iv). (B) Cells viability as assessed by 
CellTiter Glo® reagent. (C) Insulin mRNA expression was normalized to condition (i). 
All gel formulations contained 2.5 wt% TPVA, 0.8 mM PEG4AE and 27.6 mM βCDAE, 
1 mM LAP, 2×106 cells/mL, and 365 nm light at 5 mW/cm2 (Scales: 200 μm). Mean ± 
SD, N = 3, * or # indicate p<0.05 compared to condition i and iii, respectively. 
 
 Since the stiffening and softening of cell-laden thiol-allylether hydrogel did not 
introduce additional radicals and did not change the size of cell spheroids significantly, it 
is indicative that the insulin expression was affected in large part due to matrix stiffness. 
We hypothesize that the up-regulation of insulin in cells encapsulated in stiffened 
hydrogels was a collective result of altered cell-cell interactions [253-255], hypoxia-
related gene expression [256, 257], or stiffness-induced mechanotransduction in the cells. 
In the stiffened gels, tighter gel networks might constrain the encapsulated cells to make 
close contact with their neighboring cells. Furthermore, the stiffened matrix may alter 
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other molecular targets downstream of mechanosensing pathways. While further 
investigations are required to elucidate the molecular mechanisms by which matrix 
stiffness affects mechanotransduction in cells encapsulated in this dynamic hydrogel, the 
current work demonstrates the concept and potential of using supramolecular host-guest 
interactions to tune matrix stiffness in cell-laden hydrogels. 
 
 
6.4  Materials and Methods 
 
Materials: 4-arm PEG-OH (10 and 20 kDa) was purchased from JenKem Technology 
USA. Poly(vinyl alcohol) (PVA, 6 kDa), 3-mercaptopropionic acid (MPA), βCD, 1-
adamantaneacetic acid and all other chemicals were obtained from Fisher Scientific 
unless noted otherwise. 
 
Synthesis of βCDAE, LAP, TPVA and PEG macromers: Poly(ethylene glycol)-tetra-
allylether (PEG4AE, 20 kDa), poly(ethylene glycol)-adamantane (PEG4AD, 10 kDa), 
allylether functionalized βCD (βCDAE),[246] and photoinitiator lithium acylphosphinate 
(LAP) were synthesized using established protocols without modifications.[38] 
Functionalized βCDAE was analyzed with 1H NMR (Figure 6.2A) and mass 
spectrometry (Agilent Technologies 6520 Accurate-Mass Q-TOF LC/MS, Figure 6.2B). 
TPVA was synthesized followed established protocol with modified purification 
method.[258, 259] Briefly, mixture of hydrochloric acid (5 ml, 12 N) and MPA (25 mL) 
was added slowly into PVA (5 g) pre-dissolved in 50 mL ddH2O at 60 
oC. After 24 hours 
of reaction (60 oC), the product was transferred to a dialysis bag (MWCO: 3600 Da, 
Spectrum lab) and dialyzed for 3 days in slightly acidic ddH2O (pH 6.5). The TPVA 
product was recovered and lyophilized. The degree of thiolation was quantified by 








Figure 6.12. (A) Degree of TPVA thiolation measured by Ellman’s assay. (B) 1H NMR 































 4-arm PEG-allylether (PEG4AE, 20 kDa) was synthesized following a published 
protocol. Briefly, 4-arm PEG (20 kDa) was dissolved in anhydrous toluene, and dried 
with evaporation by reduced pressure. Dried PEG was re-dissolved in anhydrous 
tetrahydrofuran (THF). Sodium hydride (1.5-fold excess of hydroxyl group) was added 
slowly to the PEG solution under continuous nitrogen purging at 40 °C. Upon complete 
liberation of hydrogen gas, allylbromide (6-fold excess of hydroxyl group) was added 
slowly to the solution. After overnight reaction in dark, sodium bromide salt was filtered 
off to obtain a PEG4AE solution. PEG4AE was precipitated in cold ethyl ether, filtered 
and dried in vacuuo. The purity of PEG4AE product was verified with H1 NMR in CDCl3 
(Figure 6.13A, 90 %, Bruker 500). 4-arm PEG-adamantane (PEG4AD, 10 kDa) was 
synthesized following an established protocol. In brief, 4-arm PEG and glassware were 
dried overnight in vacuum oven. Under continuous stirring and purging with nitrogen, 
dried PEG was dissolved in anhydrous dichloromethane (DCM). A required amount of 1-
adamantaneacetic acid (2-fold excess of hydroxyl group), 4-dimethylaminopyridine 
(DMAP, 1-fold of hydroxyl group) and N,N-diisopropylcarbodiimide (DIC, 4-fold excess 
of hydroxyl group) were added to PEG solution. After an overnight reaction, PEG4AD 
was filtered, precipitated in cold ethyl ether and dried in vacuuo. Dried PEG4AD was 
redissolved in ddH2O, filtered and transferred to a dialysis bag. After two days of dialysis 
in slightly acidic ddH2O (~pH 6.8), PEG4AD were freeze-dried. The purity of PEG4AD 














Figure 6.13. 1H NMR of (A) PEG4AE (20 kDa), and (B) PEG4AD (10k Da). All 
dissolved in CDCl3 (at 7.26 ppm).  
























Hydrogel fabrication and reversible stiffening: Thiol-allylether hydrogels (45 
μL/gel) were formed by light mediated photo-click reactions using precursor 
solution prepared in the order of mixing pH 7.4 PBS, 1 mM LAP, PEG4AE, 
βCDAE and TPVA. Immediately after mixing the components, solution was 
injected in between two glass slides separated by 1 mm thick spacers. Hydrogel 
slabs were prepared by exposing the solution to 365 nm light at 10 mW/cm2 for 5 
minutes. The elastic moduli (G’) of hydrogels were measured after 48 hours of 
swelling in PBS at 37 oC. Hydrogel stiffening was achieved by incubating βCD-
immobilized hydrogels in PEG4AD solution (48-well plate, 200 μL/well/gel) and 
placed on an orbital shaker (130 rpm) for 40 hours unless mentioned otherwise. 
After measuring the stiffness of hydrogels, gels were placed in either pH 7.4 PBS 
or 1 wt% of βCD (48-well plate, 400 μL/well/gel) for softening.  
 
Rheometry:  For rheometrical property measurements, hydrogel discs (8 mm in diameter 
and 1 mm in height) were fabricated as described previously and placed in pH 7.4 PBS 
for 48 hours.  Frequency sweep (0.01 to 10 Hz, at 1 % strain) and strain sweep (0.1 % to 
5 %, at 1 Hz frequency) oscillatory rheometry were performed on a Bohlin CVO 100 
digital rheometer.  Shear moduli of the hydrogels were measured using a parallel plate 
geometry (8 mm) with a gap size of 750 μm. The average of elastic moduli obtained from 
the linear viscoelastic region (LVR) was reported. In situ gelation rheometry for 
hydrogels was conducted in a light cure cell using a parallel plate geometry (25 mm) at 
room temperature. Briefly, the macromer solution was placed on a quartz plate in the 
light cure cell, and irradiated with liquid light guide (365 nm, 10 mW/cm2). Light was 
turned on 30 seconds after the time sweep in situ rheometry (5 % strain, 1 Hz frequency, 
and a gap size of 90 μm). Gel point was determined at the time when G’ surpassed loss 
modulus (G”).  
 
βCDAE immobilization efficiency: Following hydrogel preparation procedure as 
described previously, hydrogels (30 µL/gel) were fabricated using syringes with cut-off 
tips as molds. Hydrogels were synthesized in the presence of βCDAE or non-modified 
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βCD. To detect the concentration of non-reacted thiol after photopolymerization reaction, 
immediately after gel polymerization, hydrogels were individually placed in 48-well plate 
containing Ellman’s reaction buffer (300 µL/well/gel). After 30 minutes of incubation at 
room temperature, these collected Ellman’s reaction buffer was compared against a 
standard curve with known cysteine concentrations. In a separate experiment, 
immediately after polymerization, hydrogels were dried in a desiccator and the first dry 
mass were obtained. After incubating gels in ddH2O for a day to allow sol fraction to 
leach out, gels were dried and the second dry mass were measured. Gel fraction of 
hydrogel was reported as the percentage of the second dry weight to the first dry weight. 
Furthermore, ATR-FTIR was used to detect the presence of immobilized βCDAE in the 
hydrogel. 
 
Cytocompatibility of βCD and PEGAD: MIN6 β-cells were cultured on 96-well tissue 
culture treated plate for two days at 37 oC and 5 % of CO2. β-cells were treated with 
different concentrations of soluble βCD and PEGAD (10 kDa) dissolved in media (high-
glucose DMEM with L-glutamine and sodium pyruvate, 10 % FBS, β-mercaptoethanol 
and antibiotic-antimycotic) at 37 oC and 5 % of CO2. After incubating for 40 hours, βCD 
and PEGAD containing media were removed, cells were supplemented with media 
containing 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) at 37 oC 
and 5 % of CO2 (100 μL/well). After 4 hours of incubation, dimethyl sulfoxide (DMSO, 
100 μL/well) was added to wells, and plate was further incubated in oven for 10 minutes 
(at 60 oC). The absorbance was measured at 540 nm and DMSO was used as a blank.  
 
Cell encapsulation and cytocompatibility: MIN6 β-cells (final density 2×106 cells/mL) 
was suspended in polymer solutions (i.e., PBS, LAP, PEG4AE, βCDAE and TPVA) and 
exposed to light for 5 minutes (365 nm at 5 mW/cm2). These MIN6 cell-laden hydrogels 
(20 μl/gel) were cultured in growth media (high-glucose DMEM with L-glutamine and 
sodium pyruvate, 10 % fetal bovine serum (FBS), β-mercaptoethanol and antibiotic-
antimycotic) and maintained at 37 oC and 5 % of CO2. Fresh media was changed every 
two days. After a week, cell-laden hydrogels were transferred to 48-well plate (2 
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gels/well), supplemented with media containing 5 wt% of PEG4AD (200 μL/well), and 
placed on a rotary platform in 37 oC and 5 % of CO2 for 3 days. For quantitative cell 
viability study, cell-laden hydrogels were incubated in 500 μL Alamarblue® reagent (10 
% in cell culture medium; AbD Serotec) at 37 oC and 5 % of CO2. After 16 hours of 
incubation, 200 μl of incubated Alamarblue® media was transferred to a transparent 96-
well plate. Using a microplate reader, the Alamarblue® fluorescence (excitation: 560 nm 
and emission: 590 nm) due to cell metabolic activity was determined. Cell viability was 
quantified by CellTiter Glo® assay (Promega). In addition, confocal imaging (FV1000 
Laser Scanning Biological Microscope) of cell-laden hydrogels were stained with 
Biotium live/dead kit (Calcein AM stained live cells green and Ethidium homodimer-1 
stained dead cells red) for an hour and washed with HBSS for 10 minutes. The confocal 
imaging was performed with a step size of 10 μm for a total image thickness of 100 μm. 
In preparation for RNA isolation, cell-laden gels were rapidly frozen using liquid 
nitrogen and stored in -80 oC until use. Collected samples were processed following 
NucleoSpin® RNA protocols (Clontech). The concentrations of pure RNA were 
determined using NanoDrop 2000 Spectrophotometer (Thermo Scientific). Reverse 
transcription PCR (rt-PCR) was performed on Applied Biosystems 2720 Thermal Cycler 
to convert RNA into cDNA using PrimeScriptTM RT Reagent Kit (Clontech). cDNA 
samples were further prepared with SYBR Premix Ex Taq II kit (Clontech) and primers 
(Sigma-Aldrich, Table S1) for quantitative real time PCR (Applied Biosystems 7500 Fast 











Table 6.1. Mouse primer sequences used in real time PCR. 











6.5.  Conclusion 
 
In summary, we have synthesized a step-growth thiol-allylether photopolymerized 
hydrogel containing chemically immobilized βCD that complexes with soluble PEG4AD 
to form a dynamic hydrogel network with tunable stiffness. Thiol-allylether hydrogels 
crosslinked by TPVA, PEG4AE, and βCDAE exhibited rapid gelation kinetics and high 
tunability in crosslinking density. The process of gel stiffening/softening was repeatable 
by exposing gels in either PEGAD or βCD solutions, respectively. Most importantly, 
MIN6 β-cell fate is regulated in hydrogels that are stiffened in situ. Thiol-allylether 
hydrogel with immobilized βCD provided a wider range of stiffness tunability over 
existing dynamic hydrogels, and should be of great interest for studying the influence of 
biomechanical properties on cell fate processes.  
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CHAPTER 7  




 In summary, thiol-ene hydrogels formed by radical mediated 
photopolymerizations have emerged as a versatile biomaterial platform for controlled 
release of therapeutics and tissue engineering applications. Thiol-ene hydrogels have 
improved network crosslinking than the conventional chain-growth PEGDA and step-
groth Michael-type addition hydrogels. Type I and type II photoinitiator can be used to 
prepared thiol-ene hydrogels via UV light or visible light irradiation, respectively. In 
addition, thiol-ene hydrogels can be rendered completely non-degradable, or degradable 
only by hydrolysis, proteolysis, photolysis, or by the combination of different 
mechanisms. The diverse gelation and degradation of thiol-ene hydrogels offer  
researchers a new platform to design hydrogel matrices suitable for protein delivery and 
three dimensional cell culture. Using this thiol-ene hydrogelation scheme, the following 
objectives were met: 
 
Objective 1: Establish a visible light mediated interfacial thiol-ene 
photopolymerization for microencapaulation of islets. I have developed a visible light-
mediated thiol-norbornene interfacial coating process to prepare step-growth conformal 
hydrogel coating on islet surface. Using MIN6 -cell aggregates as a model, I evaluated 
the parameters critical in determining coating thickness (e.g., molecular weight of 
PEGdSH, polymerization time, and macromer concentration). The results of live/dead 
staining and GSIS demonstrated high cytocompatibility of thiol-ene hydrogel coating on 
murine islets. This visible light mediated thiol-ene interfacial photopolymerization 
provides an alternate coating option and should be of great interest to the field of islet 
transplantation. Future work will focus on modifying thiol-ene gel formulation to create 
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multi-functional immuno-isolation barrier, and ondetermining the inflammatory response 
and long-term efficacy of the transplanted coated islets on maintaining euglycemia. 
 
Objective 2: Synthesize biomimetic and anti-inflammatory thiol-ene hydrogel for 
macroencapsulation of β-cells. Step-growth thiol-ene photopolymerized hydrogel was 
synthesized using derivatives of βCD and PEG. Thiol-norbornene hydrogels crosslinked 
by βCD-SH and PEGNB exhibited faster gelation kinetics and higher crosslinking 
efficiency when comparing with thiol-allylether hydrogels crosslinked by PEGSH and 
βCD-AE. Furthermore, the gelation kinetics of thiol-norbornene depended highly on the 
functionality of macromer used. In addition, βCD/PEG hydrogels afforded higher 
loading, as well as prolonged and sustained delivery, of hydrophobic curcumin. The 
results of live/dead staining, cell viability assay, and GSIS demonstrated that cell viability 
was maintained in these hydrogels, but in some cases affected by hydrogel properties 
(e.g., stiffness).  
 
 In addition, I have explored the crosslinking of various bis-cysteine containing 
peptides with macromer 8-arm PEGNB to form biomimetic hydrogels suitable for in situ 
cell encapsulation. Initial efforts to polymerize thiol-norbornene PEG-peptide hydrogels 
through visible light and eosin-Y mediated crosslinking encountered challenges in 
gelation efficiency. During the optimization processes, I found that the addition of 
soluble tyrosine during polymerization significantly improved the crosslinking efficiency 
of PEG-peptide hydrogels. Furthermore, soluble tyrosine drastically enhanced the 
cytocompatibility of the resulting PEG-peptide hydrogels, as demonstrated by in situ 
encapsulation and culture of pancreatic β-cell line (MIN6) and primary mouse islets.  
 
Objective 3: Investigate the effect of biomechanical stimulus on the survival of β-
cells. A step-growth thiol-allylether photopolymerized hydrogel containing chemically 
immobilized βCD that complexes with soluble PEG4AD to form a dynamic hydrogel 
network with tunable stiffness. Thiol-allylether hydrogels crosslinked by TPVA, 
PEG4AE, and βCDAE exhibited rapid gelation kinetics and high tunability in 
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crosslinking density. The process of gel stiffening/softening was repeatable by exposing 
gels in either PEGAD or βCD solutions, respectively. Most importantly, MIN6 β-cell fate 
is regulated in hydrogels that are stiffened in situ. Thiol-allylether hydrogel with 
immobilized βCD provided a wider range of stiffness tunability over existing dynamic 
hydrogels, and should be of great interest for studying the influence of biomechanical 
properties on cell fate processes. Future work will focus on evaluating the molecular 
mechanisms by which matrix stiffness affects mechanotransduction, cell-cell interactions 
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2. Shih H, and Lin C. “Tuning stiffness of cell-laden hydrogel by reversible host-guest 
interactions” American Chemical Society National Conference, San Diego, CA, Mar. 
2016. Oral presentation. 
3. Shih H, and Lin C. “Tuning stiffness of cell-laden hydrogel by photo-reversible host-
guest interactions” Society for Biomaterials Annual Meeting and Exhibition, 
Charlotte, NC, Apr. 2015. Oral presentation. 
4. Shih H, and Lin C. “Interfacial thiol-ene photochemistry for forming orthogonal 
immune-isolation coating on pancreatic islets” Society for Biomaterials Annual 
Meeting and Exhibition, Denvor, CO, Apr. 2014. Oral presentation. 
5. Hao Y, Shih H, Munoz Z, Kemp AD, and Lin C. “Visible light cured thiol-vinyl 
hydrogels with tunable degradation for 3D cell culture” Society for Biomaterials 
Annual Meeting and Exhibition, Denvor, CO, Apr. 2014. Oral presentation. 
6. Munoz Z, Shih H, and Lin C. “Gelatin hydrogels formed by orthogonal thiol-
norbornene photochemistry for cell encapsulation” Society for Biomaterials Annual 
Meeting and Exhibition, Denvor, CO, Apr. 2014. Poster presentation. 
7. Shih H, and Lin C. “Visible light-mediated multi-scale thiol-ene hydrogels for 3D 
cell culture” Society for Biomaterials Regional Conference, Cleveland, OH, Oct. 
2013. Oral presentation.  
8. Shih H, Fraser AK, and Lin C. “Visible light-mediated multi-scale thiol-ene 
hydrogels for 3D cell culture” Society for Biomaterials Annual Meeting and 
Exhibition, Boston, MA, Apr. 2013. Oral presentation. 
9. Fraser AK, Shih H, and Lin C. “Preparation of microgels using thiol-ene “click” 




10. Ki CS, Shih H, and Lin C. “Facile preparation of photodegradable hydrogel by 
photo-mediated crosslinking” Society for Biomaterials Annual Meeting and 
Exhibition, Boston, MA, Apr. 2013. 
11. Fraser AK, Shih H, and Lin C. “Preparation of photopolymerized dual-layer 
microgels” 18th IUURC, IUPUI, Indianapolis, IN, Nov. 2012. 
12. Shih H, and Lin C. “Manipulating thiol-ene hydrogel degradation for controlling 3D 
cell morphogenesis” Material Research Society Spring Conference, San Francisco, 
CA, Apr. 2012. Oral presentation. 
13. Shih H, and Lin C. “Dual-mode degradable hydrogels formed by thiol-ene photo-
click reactions” Society for Biomaterials Regional Conference, West Lafayette, IN, 
Oct. 2011. Poster presentation. 
14. Raza A, Shih H, and Lin C. “Thiol-ene hydrogels for generation and recovery of 
pancreatic beta-cell spheroids” Society for Biomaterials Regional Conference, West 
Lafayette, IN, Oct. 2011. 
15. Shih H, Gregson KS, and Gregory RL. “Dental materials and oral bacterial 
interactions” Biomedical Engineering Society Annual Conference, Austin, TX, Oct. 
2010. Poster presentation. 
16. Shih H, Gregson KS, and Gregory RL. “Impact of oral bacteria on the surface and 
mechanical properties of a dental material” American Association for Dental 
Research Annual Conference, Washington, DC, Mar. 2010. Poster presentation. 
 
Leadership Experience  
2013 – 2014  
President of Biomedical Engineering Graduate Student Association (IUPUI) 
 
2010 – 2011  
Treasurer of Society of Biomedical Engineering 
Office of Student Involvement Leadership Consultant (IUPUI) 
 
Community Services  
 American Chemical Society National Conference (2014) 
 Minority Engineering Advancement Program (2008-2013)  
 Preparing Outstanding Women for Engineering Roles Summer Program (2010-2014) 
 IUPUI Student Organizations Leadership Development Workshops (2009-2011)  
 
 
